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ABSTRACT 
The endothelial layer, which covers the internal surface of the arteries and arterioles, 
plays a vital role in maintaining adequate perfusion through constantly adjusting arterial 
diameter to metabolic demand. This explains why endothelial dysfunction is known as 
an early marker of cardiovascular diseases. Flow mediated dilation (FMD) is a well-
known technique to assess non-invasively the endothelial function. During FMD, blood 
circulation of a large artery, such as the brachial, is blocked for five minutes and then 
suddenly released leading to reactive hyperemia due to increase in the diameter of the 
tested artery. Such a change in the artery diameter can be measured using high 
frequency ultrasound imaging. As the FMD-ultrasound technique is remarkably 
operator dependent and requires a very expensive setup, it has been limited to clinical 
research only. The main objective of the present study is to assess the endothelial 
performance via a forward model between central blood pressure (CBP) and radial 
Photoplethysmography (RPPG). To this end, CBP, RPPG and ultrasound images of the 
brachial artery are non-invasively and simultaneously recorded from 93 subjects. 
Ultrasound images are analyzed by an automatic edge-detection software providing a 
precise measurement of the arterial diameter. Using a threshold of 10% dilation, 
subjects are categorized into normal (FMD≥10%) and impaired endothelium groups 
(FMD<10%). Using system identification techniques, an individual CBP-RPPG model 
is estimated for each subject. The fitness of the individual model's output is used as a 
feature for discriminating normal from unhealthy subjects. The difference between the 
fitness during baseline (before blockage) and after cuff release is found to be a powerful 
criteria with results showing 86% and 96% of sensitivity and specificity when compared 
to FMD-ultrasound as reference. These results support the possibility of using this PPG-
based technique to assess the endothelial performance non-invasively, hence opening 
the way towards a practical, low-cost alternative to perform mass-screening. 
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ÜBERSICHT 
Die Endothelschicht, die die innere Oberfläche der Arterien und der Arteriolen bedeckt, 
spielt eine wesentliche Rolle bei der Aufrechterhaltung einer adäquaten Perfusion durch 
einen konstanten anpassenden arteriellen Durchmesser zur metabolischen Nachfrage. 
Dies erklärt, warum endotheliale Dysfunktion als frühzeitiger Marker von Herz-
Kreislauf-Erkrankungen bekannt ist. Durchfluss-vermittelte Dilatation (FMD) ist in 
diesem Zusammenhang eine bekannte Technik, um die endotheliale Funktion nicht-
invasiv zu bewerten. Bei FMD wird der Blutfluss einer großen Arterie getestet, indem 
sie zunächst für fünf Minuten blockiert und anschließend wieder geöffnet wird. Die 
dadurch verursachte reaktive Hyperämie durch die erweiterte Aterie kann mittels 
Ultraschall vermessen werden. Da die FMD-Ultraschalltechnik bemerkenswert 
bedienerabhängig ist und eine sehr aufwändige Einrichtung erfordert, wurde sie nur auf 
die klinische Forschung beschränkt. Das Ziel der vorliegenden Studie ist es, die 
Endotherialfunktion mittels einer Transferfunktion zwischen CBP und 
Photoplethysmo-graphie (RPPG) zu bewerten. Zu diesem Zweck sind CBP-, RPPG- 
und Ultraschallbilder der Arteria brachialis nicht-invasiv von 110 Probanden 
aufgenommen worden. Die Ultra-schallbilder werden durch die Verwendung einer 
automatischen Kantenerfassungssoftware analysiert. Bei einer Schwelle von 10% 
Dilatation werden die Probanden in normale (FMD> 10%) und beeinträchtigte 
Endothelgruppen eingestuft. Unter Verwendung von System-identifikationstechniken 
wird ein individuelles CBP-RPPG-Modell für jedes Individuum ermittelt. Die Fitness 
der einzelnen Modell-Resultate wird für die Unterscheidung von normalen von 
ungesunden Probanden verwendet. Der Unterschied zwischen der Fitness und der 
Fiteness in der Baseline (vor der Blockade) und nach der Öffnung ist signifikant 
verglichen mit dem FMD-Ultraschall als Referenz. Die Ergebnisse dieser Studie zeigen, 
dass die Untersuchung der Endothelfunktion durch das PPG-basierte Verfahrenauch 
nicht invasiv erfolgen kann und eine praktische und kostengünstigere Alternative 
darstellen. 
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CHAPTER I 
INTRODUCTION 
1.1 INTRODUCTION 
CV disease plays an important role on human’s mortality and morbidity to what extent 
that it is globally known as the world largest killer (Finegold et al. 2013; Go et al. 2014; 
Nowbar et al. 2014). The silent nature of CV diseases makes it more complicated 
compared to other chronic and death-leading diseases. This matter usually leads to late 
detection so that in many cases, CV abnormalities can only be controlled but not fully 
treated. Short-breathing, sweating, obesity and thoracic pain could be addressed as the 
most prevalent symptoms of CV diseases. 
 Nowadays, the possibility of capturing CV abnormalities has been significantly 
increased via high-tech technologies. Such achievement can be known as a result of 
contribution of other related disciplines. For instance, CV engineering -in both invasive 
and noninvasive aspects- could provide novel approaches for early detection of CV 
abnormalities (Abdolrazaghi et al. 2010; Haverich & Wilhelmi 2011; Nugent & 
Edelman 2003). Obviously, engineering-based technologies can enhance the reliability 
and accuracy of diagnostic techniques while improving the quality of therapy. However, 
there are still considerable cases in which CV diseases cannot be easily detected.  
 The CV system is consisted of the heart, vasculature and blood which cover 
human bodies from head to toe via closed network of vessels. Such a ubiquitous system 
circulates blood across the body from individual's birth to death. It is responsible for 
supporting the entire body with nutrition and oxygen while removing generated by-
products and deoxygenated blood along each cardiac cycle.  
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 Many factors could affect the process of blood circulation and CV performance. 
As such, physical activity, eating style, smoking, excessive alcohol consumption and 
mental stress can be mentioned (Harvey 2006). Surprisingly, genetics also play an 
incredible role on existing and progressing of CV (Go et al. 2014). Aging is another 
natural factor that gradually change the performance of CV system along individual’s 
lifetime (North & Sinclair 2012). In this process, the vascular stiffness is gradually 
increased leading to local blockage and further abnormalities (Higashi et al. 2012).  
 Unquestionably, vascular abnormalities play a significant role on CVD 
(Custodis et al. 2010). As such, endothelial disorders can be mentioned (Taimeh et al. 
2013). Endothelial layer is a thin layer of cells which are located across the interior 
surface of vessels. Blood clotting, inflammation, vasodilatation and vasoconstriction 
can be mentioned as some of vital features which are handled by the endothelial layer 
(Sandoo et al. 2010). In addition, the process of vascular tuning is mainly handled by 
this layer along each cardiac cycle (Lerman & Zeiher 2005). Like other CV disease, the 
endothelial-related abnormalities do not have any significant symptom(s) and thus, 
cannot be detected in early stages. This is a very general abnormality particularly among 
elderly people. Such abnormality is scientifically known as the endothelial dysfunction. 
Once it occurs, the physiological process of vascular tuning fails and disturbs the 
circulation causing further CV abnormalities to arise (Solomon et al. 2003). 
 The endothelial activity can be clinically evaluated via High Sensitive C-
Reactive Protein test (HSCRP) which represents the value of "C protein" in blood 
sample. However, this parameter is not exclusively used for assessing the endothelial 
performance. In other words, inappropriate value of C protein in blood sample may 
show malfunctioning of other organs (e.g. liver, kidney) rather than the ED (Recio-
Mayoral et al. 2011). Therefore, the HSCRP test is not known as an exclusive test to 
assess the endothelial performance.   
 Alternatively, the endothelial activity can be evaluated via ultrasound imaging. 
In this technique, the endothelial layer is physiologically stimulated by blocking the 
blood circulation in a large artery (e.g. radial artery). This technique is known as the 
flow mediated dilation (FMD) in which blood circulation in an artery is fully occluded 
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via a pressure cuff. Soon after five minutes, the pressure cuff is suddenly released 
resulting in retrieving blood circulation while providing a state of reactive hyperemia. 
The reaction of the functional endothelial cells to such a physiological stimulus is 
secretion of chemical substance of Nitride Oxide (NO). Once NO is released, 
vasodilatation occurred causing vessel size to increase. The endothelial activity along 
the FMD stimulation can be captured via ultrasound imaging. In this regard, the 
variation between brachial diameters in baseline and after cuff release shows the current 
performance of the endothelial layer (Corretti et al. 2002; Harris et al. 2010). This 
approach is known as FMD-Ultrasound (FMD-US) technique. The FMD-US technique 
has been well established and known as the most attended technique to assess the 
endothelial performance non-invasively.  
 Interestingly, Photoplethysmography (PPG) has also been attended as a 
potential tool to assess the endothelial performance non-invasively. In fact, it is a well-
known technique in which variations of blood flow over each cardiac cycle can be easily 
detected via a cost-effective optical system (Webster 1997). The PPG signal has been 
widely used in clinical applications over last two decades (Allen 2007). It is also known 
as a vital signal and can be known as inseparable part of today's patient monitoring 
systems. One of the recent work in this field has been done by Rosmina Jaafar (Jaafar 
2009). Results of this research have confirmed the suitability of PPG for ED assessment. 
In fact, it has shown that the endothelial performance can be also assessed via PPG. In 
this research, endothelial layer is physiologically stimulated -using the FMD test- across 
the peripheral artery while endothelial reaction is assessed from subject's index finger. 
Truly, implementation of this technique is considerably cost-effective, less operator 
dependent and simpler compared to the FMD-US technique. However, the main 
limitation of this technique is the possibility of capturing both endothelial and non-
endothelial factors due to a physiological phenomenon known as the auto-regulation. 
Another limitation of this work is to measure the vessel diameter manually. In addition, 
occlusion of arterial blood circulation is done via a typical pressure cuff which is not 
match with the guideline of the FMD test (Corretti et al. 2002).  
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1.2 PROBLEM STATEMENT 
Interestingly, there is a good consensus considering the ED as an early marker of many 
CV abnormalities such as atherosclerosis, hypertension and diabetics (Bonetti et al. 
2003; Lerman & Zeiher 2005; Stam et al. 2006). In past (and even somewhere now) the 
ED is indirectly derived from other CVDs such as hypertension and diabetics (Calles-
Escandon & Cipolla 2001; Schalkwijk & Stehouwer 2005). In other words, the ED is 
detected when an abnormality has already occurred whereas an early detection of ED 
may help in controlling disease at initial stages and thus, prevent from further CV 
abnormalities.  
 Recently, FMD-US technique has been well established. In fact, it is the most 
attended technique to assess the endothelial performance non-invasively. Using this 
technique, ED or endothelial abnormalities can be faithfully detected in early stages.  
However, implementation of this method requires an expensive system setup (e.g. 
ultrasound machine, high frequency transducer, etc.). In addition, this technique should 
be done by an experienced and skilled operator who has adequate knowledge about 
human physiology and system setup. Moreover, an additional vessel-edge-detection 
program is needed in order to trace the endothelial functionality based on ultrasound 
images. As conclusion, main limitations of the FMD-US technique can be summarized 
as below (Corretti et al. 2002): 
1) Expensive system setup (mainly ultrasound and high frequency transducer) 
2) Highly operator dependent  
3) Need to an additional software in order to analysis vessel diameter 
 Referring to Rosmina Jaafar's work explained above, assessing the endothelial 
performance from a small artery (index finger) may reflect both endothelial and non-
endothelial factors. Accordingly, another problem of using the recent PPG system 
would be: 
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4) Assessment of endothelial performance in conjunction with effect(s) of 
autoregulation in a small artery  
Thus, reliability of the PPG technique -in conjunction with FMD-US- still needs further 
investigation(s). Therefore, the next step towards establishing PPG technique is to 
investigate the possibility of assessing the so-called pure endothelial performance (i.e. 
excluding endothelial non-factors) via a novel approach. Such technique is also 
supposed to be cost-effective and operator independent. Hence, there is a need for a 
novel and reliable approach to facilitate endothelial evaluation preferably with a cost-
effective and operator independent system.   
1.3 RESEARCH OBJECTIVES 
The main objective of this research is to assess the pure endothelial performance via 
PPG. In this regard, parametric modelling is considered not only to assess the ED but 
also to trace the endothelial performance before (baseline) and after conducting the 
FMD stimulus.  
 It has been known that the aorta is coupled to the heart and thus, central (aortic) 
blood pressure (CBP) is not simply affected compared to BP in following arteries. From 
the other side, obtaining a PPG signal is considerably easy and cost-effective, as 
mentioned above. Since this research aims to investigate the pure endothelial 
performance (i.e. in a large artery), radial site (wrist) is considered to obtain the PPG 
signal. Accordingly, a forward model between CBP and the radial photoplethysmogram 
(RPPG) [CBPRPPG] is considered to assess the endothelial performance among 
both healthy and un-healthy groups, as shown in Figure 1.1. The secondary objectives 
of this research are as follows: 
1. To estimate a dynamic CBPRPPG model for each subject at rest 
2. To investigate the effect of the FMD test on a model (i.e. the goodness of a 
model before and after applying the FMD stimulus) 
3. To propose a reliable approach to identify the ED  
4. To compare results of the proposed technique and the FMD-US technique 
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Figure 1.1 Research in one view: endothelial assessment by comparing goodness 
of CBP→RPPG model in baseline (top) and after the FMD stimulus 
(bottom) 
 
1.4 RESEARCH SCOPE 
Specifically, this research aims to improve the ED assessment via the PPG technique. 
Such improvement possesses two aspects; (i) taking a large artery to assess endothelial 
functionality in order to avoid capturing non-endothelial effects (e.g. auto-regulation) 
and (ii) analyzing the endothelial response based on a parametric model -between CBP 
and RPPG (CBP→RPPG)- in order to better trace the dynamic reaction of the 
endothelium. To this end, data were collected among both healthy and risky subjects in 
the HUKM. In general, subjects with stroke or myocardial infarction are excluded from 
this research. Instead, subjects between 30-60 years old with and without CVD are 
considered and participants. However, utilizing an in-use ultrasound machine can be 
mentioned as a big limitation of this work. Accordingly, the sample size and 
unbalancing between numbers of each group seems to be an unavoidable limitation in 
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this study. Regardless of such limitations, investigation of suitability of the proposed 
technique -in conjunction with FMD-US technique- among both healthy and non-
healthy groups can be mentioned as the objective of this work. 
1.5 HYPOTHESIS OF THE RESEARCH 
In this research, we propose an alternative approach for evaluating the endothelial 
activity via CBP RPPG model. This model is supposed to have a stable behavior 
under normal circumstances (baseline). In contrast, the goodness of this model is 
supposed to be affected (i.e. parametric changes) during the FMD stimulus. In this 
regard, the hypothesis of this research can be addressed as below: 
 Goodness of CBP RPPG model (i.e. fitness curve) can be used -as a criterion- 
to assess the endothelial performance 
 After the FMD stimulation, goodness of CBP RPPG model is significantly 
varied among healthy subjects whereas it is not significantly changed among 
unhealthy subjects  
 There is a significant variation between values of height of peak of healthy and 
unhealthy subjects 
 There is no significant variation between values of height of peak among male 
and female subjects 
 The proposed model has similar result as the FMD-US technique 
1.6 THESIS ORGANIZATION 
Chapter I (Introduction) conveys the general concept of this research. It gives an 
overview of this investigation including: importance of this research, problem 
statement, proposed method and research objectives. 
 Chapter II (Literature Review) describes the human CV system and its 
constructive portions. Then, the role of endothelial layer on blood circulation and CV 
performance is studied. Afterwards, clinical importance of endothelial layer and 
symptom(s) of ED are reviewed. Then, some potential techniques to assess the 
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endothelial functionality are introduced. After that, current techniques to access the 
endothelial performance are described. Furthermore, the nature of PPG is explained and 
its clinical usage in today's healthcare industry is reviewed. 
 Chapter III (Methodology) covers the details of data acquisition: from protocol 
to hardware configuration and system setup. The proposed technique is explained in 
details including signal processing and system identification (modelling). This section 
is divided into two parts: (i) procedure of estimating a dynamic model between the CBP 
and RPPG and (ii) endothelial assessment via this model. Statistical analysis is then 
performed. 
 Chapter IV (Results and discussion) include results of the proposed technique 
explained in chapter three. The results are verified in conjunction with the FMD-US 
technique (as a reference technique). Then, the results are discussed and statistically 
analyzed to find out values of sensitivity, specificity and accuracy of the proposed 
technique. At the end of this chapter, advantages and disadvantages of this technique 
are discussed. 
 Chapter V (Conclusion and future work) summarizes the proposed technique 
and its results in conjunction with the FMD-US technique. In addition, limitations of 
the proposed methodology are explained and some suggestions are given in order to 
improve the quality of future works. 
  
 
CHAPTER II 
LITERATURE REVIEW 
2.1 HUMAN CARDIOVASCULAR SYSTEM 
The CV system is an asympathetic organ which circulates blood through our bodies. 
This ubiquitous system is the human’s longest organ which plays a vital role on organic 
interactions along different metabolic conditions. The heart is always beating to supply 
entire organs by essential substances and fresh oxygen while removing deoxygenated 
blood, urea and by-products along each cardiac cycle. This process is known as systemic 
and pulmonary circulations respectively. Figure 2.1 shows the direction of pulmonary 
(red) and systemic (blue) blood circulations.   
 
Figure 2.1 Direction of pulmonary (blue) and systemic (red) blood circulations 
Source: Whittemore 2009 
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The CV system consists of three components; the heart, blood and vascular bed. In 
general, the heart can be considered as a muscular pump to propagate the blood within 
a closed network of vessel. The heart is continuously beating from birth to death, even 
at rest. The electrocardiography (ECG) is a well-known technique to represent electrical 
activity of the heart by placing several electrodes across the chest (Goldberger 2012). 
The general action of heart can be faithfully assessed by the ECG signal. It is always 
known as a vital sign and has a wide range of application in today's healthcare industry. 
 The blood is a limited volume of hemodynamic fluid which travels across our 
bodies to transfer nutrients, oxygen and humoral agents while returning generated by-
products and urea to the heart. It is frequently purified along each breathing cycle to get 
fresh oxygen. The hemodynamic properties of blood (i.e. blood pressure and flow) are 
widely used in cardiovascular engineering and bio physics. 
 The vascular bed is an asymmetric T-shape elastic tube which covers our body 
from toe to head (Reinhold et al. 2012). It can be studied as the vital bio-transit path 
which facilitates blood circulation across our bodies. The vascular bed is consisted of 
artery, vein and capillary with similar functionality (streaming blood) but different 
structural characteristics. The arterial network is responsible for forwarding fresh blood 
from the heart to the entire organs while venous network is transfers deoxygenated 
blood from entire organs to the heart. Besides, the capillary facilitates blood circulation 
between artery and vein. In fact, capillary connects the arterial network to the vein 
system and thus, plays an important role on human microcirculation process. Vessels 
are geographically dissimilar in length, width and geometrical configurations (i.e. 
tapering, branching and thickening) and thus, have a different impedance (Mazumdar 
2015; P. Segers 2010). Compare to artery and vein, the capillary has a lower conduit 
diameter with a thicker layer of cell. It facilitates exchanging of water, oxygen, carbon 
dioxide, nutrients and waste chemical substances between blood and surrounding 
tissues (Daneshfard et al. 2014). The index finger and auricle are two popular sites for 
capturing the microcirculation. Figure 2.2 shows the capillary in conjunction with an 
artery and vein.  
11 
 
 
Figure 2.2 The capillary, a connection path between artery and vein 
Source: Whittemore 2009 
 Since the vascular network is coupled to the heart, even small abnormality in 
the vasculature, particularly in coronary vessels, disturbs the cardiac performance and 
may lead to sudden heart attacks (Murthy et al. 2012). As such, the atherosclerosis (i.e. 
caused by endothelial dysfunction) can be mentioned in which fatty materials are 
gradually accumulated together and slowly decreased the vessel conduit (Libby et al. 
2002). Another prevalent abnormality of the vessel is the vascular stiffness -known as 
arteriosclerosis- which naturally increases along the human's lifetime (Lee & Oh 2010).
  
2.2 ENDOTHELIAL LAYER 
The endothelial layer is a thin layer of cell which entirely paves the interior surface of 
our vascular tree (Reinhold et al. 2012). This layer is also known as the innermost layer 
of vessel which is in direct and permanent touch with blood. There are various 
biological interactions which are mainly or partly handled by this multifunctional layer 
in both pulmonary and systemic circulations. The vascular tuning, coagulation, 
fibrinolysis, leukocyte adherence, platelet interaction and vascular permeability are 
mainly done by the Endothelial cells (Dignat-George & Boulanger 2011). 
 It has been demonstrated that endothelial layer has a network-like functionality 
meaning that a local endothelial performance represents the functionality of the 
endothelial performance across the entire vasculature (Celermajer 1997). The 
endothelial functionality is controlled by autonomous system and can be affected by 
local metabolic conditions (Bouïs et al. 2001). The endothelial performance is one of 
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the most reliable indicators to predict CV events (Kuvin et al. 2001). Figure 2.3 
illustrates the pathology of this vital layer.  
 
Figure 2.3 The human's innermost layer of vessel 
Source: Félétou 2011 
2.2.1 Role of Endothelial Layer on Blood Circulation Process 
It is clear now that the density of blood alters frequently along each cardiac cycle mainly 
due to current metabolic condition. In addition, it may vary following changes in local 
interactions or even external stimulus. Therefore, the intravenous diameter should be 
accordingly adjusted in order to retrieve blood transferring and prevent from any size-
related disturbance on blood circulation. Such a complex action is mainly handled by 
the endothelial cells (layer). In fact, the endothelial layer plays a homeostasis role to 
regulate blood flow along different metabolic conditions. 
 As quoted earlier the endothelial cells are located across the innermost layer of 
vessels and thus can affect blood circulation from hemodynamic viewpoint (e.g. blood 
pressure and flow) by changing the resistance of blood stream (vessel). This matter has 
been attended mostly in CV engineering and hemodynamics. For instance, Pries et al. 
proposed a model-based technique to measure the flow resistance in small vessels in-
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vitro (Pries & Secomb 2005). In this work, the vessel diameter and hematocrit were 
studied. However, obtained in-vitro results were not similar to an observation which 
was invasively acquired from rats. They reported that the flow resistance in small 
vessels is considerably higher than what they measured in-vitro. After peer 
investigation, the endothelial layer was introduced as the main cause of such 
discrepancy and thus, the role of endothelial layer in vascular resistance, blood pressure 
and blood flow was endorsed again.  
 The endothelial layer has been also studied from permeability viewpoint. It is 
demonstrated that the endothelial layer acts as a sieve to pass nutritious particles into 
surrounding organs while transmitting by-products from surrounding organs into the 
blood circulation (Curry & Adamson 2012; Mehta & Malik 2006). In fact, the 
endothelial cells operate as a gate to pass favorite substances into surrounding organs 
and vice versa, then the waste substances get to the circulatory system. This process is 
mostly done in capillaries which are the thinnest component of vascular bed in 
conjunction with our autonomous system. Figure 2.4 shows this feature via a graphical 
illustration.  
 
Figure 2.4 The endothelial cells as a transmitter  
Source: Anon 2012 
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2.3 ENDOTHELIAL DYSFUNCTION 
As quoted earlier, there are several interactions which are mainly or partly handled by 
the endothelial cells but the endothelium is normally known as a vascular tuner along 
different metabolic conditions. Although this matter is still being investigated but it was 
already discovered that the Nitride Oxide (NO) plays an important role on adjustment 
of vascular conduit (Tousoulis et al. 2012). This chemical substance is also known as 
an endothelium-dependent vasodilator. In fact, the process of vasodilatation and 
vasoconstriction are mainly handled by releasing sufficient volume of NO in 
conjunction with other chemical substances. The endothelial dysfunction is normally 
referred to the unbalancing between vasodilators and vasoconstrictors which are 
released by endothelial cells. An inappropriate secretion of NO may affect vascular 
tuning and lead to further CV abnormalities. The endothelial dysfunction has been 
captured as a root of many CV diseases such as hypertension and diabetics (De Vriese 
et al. 2000; Landmesser & Drexler 2007). This matter motivates scientist to investigate 
the possibility of endothelial assessment -as a reliable indicator- to predict CV events. 
The endothelial layer is shown in Figure 2.15. 
 
Figure 2.5 The Endothelial layer: normal (left) impaired (right) 
Source: Anon 2012 
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2.3.1 Symptoms of Endothelial Dysfunction 
Investigations have shown that ED does not reveal any symptom(s) in early stages. For 
instance, Al Suwaidi et al. conducted a cross-sectional study to investigate the 
possibility of detecting the ED at the beginning (Al Suwaidi et al. 2000). In this research, 
the endothelial functionality was examined among three groups, namely people with 
normal endothelium as well as those with mild and severe ED. During a long-term 
follow-up research which involved 157 subjects, only ten cardiac events were observed 
among those people with severe ED whereas no significant symptom(s) were observed 
among this group at the beginning. Thus, they concluded in their report that the ED 
cannot be detected at the beginning. 
 Nowadays, the silent nature of ED is known as a real threat and as such, several 
teams have investigated the possibility of ED assessment via extra clinical approaches 
(e.g. sleep and depression). In a very strange but interesting work, Sherwood et al. 
showed that there is an association between ED and depressive symptomatology 
(Sherwood et al. 2005). They measured the endothelial activity among 143 subjects in 
total and then reported that the endothelial reaction is reduced among those people with 
certain depression compared to others. They then used the antidepressant drugs and 
observed a slight improvement on endothelial reaction after administration of such 
drugs. The association between ED and depression has also been addressed by 
Mausbach et al. in another similar work (Mausbach et al. 2012).  
 In another research by Kohler et al. the endothelial performance was examined 
on 79 subjects which included 64 patients -who suffered from sleep apnea- and 15 
healthy subjects (Kohler et al. 2008). Results of this investigation showed that there is 
a poor endothelial activity among patients with sleep apnea compared to others. Thus, 
it was concluded that the endothelial functionality may have inadequate activity among 
those people with sleep apnea.  
2.3.2 Clinical Importance of Endothelial Dysfunction 
The ED has been remarkably addressed as an initial marker of CV disorders. As an 
evidence, Perticone et al. reported that the ED occurred prior to hypertension (Perticone 
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et al. 2001). In this research, the endothelial cells was pharmacologically examined by 
injecting some chemical stimulant (e.g. sodium nitroprusside and acetylcholine) among 
a total of 225 untreated hypertensive patients. The endothelial reaction was assessed via 
dose-response curve to intra-arterial infusions. A very poor endothelial response was 
observed among these patients that led to a conclusion that the endothelial cells was 
already impaired among hypertensive patients. Therefore, they suggested that 
endothelial dysfunction can be used as an indicator of ongoing CV abnormalities among 
hypertensive patients. 
 In another similar study by Budhiraja et al. ED was introduced as one of the 
main factors of increasing blood pressure (Budhiraja et al. 2004). They reported that an 
inadequate secretion of endothelium-derived vasodilators (i.e. NO) may lead to 
unbalancing of bioavailability of NO so that high blood pressure could be consequently 
occurred.    
 The role of ED in diabetes has been also investigated (Sena et al. 2013). 
Although such association was already discovered but the issue of causality was still 
not fully understood (Caballero 2003). This matter was recently investigated by 
Balletshofer et al. in which they evaluated the endothelial functionality among a group 
of healthy individuals with at least one first-degree relative with certain type II diabetes 
(Balletshofer et al. 2000; Tesauro et al. 2007). Although they did not reveal any 
significant symptom(s) at the beginning but results confirmed the existence of ED 
among this group. Thus, the potential value of endothelial dysfunction assessment -as 
an early marker of diabetes- was endorsed again. Similarly, Schalkwijk and his co-
worker reported that in type I diabetes, the ED occurred prior to diabetic micro-
angiography whereas in type II diabetes, the endothelial cells became impaired as a 
consecutive result of diabetes (Schalkwijk & Stehouwer 2005).  
 Hyperglycemia is another prevalent abnormality in which glucose is 
accumulated within vessels. This abnormality is known as an initial stage of diabetes. 
Interestingly, there is a meaningful relationship between hyperglycemia and the ED 
(Bakker et al. 2009). Such relationship relies on the finding that an impaired vaso-
regulation in presence of hyperglycemia is most probably caused by the ED. Therefore, 
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endothelial disorder may be considered as an early stage of hyperglycemia which in 
return, may lead to diabetes. 
 Atherosclerosis is a well-known chronic abnormality in which fatty particles are 
accumulated together and gradually formed a vascular blockage (Sanz & Fayad 2008). 
The association between ED and atherosclerosis was first investigated by Ludmer et al. 
(Ludmer et al. 1986). In this research, the acetylcholine was used to induce the 
endothelial cells. It was injected into a total of eighteen subjects which included; eight 
patients with advanced coronary disease, four healthy and six patients with mild 
coronary atherosclerosis while the endothelial reaction was assessed via angiography. 
Although acetylcholine was supposed to induce the endothelial cells to release the NO 
and dilate vessel diameter but a paradoxical reaction was observed among 
atherosclerotic patients in which acetylcholine led to vessel constriction instead. They 
concluded that the endothelial cells are already impaired among atherosclerotic patients. 
Therefore, the ED can be considered as an early sign of atherosclerosis.  
  The ED is even known as one of the principle factors of forming the 
atherosclerosis. In this regard, Bonetti et al. studied the role of ED on fat accumulation 
within the vessel  (Bonetti et al. 2003). They described that the main cause of 
atherosclerosis is due to unbalance bioavailability of the NO as a potent substance of 
vascular tuning leading to ED as a reliable marker for detecting atherosclerosis in the 
early stage. ED is later captured as a prior disorder of atherosclerosis (Davignon & Ganz 
2004). The relationship between the ED and atherosclerosis has been particularly 
attended over last decades. In fact, it is a very common abnormality among elderly 
people. A fatty bulk disturbs blood circulation by narrowing the vascular diameter 
causing the blood pressure and blood flow to increase (Insull 2009). Therefore, it is 
highly considered as a reliable indicator of atherosclerosis in preclinical stages (Mudau 
et al. 2012). Figure 2.6 illustrates the atherosclerosis in a vessel. 
18 
 
 
Figure 2.6 A normal vessel (left) versus an atherosclerotic vessel (right)  
Source: Atherosclerosis 2016 
 The ED has been captured as a vascular disorder which most probably occurred 
before vascular abnormalities. Therefore, the clinical importance of ED has been 
particularly attended as a reliable indicator of vascular malfunctioning in preclinical 
stages (Puddu et al. 2000). 
 The association between ED, diabetes and atherosclerosis was also addressed 
by Järvisalo et al. in which endothelial performance was assessed via FMD technique 
(Järvisalo et al. 2004). The test was done on 75 children including 45 type I diabetes 
and 30 healthy. They noticed a lower peak of FMD and an increased in carotid intima-
media thickness among diabetics compared to others. They also highlighted that the 
intima-media thickness was even larger among the 16 children who had certain ED as 
well as diabetes. They, then, suggested that ED in diabetic children may increase the 
chance of atherosclerosis. As a conclusion, the clinical importance of ED -to detect CV 
abnormalities in early stages- has been remarkably addressed in many studies (Meigs et 
al. 2004; Meigs et al. 2006; Rossi et al. 2005).  
2.4 INTRODUCTION OF POTENTIAL TOOLS FOR ENDOTHELIAL 
ASSESSMENT 
Referring to chapter I, the main objective of this research is to assess the ED non-
invasively via a dynamic model between central blood pressure (CBP) and radial 
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photoplethysmogram (RPPG). In general, the proposed technique is consisted of two 
aspects: PPG and system identification (SI). Hence, these methods are firstly introduced 
in the following sections. Reasons of taking CBP -as model input- and current 
techniques to access it are then explained in order to better understand the proposed 
model. Finally, currently available methods to assess ED -including PPG and SI- are 
explained. 
2.4.1 Photoplethysmography 
Photoplethysmography (PPG) is an opto-electrical system for capturing blood volume 
change in small vessels. Basically, PPG probe is consisted of a light source (e.g. LED) 
for emitting light as well as a photodetector for collecting the light beams. These two 
components can be placed either in the same side (reflection mode) or opposite side 
(transmission mode) as can be seen in Figure 2.7 (Webster 1997). Basically, emitted 
beams can be passed, reflected or absorbed at the time of hitting to the skin. However, 
only passed beams can be collected by the photodetector. In fact, the passed beams 
reflect the blood flow change over each cardiac cycle. Such variation can be seen by 
representation of an obtained data through an electrical signal known as PPG signal. 
 
Figure 2.7 Configuration of a typical PPG probe in transmission (a) and reflection 
mode (b) 
Source: Webster 1997 
Simple configuration of PPG sensors makes this technology considerably cost-
effective, easy to use, portable and operator independent compare to other vascular 
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screening technologies. Therefore, it has been widely used over last decades mainly for 
monitoring of autonomous functions, vital signs and blood oxygen saturation (i.e. SpO2) 
(Allen 2007). 
a) Role of PPG in Cardiovascular Engineering 
Indeed, the PPG can be considered as a pioneer technology to access blood oxygen 
saturation (SpO2) (Bagha & Shaw 2011). In this technique, the SpO2 signal could be 
obtained by illuminating light beams across an auricle while wavelength was quickly 
changed between red and infra red. The amplitude of collected light was significantly 
varied due to dissimilar behavior of illuminated wavelengths to SpO2 floated in the 
blood. Such a variation represented the degree of oxygen saturation in target vessel. 
This technique has been gradually developed and well established in today's clinical 
practices.  
 PPG was also considered for obtaining heart rate which is known as a reliable 
vital sign particularly in ambulatory medicine. However, a pure PPG signal was affected 
by some unwanted distortion mainly caused by respiratory movement. Such 
unavoidable noise may hide some significant information in a PPG signal. In 2005, Foo 
et al. improved the quality of PPG signal by removing the respiratory noise via an 
algorithm-based digital filtering (Foo et al. 2005). The accuracy of PPG-derived heart 
rate was then reinvestigated by Yu et al. (Yu et al. 2006). In this work, both ECG and 
PPG signals were simultaneously recorded among 158 accident patients for seven 
seconds. Using standard signal processing techniques, hear rate was calculated from 
each signal independently. Obtained heart rates were then compared to each other 
resulting in an excellent match between ECG-derived and PPG-derived heart rates with 
over 92 percent of similarity. Thus, suitability of the PPG technique -for obtaining the 
heart rate- was endorsed again. 
 PPG has been also considered as a potential tool to predict vascular risks. In this 
regard, Kalaivani Chellappan has proposed a model based approach to predict 
physiological age of vessels through empirical data modeling (Chellappan 2009). In this 
work, an electrical lumped model was used in order to model arterial blood flow and 
the left ventricular pressure. In fact, electrical elements were used to represent vessel 
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resistance, compliance and blood inertia. Such parameters were then validated using 
actual ageing, effect of exercise and CV risks. This approach was proposed based on 
similarity between components of PPG waveform and the above mentioned parameters. 
Accordingly, PPG was introduced as a practical approach to obtain vascular parameters 
non-invasively.  
 Respiratory rate is another vital sign that can be reliably obtained via PPG 
(Nilsson et al. 2000). In this regard, Leonard et al. proposed an automated algorithm for 
determination of respiratory rate based on PPG signal (Leonard et al. 2006). A 
comparison analysis was done between the PPG-based method and the ECG technique. 
Results showed a reliable accuracy in the PPG approach. Since then, this concept has 
been improved and well established in the healthcare industry as a reliable approach to 
obtain the respiratory rate (Sahni 2012). 
 Cardiac output can be also accessed via PPG. This parameter is scientifically 
known as the stroke volume which indicates the volume of blood rushed out from the 
heart towards the arterial network (Allen 2007). The stroke volume was previously 
calculated using Doppler-pulse technology (Pemberton et al. 2005). In this technique, 
stroke volume was calculated by multiplying values of aortic diameter and aortic 
velocity obtained via Doppler-ultrasonography. Irrespective of costly setup, further 
investigations showed that the stroke volume -obtained by the Doppler technique- is not 
reproducible and may vary from time to time (van Geldorp et al. 2011). Alternatively, 
PPG was used as a potential tool to access the stroke volume (Pollonini et al. 2015). In 
this research, data (i.e. ECG and PPG) were simultaneously obtained among fifteen 
healthy young subjects in baseline and during an incremental cycling protocol. In fact, 
the exercise was used to improve the blood supplement inside the aorta. Using linear 
models, hemodynamic variables (e.g. heart rate, pulse transit time, etc.) were calculated 
and compared to baseline values confirming the suitability of PPG for stroke volume 
assessment.  
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b)  Advantages and Limitations 
PPG is remarkably cost-effective compare to other sensors particularly in the domain 
of cardiology. In addition, it is really operator independent and very easy to use. 
Moreover, this system is portable, noninvasive and safe. As quoted earlier, this 
technique is widely used for representation of vital signs. Nowadays, this technology is 
widely used in daily clinical monitoring and ambulatory diagnosis. However, this 
technique is so sensitive to motion artifacts as explained earlier. Therefore, appropriate 
adjustment of a PPG probe -over site of interest- is highly required. Besides, the issue 
of environmental light(s) around the PPG sensor should be taken into account as it may 
disturb the quality of PPG signal. In this regard, data should be preferably collected in 
a twilight atmosphere (Allen 2007). 
2.4.2 System Identification 
The system identification is a mathematical technique to identify the relationship 
between system input(s) and output(s). Basically, this toolbox provides a reliable way 
for analysis dynamic systems while studying the role of associated parameters in system 
performance. In fact, in complex systems, the association between involved parameters 
and system performance is usually unclear. The human's biological system is one the 
most complex systems in which internal interactions are not fully discovered whereas 
overall role of each organ is more or less known. For instance, the vital role of 
endothelial cells in vascular tuning has been known whereas its fundamental function 
to secrete sufficient volume of NO is still being investigated. This technique was 
implemented in the Matlab "system identification" toolbox by Ljung (Ljung 1999). 
Since then, it has been improved and updated (Ljung 2010). A basic schematic of a 
typical model is illustrated in Figure 2.8.  
 
 
 
23 
 
ε(t): Disturbance 
Model Input (u(t)) Model Output (y(t)) 
 
 
 
Figure 2.8 Schematic view of a typical model  
 Considering u(t) as model input and y(t) as model output, the mathematical 
relationship between parameters of a model can be expressed via equation 2.1: 
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where na is the order of denominator (number of poles), nb is the order of numerator 
(number of zeros plus one), nk is the input-output delay and e(t) is the residual noise. 
a) Criterion of a Reliable Model 
According to the theory of the system identification, the goodness of a model is 
normally evaluated in terms of the following criteria (Ljung 1999):  
 Model Validity: In general, model validity indicates how valid an estimated 
model is. In other words, it refers to the degree of similarity between measured and 
estimated data. Such comparison is normally discussed via the parameter of fitness 
expressed in terms of percentage. In Matlab, a value of fitness is computed by the 
following equation (Ljung 1999):   
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where, y(t) represents a measured data at time (t),
^
y (t) represents an estimated data at 
time (t),

y  represents mean value of initial data and N represents number of samples. 
+ Model 
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There is no certain value -for fitness- to evaluate the suitability of an estimated model. 
But higher fitness value is obviously desirable. 
 Reproducibility: The term "reproducibility" simply refers to the sustainability of 
results along different times of try. This parameter refers to the constancy of model 
behavior along different sets of similar data. Although results may not be exactly same 
for each data but the issue of constancy should be met among all obtained values of 
fitness in order to ensure the stability of a model. 
 Final prediction error (FPE): the final prediction error is another factor for 
evaluating models. In Matlab, it is calculated using the following equation: 
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where p is the number of estimated parameters and N is the number of samples. The V 
is known as the loss function which is defined as: 
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where θN addressing the vector of estimated parameters from the N data samples, ε is 
the residual error and det() is the matrix determinant operator. 
b) Role of System Identification in Cardiovascular Engineering 
Truly, system identification can be known as an applicant tool for discovering unknown 
parameters in CV engineering and hemodynamics. In a pioneer work by Pauca, an 
algorithm was proposed for non-invasive estimation of arterial pressure waveform from 
radial blood flow changes (Pauca et al. 2001). In this work, arterial pressure waveform 
and radial blood flow changes were simultaneously recorded and their relationship was 
then studied via system identification. Using this model, radial flow waveform could be 
estimated based on radial pressure waveform. This model was then inversed to facilitate 
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the estimation of pressure waveform from the volume change signal. This technique 
was then validated and improved (Bogert & van Lieshout 2005). 
 In continue using system identification techniques to explore CV characteristics, 
Xiao et al. proposed a novel approach for assessing neural cardiovascular regulation 
(Xiao et al. 2005). Using this method, effective parameters on the regulatory of 
cardiovascular system were characterized via system identification. Heart rate, 
peripheral resistance and sympathetic reaction were identified as most effective factors 
on neurology of cardiovascular operation. This concept was later improved by Jalali et 
al. offering analysis of correlation between arterial blood pressure and heart rate 
waveforms as well as durability in the performance of sympathetic nerves system (Jalali 
et al. 2011).   
 The role of system identification was highlighted again when Voss et al. 
discovered some potential causes of variation in heart rate through a model based study 
(Voss et al. 2009). In this study, association between heart rate, blood pressure and lung 
volume was investigated and two autonomic factors were identified as main causes of 
abnormality; heart rate baroreflex and respiratory arrhythmia. In addition, effects of 
respiratory (i.e. mechanical movement) were introduced as a kinetic factor which may 
improve the trend of abnormality. In order to evaluate this finding, a pharmacological 
method was considered to neutralize effect of the autonomic factors. This concept was 
then implemented among fourteen healthy subjects resulting in deactivating autonomic 
effects and improves the stability of heart rate and blood pressure. Therefore, they 
endorsed the great power of system identification in cardiovascular engineering by 
declaring that: "system identification is an inverse modeling technique that provides a 
means for creating a closed-loop model of cardiovascular regulation for an individual 
subject without altering the underlying physiological control mechanisms".  
 Possibility of employing system identification technique in clinical practices 
was then endorsed by Lowe et al. (Lowe et al. 2009). Similar to previous work, data 
were simultaneously recorded among thirty nine patients who were suffering from 
coronary heart diseases. Then, a parametric model was individually estimated for the 
first twenty subjects. Generalized model was then computed by averaging among 
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confidents of all individual models. This model was then applied to another nineteen 
subjects in order to estimate their CBP waveform. Results were then compared with 
measured data (invasively acquired). Results showed a very convinced similarity 
between model-derived and measured CBP waveforms with the root mean squared error 
of 2.2 ± 0.9 mmHg only. 
2.4.3 Estimation of Central Blood Pressure via System Identification 
a) Clinical Importance of Central Blood Pressure (CBP) 
The fresh blood is originally rushed out from the left ventricle into the aorta which is 
the first and widest arterial segment in human bodies. In fact, the aorta is coupled to the 
heart and form a unique configuration for passing blood from the heart to faraway limbs 
(Levick 2013). Blood pressure within the aorta is known as the aortic blood pressure 
(ABP) or central blood pressure (CBP). It is then exponentially declined within the aorta 
and then passed through following small (McEniery et al. 2014). 
 In early of last decade, clinical importance of central (aortic) stiffness was 
highlighted as a potential tool of early detection of cardiovascular abnormalities (Safar 
2000). This concept was later confirmed by Laurent et al. in which aortic stiffness was 
computed by measuring the carotid/femoral pulse wave velocity among 1980 
hypertensive patients (Laurent et al. 2001). They found a relationship between aortic 
stiffness and hypertension prevalence and thus, introduced the aortic stiffness as an 
independent predictor for CV mortality among hypertensive patients. 
 The CBP has also been used for early diagnosis of renal diseases. For instance, 
Safar et al. (Safar et al. 2002) studied the relationship between central waveform and 
death-leading renal diseases among 180 certain renal patients who were undergoing 
hemodialysis. In this study, brachial BP, carotid/brachial ratio and aortic wave velocity 
were frequently recorded and documented along ten years. After precise analysis among 
all recorded data, they concluded that both CPB signals and amplification ratio between 
central and peripheral waveforms are two independent predictors of CV diseases among 
renal patients. 
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 Investigations have shown that there are some fundamental differences between 
CBP and brachial pressure waveforms. For instance, there is a significant difference 
between the systolic pressures of the aorta and brachial artery, although diastolic and 
mean arterial pressures are relatively similar (McEniery, Hall, Qasem, Wilkinson, 
Cockcroft, et al. 2005). Such a discrepancy is occurred mainly due to wave reflection 
caused by increasing vascular stiffness moving away from the heart (Hirata et al. 2006).  
 This concept was later challenged by Ohte et al. as they reported that the 
diastolic pressure varied from aorta to brachial artery (Ohte et al. 2007). In this research, 
CBP and brachial BP of 82 subjects -who were suspected with coronary artery diseases- 
were simultaneously recorded during cardiac catheterization. After analysis, they 
revealed that there is a significant variation between bottom peak of central and brachial 
pressure signals. They found that the central diastolic value is lower than brachial 
diastolic value mainly due to the issue of wave reflection and vessel compliance. 
However, they soon published another work confirming the amplification ratio between 
central and brachial arterial pressure (Ohte et al. 2007). This matter was later endorsed 
by several other researchers (McEniery et al. 2014; Segers et al. 2009). Figure 2.9 
illustrates the amplification ratio in upper limb arterial network; from aorta to radial. 
 
Figure 2.9 Amplification of a typical pressure pulse in upper limb 
Source: McEniery et al. 2014 
The CBP has also been introduced as a potential parameter for representing cardiac 
output. For instance, Roman et al. investigated the possibility of detecting hypertrophy 
(and vascular abnormalities) via CBP and peripheral blood pressure waveform (Roman 
et al. 2007). In this statistical work, the CBP and PBP were simultaneously recorded 
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among 3520 subjects. After five years follow-up study and statistical analysis, they 
revealed that hypertrophy can be more reliably predicted via CBP rather than brachial 
blood pressure signal. They reported the hazard ratios of CBP-based detection and PBP-
based detection for 1.15 and 1.10, respectively. Afterwards, they investigated the 
possibility of detecting geometrical abnormalities of the heart via CBP signal. They 
observed a significant difference in CBP shape among hypertrophic patients compare 
to healthy subjects. Thus, it was concluded that systolic central pressure is more precise 
to identify the left ventricular hypertrophy rather than peripheral pulse (Roman et al. 
2010). 
 Over last decades, a global interest has increased to discover other aspects of the 
CBP waveform as a prospective indicator of CV abnormalities. In this regard, Pini et 
al. have shown that the CBP can be used for early detection of CV abnormalities among 
elderly people (Pini et al. 2008). In this research, 398 subjects including 173 
normotensive and 225 untreated hypertensive were selected to participate in a long-term 
study. During eight years of study, brachial, central and carotid blood pressure signals 
were frequently measured while CV abnormalities and death cases were also 
documented. After doing multivariate analysis, they endorsed that the CBP could be a 
better choice for predicting cardiovascular events.  
 As explained, it has been demonstrated that the CBP conveys significant 
physiological information that can be employed for early detection of CV abnormalities 
as well as assessing cardiac output. Therefore, the CBP has come to the center of 
attention since last decade to the extent that many believe it may be a better choice -
compared to brachial pressure- for prediction of cardiovascular events (McEniery et al. 
2014; Williams & Lacy 2010). In practice, however, measuring the central blood 
pressure is not easy. Possible approaches to access CBP waveform are explained below. 
b) Practical Techniques to Access the CBP 
CBP can be obtained through both invasive and non-invasive approaches. The heart 
catheterization is the most reliable way to obtain CBP waveform. In this approach, the 
central pressure can be directly measured by a thin flexible catheter during a tough 
invasive operation. Figure 2.10 shows an overview of this technique for measuring the 
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central pressure. Although this technique is highly precise but it is usually used for 
patients who are suffering from coronary heart disease. Moreover, this technique is 
considerably risky and complex. These limitations make it unsuitable for daily usage in 
clinics. Thus, global interest has been motivated to replace the catheter-based 
techniques with non-invasive approaches. In this regard, scientist has proposed several 
methods to estimate the CBP waveform from distal pressure signal (e.g. radial, brachial 
or carotid). Such techniques are listed in Table 2.1. 
 
Figure 2.10 Cardiac catheterization from the femoral artery 
Source: Anon 2016 
  
 
Table 2.1  Non-invasive techniques to access CBP waveform 
 
Methodology 
 
Target Site 
 
Method of Estimating 
CBP 
Commercially 
available apparatus 
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Radial Tonometry 
 
Wrist 
- General Transfer Function 
- - Late Systolic Shoulder 
- - Algorithm  
BPro, SphygmoCor 
SphygmoCor 
HEM9000AI 
Brachial Cuff  
Pulse Volume 
Plethysmography 
 
Upper Arm 
 
- General Transfer Function 
Vicorder, Centron 
CBP301 
XCEL, ARCsolver 
Supra-systolic Brachial  
Cuff Pulse Volume  
Plethysmography 
 
Upper Arm 
- Late Systolic Wave 
Amplitude 
- Algorithm  
Arteriograph 
Cardioscopell 
 
 Carotid pressure had been particularly considered as a surrogate site for 
obtaining the central pressure mainly due to similar characteristics and close vicinity to 
the aorta (Segers et al. 2005). Although carotid blood pressure has been widely used in 
CV researches (e.g. to calculate pulse wave velocity) but investigations show that it 
cannot be considered as a fair surrogate because measuring the carotid blood pressure 
is not easy particularly among obese subjects (McEniery et al. 2014). Furthermore, there 
is a small amplification between carotid and aortic pressures so that the carotid pressure 
cannot reliably represent the aortic pressure (McEniery, Hall, Qasem, Wilkinson & 
Cockcroft 2005; Nichols et al. 2011; Van Bortel et al. 2001).  
 The global attention was then focused on estimating the CBP waveform from 
the radial pressure pulse. It can be obtained by placing a high sensitive piezoelectric 
sensor over the radial artery for converting the pulsatile blood flow to an electrical 
signal. For the first time, Chen et al. proposed a way in which the aortic blood pressure 
can be mathematically derived from the radial pressure pulse (Chen et al. 1997). It this 
work, the central aortic pressure and radial pressure pulse were simultaneously recorded 
among 20 patients. Then, an individual parametric model between central and radial 
pressure pulse was estimated via system identification. The generalized transfer 
function was then computed by averaging among coefficients of all individual models. 
Using this technique, CBP could be accurately estimated from radial pressure pulse with 
overall error of less than 0.2 ± 3.8 mmHg. This approach was then used in clinical 
studies as a commercial apparatus named SphygmoCor (Pauca et al. 2001). Since then, 
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the algorithm has been developed and validated (Ding et al. 2011; Sharman et al. 2006). 
This approach has been well established in today's medicine to that extent that it has 
been refereed as a reference technique in similar proposed studies (Hickson et al. 2009; 
Stea et al. 2014). 
 Referring to Table 2.1, there are two techniques to access CBP waveforms non-
invasively; brachial cuff pulse volume plethysmography and supra-systolic brachial 
cuff volume plethysmography. Although the same approach is used in this technique 
but input of models are different from each other. For instance, model input of the first 
technique is brachial plethysmography whereas model input of the second technique is 
supra-systolic volume waveform. 
2.5 METHODS TO ASSESS ENDOTHELIAL FUNCTION 
In general, endothelial assessment can be done via clinical, invasive and non-invasive 
approaches. There are fundamental diversities among these approaches so that each 
method can be used in a particular situation. However, ED assessment in early stages 
can be known as the common goal of all proposed approaches.  
2.5.1 Clinical Tests 
According to the pathology of vascular system, ED leads to inflammation in human 
body (Karsan & Dauphinee 2010; Van den Oever et al. 2010). Such inflammations can 
be then accessed via some clinical tests. C-Reactive Protein (CRP) test can be 
mentioned as the well-known experiment of such tests. High Sensitive CRP (HSCRP) 
is also another test of this approach in which inflammation or its related chemical factors 
are measured based on a certain volume of blood sample. This test is normally done via 
high-tech laboratory devices. As a result, HSCRP test is more reliable rather than 
normal CRP test. However, ED cannot be exclusively accessed via clinical tests as 
inflammation factors may belong to other abnormalities (e.g. liver or kidney diseases, 
etc.) rather than ED. In other words, there is no way to confirm whether inflammations 
in blood samples are caused by ED or not. Therefore, clinical tests are normally used in 
conjunction with other examinations to detect the ED. Moreover, this approach may not 
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be able to detect ED in early stages. Therefore, this technique is not known as an 
exclusive test to assess the endothelial functionality (Devaraj et al. 2011).     
2.5.2 Invasive Methods 
In general, invasive approach refers to those techniques in which the assessment of ED 
is done invasively. As such, epicardial vasoreactivity and Doppler wires can be 
mentioned. Table 2.2 contains the most popular endothelial assessment techniques 
which are explained below. 
Table 2.2 Comparison of the most popular techniques to assess the endothelial 
performance 
Methodology Site of interest Advantages Disadvantages 
Coronary epicardial 
vasoreactivity 
Epicardial 
marcovascular conduit 
arteries 
Direct assessment to 
coronary vessels  
Invasive, Expensive, 
Limited to coronary 
patients, challenging 
for reproducibility 
Doppler wires Coronary 
microvascular 
Direct assessment to 
coronary vessels 
Invasive, Expensive, 
Limited to coronary 
patients, challenging 
for reproducibility 
FMD Brachial artery, 
Femoral artery 
Easy assessment, well 
correlate with invasive 
epicardial vascular 
function 
Need standardization, 
highly operator 
dependent 
Plethysmography Peripheral artery Easy assessment, 
stimulation by drug 
injection  
Time consuming 
EndoPAT Finger 
microcirculation 
Easy assessment, well 
correlate with invasive 
approaches 
Highly sensitive, 
possibility of capturing 
non-Endothelial 
derived changes 
FMD: Flow-mediated dilatation. PAT: peripheral arterial tonometry. 
Source: Flammer et al. 2012 
The epicardial endothelial assessment is a pioneer suggestion to assess the endothelial 
performance. This technique was first proposed by Ludmer et al. aiming to stimulate 
the endothelial layer chemically (Ludmer et al. 1986). In this approach, the endothelial 
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cell is stimulated by injection of acetylcholine while the endothelial reaction is captured 
either by US or coronary angiography operation. In respond to this stimulation, the 
intact endothelial cell show proper reaction by dilating vessel conduit (vasodilatation) 
whereas impaired endothelial cell react inversely to constrict the vessel diameter 
(vasoconstriction). This test can be also done by other chemical substances such as 
Salbutamol and Serotonin (Puri et al. 2012). This technique was highly attended in 
1980s to that extent that many researchers took this approach as a gold standard 
technique to assess endothelial performance (Anderson 1999).  
 However, this approach was then challenged mainly due to administration of 
exogenous vasodilator substance. In fact, this technique represented the endothelial-
independent reaction and thus could not be expanded to the endothelial-dependent 
dilatation. Later, this technique was modified by using both endothelial-dependent and 
independent substances (Drexler & Zeiher 1991). However, the epicardial endothelial 
assessment technique was invasive and thus could not be recognized as a suitable 
approach particularly for healthy subjects.  
 Functionally of endothelial layer was also assesses via an elastic-thin Doppler 
wire. Using this technique, endothelial cells were stimulated by infusion of chemical 
substances (e.g. nitroglycerin) while velocity of blood flow -along the site of interest- 
was measured using the Doppler wire as shown in Figure 2.11 (Anderson 1999). 
According to the human physiology, infusion of a vasodilator substance makes the 
blood vessel larger. In such case, blood flow velocity is supposed to be varied 
(decreased) compare to baseline and vice versa. However, this approach needed a 
special system setup and an experienced operator. Moreover, such operation was found 
risky as there is a possibility of cutting vessel walls. Furthermore, this technique could 
not be used for early assessment of ED (i.e. limited to coronary patients only).  
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Figure 2.11 Endothelial dysfunction assessment via a Doppler wire 
Source: Shimokawa 2016 
 In another less invasive approach, possibility of endothelial assessment using 
the concept of pulse wave analysis was investigated by Hayward et al (Hayward et al. 
2002). In this work, the glyceryl trinitrate was used to stimulate the endothelial layer. 
Then, the parameter of augmentation index was used to trace the vascular reaction 
before and after administration of glyceryl trinitrate among eleven subjects. It was found 
at the end that the augmentation index is significantly varied (up to 6%) after stimulating 
the endothelial layer. Therefore, the pulse wave analysis was introduced as a potential 
technique to assess the endothelial functionality. Capability of such technique was later 
endorsed by other groups (Lind et al. 2003; Wilkinson et al. 2002). For instance, 
possibility of assessing the endothelial performance via pulse wave analysis was 
investigated by Jadhav et al. (Jadhav & Kadam 2004). In this work, pulse wave velocity 
was measured among totally 102 subjects. In addition, endothelial performance was 
captured via ultrasonography. Results showed an excellent correlation between these 
two techniques. As a conclusion of this work, pulse wave velocity was introduced as a 
potential parameter to assess the endothelial dysfunction non-invasively. 
 In another similar approach, endothelial performance was evaluated using a ratio 
in blood flow before and after injection of acetylcholine (i.e. chemical vasodilator). In 
this technique, blood was taken from the coronary artery. In healthy group, an increase 
in blood flow was observed as a result of endothelial-derived vasodilatation. However, 
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no change in blood flow (vessel diameter) was observed among non-healthy subjects. 
Using this approach, the endothelial functionality is normal if the blood flow become at 
least two times higher after administration of acetylcholine (Camici & Crea 2007). 
 In a comprehensive work by McEniery et al. (McEniery et al. 2006) the 
association between ED and aortic pulse wave velocity, augmentation index and central 
pulse pressure was investigated among 89 subjects. In this work, the endothelial cells 
was stimulated by sublingual nitroglycerin and inhaled albuterol. Values of the 
mentioned parameters were compared before and after the stimulation. In addition, the 
endothelial performance was assessed via ultrasound imaging. It was observed that the 
endothelial performance is significantly and inversely correlated with aortic pulse wave 
velocity, augmentation index and central pressure pulse.  
 However, invasive operation can be highlighted as a common disadvantage of 
all mentioned endothelial assessment techniques which are discussed above. Besides, 
the coronary artery is mostly used in these techniques. Such disadvantages limit these 
techniques to patients who are suffering from coronary diseases (near to do angiography 
or open heart surgery). In other words, invasive techniques cannot offer a possible way 
for examining the endothelial layer among healthy subjects. Therefore, the global 
interest has been motivated to propose non-invasive approaches to evaluate the 
endothelial activity. 
2.5.3 Non-invasive Methods 
Compare to invasive approach, non-invasive approach has been particularly attended 
over last two decades mainly due to possibility of mass-screening. Indeed, it relies on 
the fact that non-invasive techniques can be used generally whereas invasive techniques 
are limited to coronary patients only. However, in non-invasive approaches, coronary 
arteries cannot be used to assess the endothelial performance as there is a limitation to 
access such arteries. Thus, large arteries (e.g. brachial, femoral) are normally considered 
to assess the endothelial functionality. Since late 1990s, it was a dilemma that whether 
a local endothelial reaction can be considered as the so-called systemic endothelial 
functionality or not. In other words, endothelial layer has the same performance through 
the vascular network or not. Interestingly, such hypothesis has been investigated and 
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confirmed by many researchers meaning that local endothelial functionality can be 
extended to entire endothelial layer in vasculature (Jambrik et al. 2004; Matsuzawa et 
al. 2013). At present, the peripheral artery has been mainly attended -as a target site- to 
assess the endothelial functionality.  
 Referring to Table 2.2, there are three non-invasive methods to assess the 
endothelial dysfunction; FMD, plethysmograph and endoPAT. It should be noted that 
such categorization is based on endothelial assessment technique and not stimulating 
the endothelial cells. For instance, in plethysmography approach, endothelial cells are 
stimulated invasively using some vasodilator substances but in fact, assessment of 
endothelial functionality is done via plethysmography non-invasively. These 
approaches are explained below.  
a)  FMD-Ultrasound 
FMD was first proposed by Celermajer et al. (Celermajer et al. 1992) in which they 
proposed a physiological way to stimulate endothelial cells non-invasively while 
endothelial reaction is captured via ultrasound (US) imaging. This technique has been 
established and used in today's medicine. In fact, this technique has been more attended 
compared to other non-invasive techniques. Accordingly, it is used as the reference 
technique in this research in order to evaluate current performance of endothelium. 
Therefore, this technique is explained in details in the following sections.  
Flow Mediated Dilatation (FMD) 
FMD is a non-invasive technique to stimulate endothelial cells (layer) via a 
physiological excitation (Corretti et al. 2002). Using this technique, blood circulation -
in a large artery- is blocked for around five minutes. Such occlusion creates the phase 
of shear stress across the vessel wall. As blood circulation is retrieved again, a density 
of blood is immediately rushed into the block site. It provides a state of reactive 
hyperemia in which the endothelial cells secrets the NO leading to vasodilatation 
(increasing the vessel diameter). The activity of the endothelial layer can be captured 
via US imaging. 
A) Procedure of the FMD test 
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The FMD test starts with measuring individual's blood pressure. Value of blood 
pressure is then used to apply an appropriate pressure over an artery of interest for 
occluding the blood circulation. After measuring blood pressure in normal situation 
(baseline), subject is asked to lie down on a bed and being in supine position. Then, a 
few minutes should be passed till blood circulation becomes stable again. In this phase, 
the current diameter of brachial artery is continuously captured for around three minutes 
via a high frequency US system. Obtained values of diameter are then averaged and 
considered as a baseline diameter.  
 Afterwards, the brachial blood circulation is fully occluded by applying 
additional 50 mmHg to value of pressure obtained in the baseline. Such occlusion can 
be done via the rapid cuff inflator apparatus. In case of blood occlusion (i.e. ischemia), 
the phenomenon of shear stress is created. Results would be a constant stress toward 
the vessel wall. Soon after five minutes, the pressure cuff is suddenly deflated resulting 
in the state of reactive hyperemia. In this situation, the normal endothelial layer is 
supposed to respond to such physiological stimulus by releasing an adequate volume of 
NO. The physical evidence of such secretion is widening the vessel conduit. The 
consequence of physiological steps during the FMD stimulus is illustrated in Figure 
2.12. 
 
Figure 2.12 Physiological conditions during the FMD test 
 In order to be able to follow the endothelial reaction after releasing the pressure 
cuff (release mode), the vessel diameter is continuously captured for another five 
minutes. Finally, the actual functionality of endothelium can be assessed by comparing 
the brachial diameter before (baseline) and after (release) the occlusion. The normal 
endothelial reaction is supposed to dilate the brachial artery for at least 10% greater than 
baseline diameter as can be seen in Figure 2.13.  
Occlusion Ischemia Reactive 
Hyperem
ia 
Release 
NO 
Vasodilatation 
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Figure 2.13 a) FMD-US practice b) Tracing the brachial diameter c) Representation 
of variations in vessel diameter through a curve  
B) The FMD Setup 
The FMD test requires special setup for conducting an appropriate stimulus over 
individual's artery. The setup is quite expensive mainly consist of a high frequency 
ultrasound system, rapid cuff inflator and additional edge detection software for 
measuring the brachial diameter during the FMD test. The system setup and role of each 
device in the FMD test is explained in the session below. 
i) Rapid Cuff Inflator 
Although brachial blockage can be done by a normal pressure cuff, but an instant 
occlusion is desirable in the FMD test. In fact, it can guarantee the efficiency of the 
shear stress and provide a better situation for exciting the endothelial cells. An instant 
occlusion has been addressed as a key factor in the FMD test (Betik et al. 2004; Dyson 
et al. 2006; Harris et al. 2010). It can be done via the rapid cuff inflator which is 
consisted of an air compressor, relay and a pressure cuff with possibility of quick 
inflation and deflation (i.e. one third of a second). A favorite pressure can be given to 
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the rapid cuff inflator so that once the switch key (relay) is pressed, the given pressure 
is applied to a site of interest along one third of a second.  
ii) Sphygmomanometer 
According to the FMD guideline, an additional 50 mmHg should be applied to the 
brachial artery for an appropriate occlusion (Corretti et al. 2002). Thus, primary 
measurement of the brachial blood pressure plays an important role in accuracy of the 
FMD test. Blood pressure can be obtained via an ordinary Sphygmomanometer 
apparatus.  
iii) Ultrasound Machine 
The ultrasound machine is another essential part of the FMD-US analysis. It provides a 
visual assessment to the endothelial activity during the FMD test so that the endothelial 
reaction can be faithfully assessed. Irrespective of the sonographer's skill, frequency of 
US transducer plays a key role on the resolution of ultrasonic images. Hence, a high 
frequency transducer -preferably above 10 MHz- is highly advised to get a high quality 
images.  
iv) Edge Detection Software 
The main part of the FMD analysis is to measure the variation of brachial size before 
(baseline) and after (cuff release) conducting the FMD stimulus. In fact, size of brachial 
vessel should be incessantly traced preferably by an automatic software. Such 
measurement should be done pixel by pixel using a precise algorithm. Only a few 
programs were found commercially available -at the time of doing this research- to 
detect the vessel wall automatically.  
 
v) Operator 
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After releasing the pressure cuff, there is a short time to capture the endothelial reaction. 
Such time can be known as a gold moment in the FMD test. Thus, an experienced and 
trained sonographer is essentially needed for capturing such gold moment. In fact, FMD 
operator should be well familiar with the FMD test as well as physiological changes 
during the stimulus. It means that a good FMD-US test can be done only by a trained 
operator. Such difficulty is however considered as one of the disadvantaged of the 
FMD-US technique as mentioned in Table 2.2. 
Difficulties of the FMD Test in Real Clinical Practice 
The FMD-US technique has been known as a reliable and reproducible approach to 
assess the endothelial functionality (Charakida et al. 2013). Indeed, this technique is 
well established and known as the most attended technique to assess the ED non-
invasively. However, this technique has also some limitations which are explained 
below.  
A) Expense of Equipment 
In order to implement this test, the FMD lab should be unavoidably equipped with 
essential elements which are addressed above as the FMD setup. In practice, providing 
the FMD setup is remarkably costly. The most expensive part of the FMD setup is a 
high frequency ultrasound machine which is usually limited in numbers in clinical 
centers. Fasting overnight should be also taken into account meaning that the best time 
of conducting the test is the morning (Corretti et al. 2002). The issue of fasting can be 
considered as a common requirement for other clinical tests (e.g. cardiac 
ultrasonography). So that, the peak time of using the ultrasound machine is mornings 
for both patient and healthy (client) groups. In such situation, priority of usage should 
be reasonably given to patients rather than those who want to checkup their endothelial 
performance. Such difficulty limits the possibility of voluntary endothelial checkup for 
healthy subjects. Thus, the FMD-US technique cannot be considered as a routine 
technique for assessing the endothelial performance particularly among non-healthy 
subjects.   
B) Skilled Operator 
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Essential role of FMD operator can be considered as another limitation of this approach. 
As quoted earlier, capturing the endothelial activity should be done right after releasing 
the pressure cuff. Any insouciance or awkward mistakes -caused by lack of experience- 
may lead to lose the gold moment for capturing the endothelial activity. Therefore, this 
technique is highly operator dependent to that extent that it cannot be done without an 
experienced operator.  
b)  PPG  
In general, plethysmography is an established technology to measure fluctuations of 
blood in an organ or whole body. Photoplethysmography is also a plethysmography-
based technology in which blood volume change is accessed optically (Shi 2009). Such 
technology is well established and widely used in today's healthcare industry. As such, 
oxygen saturation signal can be mentioned which is obtained using a finger PPG sensor. 
Interestingly, PPG has been considered as a potential tool for detecting vascular 
abnormalities as it represents the blood volume change along each cardiac cycle. For 
instance, possibility of detecting atherosclerosis -as an indicator of ED- was first 
investigated by Barnes et al. (Barnes et al. 1977) in which the PPG signal was taken 
from supraorbital and frontal sites among 78 patients who were undergoing 
arteriography. Statistical analysis showed abnormal shapes of PPG waveforms among 
those with certain vascular occlusion confirmed by arteriography. Thus, it was reported 
that the PPG approach could detect the vascular blockage with over 93% of similarity 
with the gold standard technique. Therefore, the Photoplethysmography was introduced 
as an alternative method for detecting occlusive abnormalities in vessels.  
 In another similar work, Lund et al. (Lund 1986) studied the possibility of 
examining the endothelial performance via digital pulse Plethysmography. In this 
research, Nitroglycerin was used -as a chemical exciter of the endothelial cells- to 
stimulate the endothelial layer. Comparison between signals obtained before (baseline) 
and after the perfusion showed a significant difference in notch area of the PPG signal. 
Thus, it was concluded that the PPG signal could be a potential tool to capture the 
endothelial reaction. This concept was then reinvestigated by several different teams 
resulting in recognition of using the PPG-based approach for assessing the endothelial 
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functionality. (Chowienczyk et al. 1999; Ruiz-Vega et al. 1997). As such, Millasseau et 
al. proposed a PPG-based technique to assess the vascular stiffness (Millasseau et al. 
2002). 
 Cardiac output has been also used to represent the vascular stiffness in the aorta. 
This parameter is scientifically known as the stroke volume which indicates the volume 
of blood which is rushed out from the heart to the following arterial network (Allen 
2007). Stroke volume was previously calculated using Doppler-pulse technology 
(Huntsman et al. 1983). In this technique, it was calculated by multiplying values of 
aortic diameter and aortic velocity obtained via Doppler-ultrasonography. Irrespective 
of its costly setup, further investigations showed that the stroke volume which is 
obtained by this technique is not reproducible and may vary from time to time (Labovitz 
et al. 1985). PPG was then considered as a potential approach to assess the stroke 
volume. Such concept was first proposed by Romano & Pistolesi in which they 
suggested a technical way for calculating the stroke volume via PPG signals (Romano 
& Pistolesi 2002). This approach was then improved and compared with invasive 
approaches. Results showed a faithful agreement between these two methods with over 
94% of similarity. The accuracy and suitability of the PPG approach has been 
investigated in several later studies (Butter et al. 2004; Whinnett et al. 2006).  
  PPG was also used to compute the pulse transit time in order to capture vascular 
occlusion (endothelial dysfunction) (Nitzan et al. 2002). In this research, ECG signal 
plus two PPG signals obtained from subject's finger and toe were simultaneously 
recorded among totally forty four healthy men. Using standard signal processing 
techniques, the time delay between ECG and pulse arrival time -in finger and toe- was 
computed. Results showed that such time delay is shorter among elderly people whereas 
it is longer among young subjects. This conclusion was in a good agreement with 
previous finding. Thus, the PPG-based approach was considered as a reliable technique 
to obtain the pulse transit time used for vascular assessment. 
c)  endoPAT 
endoPAT is a well-known commercially available device to assess the endothelial 
dysfunction non-invasively (Itamar 2009). Using this device, endothelial cells are 
stimulated using the FMD test while endothelial reaction is captured from subject's 
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index finger. In fact, an arm is used as a reference while the other arm is used as the so-
called experimental arm. As mentioned earlier, releasing the pressure cuff creates the 
phase of reactive hyperemia in which NO is secreted. Accordingly, vascular diameter 
is increased so that blood pressure and blood flow are varied. Such variations are then 
captured using the endoPAT device which indicates the endothelial response. In other 
words, characteristics of blood flow signal before (baseline) and after stimulating the 
endothelial cells are used -rather than vessel diameter- to represent the actual 
endothelial functionality (Faizi et al. 2009).  
 Investigations have shown that results of endoPAT are reproducible (Tierney et 
al. 2009). Moreover, it is operator independent and thus can be easily performed even 
by users. Furthermore, no ultrasound machine is needed in this approach. Therefore, its 
system setup is highly cost-effective compared to FMD-US. In addition, it does not 
require any additional program to analysis the test (i.e. vascular changes). However, 
comparison between endoPAT and FMD-US technique has shown that there is a 
disparity between these two techniques. For instance, Takasa and his co-worker (Takase 
& Higashimura 2013) examined the endothelial functionality of 47 hypertensive 
patients via FMD-US and endoPAT system. Using FMD-US technique, endothelial 
reaction was assessed via ultrasonography whereas in endoPAT, it was examined based 
on finger PPG signals. Comparison between results has shown that endoPAT is not able 
to measure NO-related dilation (i.e. which is a basic substance of endothelial reaction) 
and hence may not be reliable.  
 In another study by Moerland et al. (Moerland et al. 2012) the accuracy of 
endoPAT system was evaluated in conjunction with conventional techniques (e.g. 
FMD-US, angiography, etc.) among both healthy and unhealthy groups (different 
population). In this study, non-invasive measurements were repeated in order to 
investigate the accuracy and reproducibility of endoPAT concerning evaluation of 
endothelial changes. It was observed that effects of robust interventions could not be 
detected among healthy subjects. Moreover, it was also observed that endothelial 
function assessed by EndoPAT could be physiologically different from endothelial 
function which is assessed by conventional techniques. Accordingly, it was concluded 
that the EndoPAT might not be suitable choice to assess endothelial dysfunction.  
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 In another study by Arrebola-Moreno et al.  (Arrebola-Moreno et al. 2012) 
accuracy of endoPAT system to capture the so-called pure endothelial factors has been 
investigated. It has shown in this study that assessment of endothelial functionality from 
subject's index finger may reflect endothelial factors as well as non-endothelial factors. 
In fact, non-endothelial factors refer to the phenomenon of autoregulation in human 
vascular system. Such physiological interaction is the tendency for blood flow to remain 
constant in case of changes in local arterial pressure. According to physiology of human 
vascular system, this phenomenon is occurred only in small arteries (e.g. finger artery, 
auricle, etc.) (Stouffer 2016). In fact, stimulation of brachial artery comprises both 
endothelial reaction and the autoregulation. Therefore, an index finger PPG signal 
reflects endothelial and non-endothelial factors. 
 Regardless of limitations of the endoPAT system, plethysmography was found 
as a potential approach to be used to assess the endothelial dysfunction. As explained, 
this approach is considerably cost-effective, operator independent and easy to use 
compare to the FMD-US technique. Therefore, improvement of such approach has been 
particularly attended over last decade. As such, doctoral research of Rosmina Jaafar can 
be mentioned (Jaafar 2009). In this study, PPG was used to access finger blood volume 
change along each cardiac cycle. It was done using the Dolphin PPG system. FMD-US 
technique was also used -as the reference technique- to assess the endothelial 
dysfunction. In addition, subject's index finger PPG signal -from both left and right 
fingers- were simultaneously recorded to analysis the endothelial reaction. This 
experiment was performed among 145 subjects including 68 healthy subjects and 77 
subjects with CV risk factors. Changes in DC component of finger PPG signal before 
(baseline) and after releasing the pressure cuff was used to represent the actual activity 
of endothelium. Goodness of this technique was then evaluated in conjunction with 
results obtained from FMD-US technique. Accordingly, sensitivity and specificity of 
the proposed technique were obtained 74% and 60% respectively. Also, the proposed 
technique could go one step forward and provide a practical way to replace the 
ultrasonography with PPG. Moreover, it was observed that the proposed technique is 
more repeatable compare to the FMD-US technique.  
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 However, recent researches have shown that this approach has some conceptual 
and technical limitations. For instance, blood occlusion across the brachial artery was 
done via a typical blood pressure device meaning that inflammation and deflation of the 
pressure cuff was done manually. On the other side, such physiological stimulus need 
be done very quickly i.e. less than a second (Corretti et al. 2002). In fact, such quick 
time could apply (create) appropriate shear stress towards the vessel wall so that the 
endothelial cells can be appropriately stimulated. In other words, manual (long) 
deflation of the pressure cuff may moderate the endothelial reaction.  
 Another technical limitation of this study was to measure the vessel diameter 
manually. Since the FMD-US technique is based on variations of the vessel diameter, 
the cross sectional area of a target vessel need to be measured continuously and 
completely. However, such a measurement was done discretely and randomly in this 
work. In fact, automated measurement of vessel diameter during the FMD test is an 
essential part of this approach (Corretti et al. 2002). In other words, accuracy of studies 
in which ultrasound images were measured manually has been considerably challenged 
(Atkinson & Batterham 2013; Bots et al. 2005). Differences between automated 
measurement (left) and manual measurement (right) can be seen in Figure 2.14. 
   
Figure 2.14 Measurement of vascular diameter using an automated program (left) 
and manual measurement 
As for conceptual problem of this work, conducting endothelial stimulation in a large 
artery and capturing the endothelial response from a different vascular segment can be 
mentioned. In other words, endothelial stimulation was truly done across a large 
(peripheral) artery but the response was captured in a small artery in which arterial 
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resistance is different (i.e. higher) from the stimulated segment.  In fact, it is 
demonstrated that vascular resistance in small arteries is considerably higher compare 
to large arteries (Bagher & Segal 2011; Muiesan et al. 2012). Thus, pathological 
characteristics of large arteries (e.g. peripheral, brachial, femoral, etc.) are different 
from small arteries (e.g. radial). Moreover, characteristics of microcirculation are even 
different from small arteries (Boulpaep 2012). Accordingly, the process of blood 
regulation in microcirculation is different from large arteries meaning that there is an 
additional parameter involved in vascular tuning rather than endothelial related factors. 
This parameter is known as autoregulation which refers to non-endothelial factors (Fung 
2013).  
 Possibility of capturing non-endothelial related factors in small arteries has been 
investigated by Nohrina et al. (Nohria et al. 2006). In this study, effects of NO -as the 
main driver of endothelial reaction- on amplitude volume pulse of nineteen healthy 
subjects were investigated. In this regards, PPG signals were simultaneously recorded 
from peripheral and radial arteries before (baseline) and after infusion of a vasodilator 
substance. Pulses were then analyzed and compared to each other using typical signal 
processing techniques. Although NO-related effects (i.e. endothelial reaction) were 
supposed to be observed through both pulses but it was observed that the endothelial 
response in brachial artery is considerably lower compared to what is captured from 
peripheral artery. Regulation of vasomotor in brachial artery was introduced as such 
phenomenon. Accordingly, it was concluded that there is some additional factors -rather 
than endothelial regulation- in small arteries which facilitate the regulation of vascular 
tone.  
 Referring to the Jaafar's work discussed above, there is a possibility of capturing 
non-endothelial factors in subject's index finger due to effects of autoregulation (Jaafar 
2009). In other words, assessment of endothelial dysfunction from a small artery 
whereas the FMD test (stimulation) was occurred in a larger vascular segment may lead 
to capturing both endothelial and non-endothelial factors. As can be seen in Figure 2.15 
(a), the FMD test was performed across subject's peripheral artery while (b) endothelial 
response was simultaneously assessed from brachial and finger arteries.   
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Figure 2.15 Sites for getting FMD response (a) and endothelial response (b)  
Source: Zahedi et al. 2008 
 Figure 2.16 illustrates endothelial response from brachial (dotted) and finger 
(solid) arteries. Referring to human physiology, endothelial response in peripheral 
artery -in which the FMD test was performed- is supposed to occurred earlier compare 
to finger artery which is away from the stimulated segment (peripheral artery). 
However, endothelial peak captured in finger artery is occurred faster than peripheral 
artery. It may rely on the fact that endothelial response in subject's finger artery is 
augmented due to effects of autoregulation explained above. In fact, both endothelial 
and non-endothelial factors contribute on blood tuning in finger artery so that the 
diameter of vessel in this segment is backed to normal situation very quickly. However, 
such process takes longer time in peripheral artery as there are only endothelial-related 
factors. Therefore, capturing endothelial response from the brachial artery may exclude 
effects of autoregulation and thus, reflect the so-called pure endothelial response.  
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Figure 2.16 Assessment of endothelial reaction of a healthy subject from finger 
(dotted) and peripheral (solid) arteries  
Source: Zahedi et al. 2008 
 As conclusion, PPG sensor is remarkably cost-effective compare to other 
sensors particularly in the domain of cardiology. In addition, it is operator independent 
and very easy to use. Moreover, this system is portable, noninvasive and safe. As quoted 
earlier, this technique is widely used for representation of vital signs. Nowadays, this 
technology is widely used in daily clinical monitoring and ambulatory diagnosis. 
However, this technique is so sensitive to motion artifacts. Thus, subject's cooperation 
is highly needed to get an optimal signal. Besides, environmental lighting should be 
taken into account as it may affect the quality of PPG signals. In this regard, data 
collection in a twilight environment is advised. As discussed, PPG has been known as 
a potential tool to assess endothelial dysfunction. Although recent researches have 
moved towards optimization of this approach but further improvements are still needed. 
For instance, utilizing PPG approach to assess pure endothelial reaction (i.e. excluding 
from non-endothelial factors) remains to be investigated.      
2.6 CHAPTER SUMMARY 
In this chapter, the human cardiovascular system and its main components are briefly 
explained. Endothelial cells, its vital role on human circulatory system and its 
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mechanism are then described. Accordingly, ED and its symptoms are reviewed. 
Afterwards, PPG and system identification are introduced as some potential tools to 
assess endothelial performance non-invasively. Applications of these techniques in 
cardiovascular engineering are then reviewed. Clinical importance of CBP waveform is 
then explained as it is a basis of CBP→RPPG models in this study. Possible techniques 
for obtaining CBP waveforms are then reviewed. Afterwards, most practical techniques 
to assess the endothelial performance are introduced. Such techniques are classified into 
clinical, invasive and non-invasive approaches. Advantage(s) and limitation(s) of each 
approach are then reviewed and discussed. FMD-US technique is then explained as the 
most established technique to assess ED non-invasively. Limitations of this technique 
are then explained and other non-invasive techniques are reviewed. Afterwards, PPG-
based approaches to assess the ED are discussed. In addition, latest PPG-based approach 
to assess the ED (Rosmina Jaafar's work (Jaafar 2009)) is explained and its advantages 
and limitations are discussed. Possibility of capturing both endothelial and "non-
endothelial" factors is introduced as the main limitation of this work. Effects of 
autoregulation in finger artery are mentioned as the main reason of such limitation. 
Afterwards, it is concluded that this work could take a considerable step towards 
establishing PPG-based techniques in order to assess the endothelial dysfunction in 
early stages. However, further investigations are still needed in order to capture the so-
called pure endothelial response. Current research aims to investigate this issue by 
capturing endothelial response from brachial arteries and analysis endothelial response 
using a different approach (i.e. parametric modeling) and upgraded system setup (e.g. 
higher frequency transducer, an automated vessel-edge-detection software, rapid cuff 
inflator, etc.). 
  
 
CHAPTER III 
METHODOLOGY 
3.1 RESEARCH STRUCTURE 
The main objective of this study is to propose a non-invasive way to assess the ED 
based on a forward model between CBP and RPPG. To this end, a pilot study was 
designed in order to investigate the suitability of the CBP-RPPG model as a proposed 
criterion of assessing the endothelial performance. In fact, the pilot study was done to 
ensure the goodness of this model among different subjects along different times. In 
addition, it provided a practical way for primary evaluation of system setup, research 
protocols and data acquisition. The pilot study was done among eight healthy men who 
were participated in this research voluntarily. All subjects were fully informed about 
the research restriction and demands and signed the consent form before participating. 
On sampling day, both CBP and RPPG signals were simultaneously recorded for three 
minutes under normal condition (baseline). Data were then analyzed and stability of the 
CBP-RPPG model was confirmed. In addition, potential difficulties and problems were 
recorded to be avoided in the main data collection. For instance, it was understood that 
battery of PPG sensor need to be charged every day because low battery may lead to 
collect low quality signals. Moreover, there is a need to manage the timing of data 
collection via an automated recording system. Accordingly, a Labview program was 
designed in order to stop collecting data automatically after a given certain time. In 
addition, it was understood that using normal wires for data collection may lead to 
collect noisy data. This matter was solved when coaxial cables were used. Also, it was 
understood that there is a need to follow a protocol in order to manage data concerning 
subject number-name, date and time in order to avoid any confusion in the main data 
collection. Furthermore, a lot of experiences concerning sensors attachment, software-
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hardware troubleshooting and collecting information at the time of data sampling were 
obtained.      
Research proposal was then revised based on the experience obtained from the pilot 
study. Head of the cardiology department, Hospital Universiti Kebangsaan Malaysia 
(HUKM) was introduced as a medical partner of this research. In addition, a sonography 
room in this ward was considered as a venue of data collection because it was equipped 
with a high frequency ultrasound machine, bed and other basic equipment. Besides, an 
experienced and skilled sonographer was appointed -by the medical partner- to conduct 
the FMD-US test. Due to limited number of ultrasound machines in the ward and 
presence of numerous inpatients, only two hours per day was allocated to this research 
for data collection; from 7 to 9 am. Following research protocol, the blood test must be 
done after the FMD-US test in order to get information about the general health 
condition of the participants at the time of giving data. Therefore, each subject was 
asked to attend the sampling session only once. All necessary documents including 
research proposal, consent form, patient information sheet and a poster (to find 
volunteers) were then submitted to ethic committee of the HUKM. The research was 
then approved allowing data collection at department of cardiology. The ethics approval 
can be seen in Appendix A. 
 As mentioned above, the FMD-US test is also used -as a gold standard 
technique- to assess the endothelial performance in conjunction with the proposed 
technique. Thus, this research is a cross-sectional analysis to assess the endothelial 
dysfunction via both approaches. Moreover, it is a single-blind study as the functionality 
of the endothelial layer is not known at the beginning. 
3.2 SUBJECT POPULATION 
In this research, no gender limitation was considered because the ED is a prevalent 
vascular disorder among both males and females (Skaug et al. 2013). The ED is mostly 
observed among middle-age and elderly groups (Seals et al. 2011). Accordingly, 
favorite age range in this study was considered between 30-70 years old. All participants 
were grouped into either healthy or unhealthy groups. The healthy group consisted of 
those subjects who were free from CV risk factors. Conversely, the unhealthy group 
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consisted of those subjects with certain CV disease(s). The whole members of unhealthy 
group were selected by a cardiologist of HUKM among HUKM in-patients. 
3.2.1 Sample Size 
Ideally, number of participants in clinical researches should be preferably as many as 
possible. However, it is normally very difficult to conduct a research with numerous 
subjects mainly due associated limitations such as the cost and time. Therefore, the 
sample size should be realistically determined to ensure research quality while 
considering unavoidable limitations. The sample size of this study was calculated via 
the following equation: 
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in which Sn and Sp are sensitivity and specificity respectively, z is the probability of 
distribution, nn is the number of healthy subjects, na is the number of non-healthy 
subjects and  is the type I error. 
 In these equations, by consideringequal to 5 %, under controlled conditions, 
the proposed PPG technique is expected to have a sensitivity of (90+6)% and specificity 
of (90+6)% with equal number of healthy and unhealthy subjects. However, the FMD-
US test is known as a very tough maneuver in clinical practices. In this regard, the 
sample size of sixty was acknowledged for FMD-based studies (Corretti et al. 2002). 
3.2.2 Inclusion Criteria 
Inclusion criteria can be considered as an inseparable part of clinical researches. In fact, 
it clarifies favorite group of study based on research objectives. In other words, it 
explains desired sample group and proffered conditions of conducting a study. In this 
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research, the inclusion criteria were separately determined for healthy and non-healthy 
as can be seen in Table 2.1. 
Table 3.1 Inclusion Criterion of healthy and unhealthy groups 
 
 
Inclusion 
Criterion 
Healthy 
Group 
 Male and female adults between 30-60 years old 
 Non-smoker, non-hypertensive, non-diabetics, non-dyslipidaemiaand 
free of CV heredity and risk factors 
 
Unhealthy 
Group 
 Male and female adults between 30-60 years old 
 Adults with certain CV abnormalities like; diabetes, hypertension, 
atherosclerosis or dyslipidaemia 
 Adults with first-degree family disorders (i.e. those with relatives who 
are suffering from CV disease (heredity)) 
3.2.3 Exclusion Criteria 
In contrast to the inclusion criterion, the exclusion criterion explains conditions or a 
specific group of people that cannot be considered in a study. Such filtering is designed 
based on research objectives. In this research, restrictions were considered for healthy 
group. Details of exclusion criterion for both healthy and unhealthy groups are shown 
in Table 2.2. 
Table 3.2 Exclusion Criterion of healthy and unhealthy groups 
 
 
 
Exclusion 
  
Criterion 
Healthy 
Group 
- 
 
 
Unhealthy 
Group 
 Those with stroke or myocardial infarction history 
 Those with CV diseases and eGFR 
 Those who underwent vascular surgery or renovascular (perwtaneous 
or surgery) 
 Those with systemic inflammatory diseases 
 Those who had the heart or lungs transplantation 
 Those who have been administrated vasodilator including Calcium 
channel blockers nitrates, beta or alpha blockers 
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3.3 DATA ACQUISITION 
A poster was designed and advertised in a notice board of UKM and HUKM in order 
to motivate people to take part in this research. As mentioned before, this poster was 
ethically and contently approved by ethical committee of the HUKM. Candidates were 
then selected based on the inclusion and exclusion criteria which are mentioned above. 
A general description of this study plus its procedure, demands and consent form were 
given to each participant in written form prior to data collection. They were asked to 
read the description and express their agreement -to participate to this study-by signing 
the consent form (Appendix B).   
 Data collection was done at the department of Cardiology, HUKM. Data were 
recorded under the same environmental condition by applying the same procedure to all 
subjects. The sampling room was temperature controlled and free of noise during all 
recording sessions. Ultrasound images were acquired by the sonographer who was 
responsible for the sector of ultrasound cardiology in the department of Cardiology, 
PPUKM. Data collection form can be seen in Appendix C. 
 The Labview program which was previously used for pre-data collection was 
upgraded and used to manage data monitoring and storing. Three windows were 
designed in this program to facilitate signal monitoring so that each signal can be 
individually displayed in a specific window. A "record" button was also designed in the 
Labview graphical panel in order to start data storing at the same time. In addition, a 
built-in timer was designed to stop data saving automatically after thirteen minutes 
(length of data collection). Figure 3.1 illustrates the graphical panel of the used Labview 
program. 
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Figure 3.1 A screen shot of the Labview program used in the data collection 
3.3.1 Subject Preparation and Sampling Atmosphere 
Following the FMD-US guideline, all subjects were asked fast overnight and refrain 
from any drug administration and doing physical activity at least three days before data 
collection (Corretti et al. 2002). At the beginning of each sampling session, the subject 
was shortly asked about these notes in order to ensure that all restrictions are rightly 
followed and he/she is in a good health condition not only for the data collection but 
also for giving blood.  
 Subject was then asked to go to another room for measuring subject's height and 
weight. These parameters were measured for obtaining the body mass index (BMI). 
After completing this part, the subject was asked to lie on a bed in supine position. Ten 
minutes was intentionally spent to ensure that subject's blood circulation is stable. Blood 
pressure was then taken from both left and right arms by a digital sphygmomanometer 
(Omron, T8 Japan). These values were then averaged and considered as the blood 
pressure values. 
 In order to do the FMD test, the blood circulation in brachial artery must be fully 
blocked. To this end, an additional 50 mmHg pressure should be applied to the brachial 
artery via an inflating pressure cuff (Corretti et al. 2002). Therefore, an appropriate 
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pressure value (i.e. systolic pressure value plus 50 mmHg) was given to the rapid cuff 
inflator machine to be applied over the brachial site. Afterwards, an adjustable pressure 
cuff was wrapped around the right upper arm. In addition, the PPG sensor and 
applanation tonometry probe were located over the right and left radial arteries (wrists) 
respectively. Hence, the CBP, RPPG and radial pressure pulse (RPP) were obtained 
(displayed) on their own channel as can be seen in Figure 3.1.The stability and goodness 
of these signals were visually evaluated by operator. 
 After locating the sensors, ECG electrodes were placed across subject's chest in 
order to record the ECG signal along the ultrasonography. In favor of obtaining high 
resolution images, all subjects were asked to strictly avoid from any movement, arm 
shaking and even talking. The brachial diameter was then continuously captured for 
three minutes by the vivid i ultrasound machine accompanied by a 10 MHz transducer. 
All ultrasound images were collected by a skilled sonographer and saved in DICOM 
format under subject's name. The convention of data saving is explained in section 
3.3.3.After obtaining brachial images, a few minutes were intentionally passed to make 
sure that the blood circulation is become stable again. Once all signals were found 
stable, the record bottom in the Labview program was pressed resulting in simultaneous 
data storing in the laptop.  
 As quoted earlier, data were recorded under normal condition (baseline) in the 
first three minutes. Soon after this time, a foot switch of the rapid cuff inflator was 
pressed resulting in sudden blood occlusion across the brachial artery. This phase 
(occlusion mode) was continued for five minutes to ensure that the FMD stimulus is 
perfectly performed. Before exceeding this time (i.e. after 4ʹ:30ʺof blockage), the 
transducer was placed over subject's right arm in order to be ready to trace the brachial 
diameter (Endothelial reaction) immediately after releasing the pressure cuff. Sharp 
after five minutes, the pressure cuff was deflated by re-pressing the foot switch of rapid 
cuff inflator so that a large density of blood was suddenly rushed into the brachial artery 
while the brachial diameter was continuously capturing via ultrasound. Data recording 
was continued for another five minutes (release mode). The main steps of data 
collection are shown in flowchart 3.1. 
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Flowchart 3.1     Steps of data collection 
Figure 3.2 shows the time chart of data collection. As can be seen in this chart, data 
were continuously recorded from thirteen minutes including baseline (3 minutes), 
blockage (5 minutes) and cuff release (another 5 minutes). A digital clock was used to 
follow the time chart.  
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Figure 3.2 Time chart of data collection 
Figure 3.3 shows the sampling environment, system setup and a subject during the data 
collection. 
 
Figure 3.3 Subject and setup during data collection 
 After finishing the FMD-US test, blood was taken by an authorized nurse in the 
ward. A new pack of syringe and needle was used for each particular subject. Obtained 
blood sample was then shared into five small tubes in order to send to laboratory office 
of the PPUKM for different blood analysis (e.g. fasting lipids, liver check). After taking 
blood, a light sweet breakfast was given to each subject. 
59 
 
3.3.2 Device and Sensor 
a) Pulse Oximeter Sensor  
In this study, the g.tech plethysmographic pulse sensor -from g.tech company, Austria- 
was used to obtain blood volume change over the brachial artery (RPPG signal). In fact, 
it is a photoelectric pulse sensor that represents the variation of blood flow along each 
cardiac cycle. Figure 3.4 illustrates the used pulse sensor in this study. 
  
Figure 3.4 The g.tech sensor (left) and its probe over the brachial artery (right) 
 This sensor works with a 9 v battery. In order to avoid battery-related 
inconvenience during data collection, two chargeable batteries were used intermittently. 
At the beginning of each session, a full charged battery was put in the sensor while the 
other one was charging. These batteries were replaced at the beginning of each session. 
The probe was fixed over the brachial artery by an elastic strap as shown in Figure 3.4. 
Output of this sensor was a voltage signal with alternation between ±1 mV. The 
goodness and stability of the RPPG signal -obtained by this sensor- was visually 
evaluated by an operator on site before start recording.  
b) The SphygmoCor 
There are several devices available in the healthcare market for estimating the central 
blood pressure (CBP) non-invasively. Among them, the SphygmoCor has been mostly 
attended due to convinced degree of accuracy and validation papers (Ding et al. 2011; 
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Sharman et al. 2006). In fact, the technology of the SphygmoCor is based on a general 
transfer function in which the CBP waveform can be estimated from the RPP signal 
non-invasively. The theory of this concept was discussed in section 2.7.1. This device 
is consisted of three main components: a hardware box, an applanation tonometry and 
a software program. 
 The SphygmoCor box contains the hardware components and external ports for 
exporting data (signals). The external ports are located at the back of the box. Using RS 
232 cable the ports can be connected to a computer in which the SphygmoCor driver is 
already installed in. In fact, this software is a windows-based interfacing system 
between the SphygmoCor and a computer to facilitate Real-Time signal monitoring and 
storing. The SphygmoCor box also has a drawer for isolating a female plug -which is 
installed in- from environmental disturbances. The applanation tonometry is a 
piezoelectric sensor which converts the pulsatile stroke into an electrical signal 
(pressure pulse). It's connected to the female plug via a cable. The mentioned 
components of the SphygmoCor are shown in Figure 3.5. 
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The SphygmoCor program 
 
The SphygmoCor box 
The drawer  
 
 
The applanation tonometry 
 
Figure 3.5 The SghygmoCor device and its components 
The SphygmoCor device can operate in two different modes; 
1. Pulse Wave Velocity (PWV): in this mode, either carotid-ECG or 
radial/femoral-ECG can be simultaneously recorded for pulse wave analysis. In this 
mode, the CBP cannot be estimated.  
 
2. Pulse Wave Monitoring (PWM): in which, both CBP and RPP can be accessed 
in arbitrary unit. 
 In this study, the SphygmoCor was worked in the PWM mode so that both CBP 
and RPP were simultaneously obtained. These signals (voltages) were collected from 
the external ports of the SphygmoCor which are located at the back of this device. The 
62 
 
signals were then connected to the data acquisition unit via two similar cables provided 
by the manufacturer. Ports of the SphygmoCor are shown in Figure 3.6. 
 
Figure 3.6 External ports of the SphygmoCor 
c) Data Acquisition Unit 
In this study, NI 9239 from National Instrument, USA was used to manage simultaneous 
data collection. It was accomplished by the Labview program to display and store 
signals in a laptop. The connection between data acquisition and laptop was done via 
type B USB cable. As can be seen in Figure 3.7 the NI 9232 has four channels to collect 
analogue signals (voltage) between ±10 V. In fact, it is an analogue to digital converter 
which facilitates data transmission into the laptop with same sampling frequency. The 
default sampling value for the NI 9239 is 1600 Hz but in this study, it was increased to 
2000 Hz in order to simplify further calculations. It means that two thousand samples 
were transferred from the data acquisition unit to the laptop in each single second.  
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Figure 3.7 The NI 9239 data acquisition unit 
d) Static Blood Pressure Measurement 
As mentioned earlier, a value of systolic blood pressure plays an important role in the 
FMD test for blocking the brachial artery. In fact, this value indicates an appropriate 
pressure value that need to be applied across the brachial artery to be fully occluded. 
Therefore, precise measurement of blood pressure should be highly taken into account 
in the FMD analyses. In this research, the Omron T8 -from Japan- was used as a digital 
sphygmomanometer to measure subject's blood pressure and heart rate. As usual, it was 
done by wrapping an inflatable pressure cuff across the brachial artery. Systolic, 
diastolic and heart rate were then obtained and documented. This device is shown in 
Figure 3.8.  
 
Figure 3.8 The Omron T8 blood pressure device 
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e) Ultrasound Imaging of the Artery 
In order to capture the endothelial reaction during the FMD test, an ultrasound machine 
with preferably high frequency transducer is needed. In this research, the GE vivid i 
ultrasound machine with a 10 MHz transducer was used. This machine has been used in 
department of cardiology, HUKM hospital for daily cardiovascular imaging. In order to 
visualize the vascular border, the top of the transducer should be covered by some 
disposable gel. Despite, the transducer should be correctly placed over the subject's skin 
in order to obtain a high resolution image. The common mistake is to locate the 
transducer in perpendicular position to an artery but it is a worst case indeed. However, 
the relationship between angle of ultrasound probe and blood stream can be 
mathematically expressed via equation 3.3: 
 cos2 0
c
v
ffd   
(3.3) 
in which ƒd is the reflected ultrasound, ƒ0 is the transmitted frequency, v is the blood 
velocity, c is the sound velocity in tissue and α is the insonation angle between the 
ultrasound beam and the velocity vector (Harris et al. 2010). According to this equation, 
if the ultrasound probe is vertically located over the skin, no image can be captured. 
However, an optimal range of α is between 60°<α<90° (Thijssen et al. 2011).  
 The vivid i ultrasound machine provides a way of recording the ECG signal 
simultaneously. To this end, the ECG electrodes should be placed across subject's chest. 
Figure 3.9. shows a typical ultrasound image in conjunction with the ECG signal. 
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Figure 3.9 The vivid i ultrasound machine 
f) Rapid Cuff Inflator  
One of the key issues in the FMD-US studies is a possibility of sudden circulatory 
occlusion across the brachial site. It can be done by a typical Sphygmomanometer. 
However, it may take a few seconds which affects the efficiency of the FMD stimulus 
so that sudden occlusion is desirable (Corretti et al. 2002). In this study, the rapid cuff 
inflator E20 from Hokanson company, USA was used. It facilitates a rapid occlusion 
(and compensation) over the brachial artery in one third of a second. This device is 
consisted of an air compressor, rapid cuff inflator, a plastic tube, a pressure cuff and a 
foot switch as can be seen in Figure 3.10.  
 In order to use the rapid cuff inflator, a favorite pressure value should be firstly 
given to the device. It can be simply done by rounding a circular lever. Possible range 
of pressure is 0-300 mmHg in which every single 1 mmHg can be seen via a digital 
display. Secondly, the pressure cuff should be wrapped across subject's brachial artery. 
Once the foot switch is pressed, the compressed air is suddenly (i.e. 0.3s) flowed from 
the tank to the pressure cuff resulting in a rapid cuff inflation and sudden brachial 
occlusion. The cuff deflation can be similarly done by re-pressing the foot switch.  
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Figure 3.10 The E20 rapid cuff inflator 
g) Hardware Configuration 
In this study, the ultrasound machine and the rapid cuff inflator were independently 
used meaning that they were not physically connected to other devices. The 
configuration between pulse sensor, SphygmoCor, data acquisition unit and computer 
is explained below. 
 As mentioned above, the SphygmoCor was connected to the computer via RS 
232 cable. The CBP and RPP signals were collected from two ports located at the back 
of the SphygmoCor as can be seen in Figure 3.6. They were connected to the first and 
second channels of the NI 9239 via two separate coaxial cables. On the other side, the 
output of the PPG sensor was connected to the third channel of the NI 9239 via a similar 
coaxial cable. The NI 9239 unit was then connected to a laptop via type B USB cable. 
The Labview program was used on this laptop so that all signals were displayed and 
stored. The setup configuration is illustrated in Figure 3.11.  
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Figure 3.11 The setup configuration 
3.3.3 Data files: Naming Convention 
A convention was used to facilitate data identification after completing data collection. 
In this regard, an exclusive identification number (ID) was given to each participant so 
that all information were saved into an excel file under subject's ID and name. In the 
excel file, all subjects were listed in first column while all parameters such as; age, 
gender, blood pressure and clinical parameters where listed in another columns. Then, 
information of each subject was written in front subject's ID and under parameter's 
name. A screenshot of this file is shown in Figure 3.12. 
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Figure 3.12 A screenshot of the excel file 
 Another file was considered for documenting results of Matlab processing. In 
this file, each sheet was allocated to one participant. The Matlab code was written in a 
way that result of each analytical section was automatically imported to subject's own 
sheet. In this study, two types of data were collected; ultrasound images and signals. 
The procedure of data saving for each of them is separately explained below. 
a) Ultrasound Images 
As quoted earlier, the vivid i ultrasound machine was used in this research. Before 
ultrasound imaging, a folder was created -in the device- under subject's ID. This folder 
was then addressed as a saving location so that ultrasound images of each participant 
were accordingly saved into subject's own folder in DICOM format. At the end of data 
collection, all images were transferred from the ultrasound machine to a hard disk via 
USB cable. 
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b) Signals 
As mentioned above, three signals were recorded in this research: CBP, RBP and RPPG. 
A single text file was used to store data (signals) of each particular subject. Each text 
file was consisted of three columns in which the CBP was saved in the first column 
while the RPP and RPPG signals were saved into the second and third columns 
respectively. The text file was named by subject's ID followed by session number. For 
example, data of subject 87 in session one was saved as: S087session1.txt. At the time 
of data collection, subject's folder was manually addressed so that signals were directly 
saved into subject' own folder. Figure 3.13 shows a screenshot of typical text file 
including three columns.  
 
Figure 3.13 Structure of data (signals) storing in text format 
3.3.4 Clinical Tests 
In order to access subject's clinical parameters at time of data collection blood test was 
considered. It addition, it provided a reliable way for realizing risk factors. Details of 
blood taking and types of analysis are explained below.  
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a) Blood Test  
Blood was taken shortly after finishing the FMD-ultrasound test when subject was still 
fasted. It was done by a nurse -in the department of cardiology- who was on-duty on 
sampling day. All blood takers were authorized and worked at this ward as a nurse. 
Around 3 cc of blood was taken from each participant using a new syringe and needle. 
Blood sample was then shared into five small tubes for different analysis. Four of these 
tubes were immediately send to HUKM laboratory for analysis of fasting lipids, blood 
urea serum electrolytes and liver panel. A single tube was send to a private laboratory 
for high sensitive C-reactive protein test (HS-CRP) which did not perform in laboratory 
of the HUKM hospital at the time of this research. 
b) HS-CRP 
The C-reactive protein is normally generated by liver if there is an inflammation in 
body(Du Clos 2000). The high sensitive C-reactive protein test is widely used to predict 
cardiovascular disease (e.g. atherosclerosis, heart attack) (Morrow & Ridker 2000). The 
normal range of HSCRP test is between 1 to 3 mg/L so that higher values are considered 
as high risk. However, result of this test is normally interpreted in conjunction with 
other risk factors such as levels of cholesterol, LDL-C, triglycerides, glucose, smoking, 
high blood pressure and diabetes. 
3.4 MEASUREMENT OF VESSEL DIAMETER (ULTRASOUND IMAGES) 
As quoted earlier, the FMD-US is a well-known technique to assess the endothelial 
performance. Using this technique the endothelial reaction -to the FMD stimulus- can 
be captured via ultrasound imaging. In fact, the variation in brachial diameter before 
(baseline) and after releasing the cuff represents the endothelial performance (Corretti 
et al. 2002). Therefore, measuring the diameter of brachial artery plays an important 
role on accuracy of the FMD-US technique. Such a measurement should be 
continuously done by an automated system.  
 In this research, the Cardiovascular Suite program -from the Quipu company- 
was used to measure the vessel border automatically (Quipu 2014). In fact, it is an 
71 
 
algorithm based program to trace the brachial diameter which is induced either by the 
FMD test or drug perfusion (e.g. nitroglycerine). In this study, no drug was used to 
stimulate the brachial vessel so that only the FMD-studio program was used. As can be 
seen in Figure 3.14 this program has five small windows which are explained in 
Appendix G. 
 
Figure 3.14 Measuring the vessel diameter by cardiovascular suite program  
 Using this program, brachial diameters were continuously measured from the 
beginning of the experiment (baseline) to the end (after cuff release). Figure 3.15 shows 
a screenshot of a typical result box.  
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Figure 3.15 A typical result window 
Result box is consisted of four windows which are explained below. 
 Window 1: This window shows the variation in diameter of brachial artery 
before and after applying the FMD stimulus. The curve is plotted in terms of the time 
(second) and values of diameter (millimeter). However, assessment to the exact value 
of the time and diameter for a specific point is only possible by moving a mouse across 
the curve while the shift key is pressed. Highest (peak) and lowest values of curves were 
obtained manually and then imported to an excel file.  
 Window 2: This window represents result of the Doppler analysis. As quoted 
earlier, this analysis was not considered in this research and hence, this window remains 
empty in Figure 4.22.  
 Window 3: This window contains a video which show the user operation (i.e. 
selection of ROI, calibration, etc.) during the FMD-Ultrasound analysis. It can be 
played any time after conducting analysis (off-line analysis). 
 Window 4: This window shows some basic parameters and their values after 
finishing the analysis. There are three parameters on the left up side of this window: D 
Window 1 
Window 2 
Window 3 
Window 4 
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Baseline, D Maximum and D recovery. The D Baseline indicates the average of brachial diameter 
in baseline while D Maximum and D recovery showing the maximum diameter during 
occlusion and recovery time (after release the pressure cuff) respectively. There are 
another two parameters on the left down side of this window; FMD and FMD showing 
the rate of brachial dilatation during occlusion and cuff release respectively.  
3.5 SIGNAL PROCESSING 
In general, signal processing is an analytical approach to prepare data (signals) for 
further analysis. In fact, it provides a practical way for applying some mathematical 
features on raw data; from waveform generation to design filter and spectral analysis. 
In this research, all signals were processed before start modeling (system identification). 
It was done by the Matlab software (version R2012a). The used Matlab code in this 
research can be seen in appendix D. Steps of signal processing are explained in 
following sections. 
3.5.1 Distinguishing and Detrending 
As mentioned before (Figure 3.13) raw signals were initially saved in different columns 
of a single text file. Thus, first step of data processing was to distinguish data. It was 
simply done by Matlab so that signals were separated from each other. At the end of 
this session, each signal was named individually (i.e. raw CBP, raw RPP and raw 
RPPG). All signals were then detrended in order to remove the linear trend. 
3.5.2 Filtering 
Raw data is always obtained with some unwanted effects known as noise. Such effects 
should be removed in order to make signal ready for further analysis. This step of signal 
processing is known as filtering. In fact, filtering can be considered as one of the key 
features of signal processing to reveal so-called real data rather than noise. The Matlab 
software is mostly used to conduct the filtering. However, realizing type -and preferably 
source- of noise can improve the quality of noise removal. 
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 In this study, subjects' breathing, hand movement and physical contact pressure 
between sensors and subject’s skin can be mentioned as potential sources of noise. It 
was observed that there is no important information above the frequency of 50 Hz. 
Therefore a low pass filter was designed based on the characteristics of signals. The 
signal processing toolbox of the Matlab was used for such analysis. The optimal cut-off 
frequency was set to 50 Hz so that higher frequencies were automatically filtered. The 
goodness of this filter was evaluated by comparing the raw and filtered signals using 
frequency responses. This filter was then applied to all signals resulting in removing 
noise while keeping important information of signals. Figure 3.16 illustrates two typical 
segments of CBP and RPPG signals before and after filtering.  
 
Figure 3.16 A typical segment of CBP (left) and RPPG (right) before and after 
filtering 
3.5.3 Resampling 
Referring to characteristics of the NI 9239 device, the default sampling frequency of 
this device is 1600 Hz. At the time of data collection, this value was rounded-up to 2000 
Hz. However, frequency analysis (i.e. using Fast Fourier Transform (FFT)) showed that 
the highest frequency of recorded RPPG signals is around 50 Hz. It was also observed 
that the highest frequency rate of PPG is between 45-50 Hz in former referred works 
(Webster 2002). Considering the Nyquist frequency in which sampling frequency 
75 
 
should be at least two times bigger than the higher frequency, signals were down-
sampled to 100 Hz to avoid unnecessary analysis over useless data. The Nyquist 
equation is as follows: 
ff
cs
  (3.4) 
in which fs is the sampling frequency and fc is the highest frequency contained in the 
signal. 
3.5.4 Segmentation 
Results of the pilot study showed that the goodness of the CBP-RPPG model is good if 
whole signal is fragmented into several segments. In other words, poor suitability may 
obtain in case of using whole CBP and RPPG signals as model input and output 
respectively. In fact, characteristics (e.g. amplitude, etc.) of model input and output 
should be preferably similar to each other in order to get a reliable model output. 
Accordingly, variations between peak values of signals can be moderated if short time-
series data are chosen as model input and output. In other words, long time-series data 
may be too different from each other resulting in low quality of estimated model output. 
Moreover, the endothelial reaction cannot be closely traced along the FMD test as it 
occurs immediately after releasing the pressure cuff. Thus, each signal was entirely 
fragmented into several segments with the same length of 3 seconds. It was done via a 
"for" loop in Matlab as can be seen in Appendix D. To this end, each signal was first 
separated into three parts: baseline, occlusion and release data. In this regard, the first 
three minutes of each signal was cut and considered as baseline data. The second and 
third five minutes were similarly cut and considered as occlusion and release data 
respectively. Figure 3.17 illustrates a typical raw data in which the phases of data 
collection are mentioned. Although data were continuously collected for thirteen 
minutes but as can be seen in this Figure, no data were obtained for RPPG signal during 
the blockage as there was no blood circulation during the blockage.  
76 
 
 
Figure 3.17 Representation of a typical raw data; CBP (top) and RPPG (bottom) 
waveforms including the phases of data collection (green arrows) 
Data (i.e. baseline and release) were then fragmented into several segments for further 
analysis. Figure 3.18 illustrates graphical representation of this step. It should be noted 
that number of segments are not exactly same among all subjects because heart rate of 
subjects were different from each other.  
 
Figure 3.18 Segmentation of the baseline data 
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3.5.5 Normalization 
According to the theory of the Matlab system identification toolbox, the amplitude of a 
given input-output pair plays a key role on suitability of the final outcome (Ljung 1999). 
It means that signals with similar amplitude can produce a better model. However, 
amplitude of signals may not be close to each other. In such case, signals can be justified 
in order to be mapped to a certain value of amplitude. In this research, amplitudes of 
CBP and RPPG signals were not close to each other as they obtained via different 
sensors with different technology. Thus, all segments were individually normalized to 
"1"for ensuring that maximum value in each segment is equal to value 1. It was simply 
done by dividing each segment to its maximum value so that the maximum value in 
each segment is 1. Figure 3.19 shows two atypical segments before and after 
normalization. 
 
Figure 3.19 Normalization of a typical CBP (top) and RPPG (bottom) segments 
3.5.6 Synchronization 
Obviously, there is a very short time delay between the central and radial pressure pulse 
waveforms (Takazawa et al. 2007). In other words, the central pressure pulse needs a 
few milliseconds to reach to the radial artery. However, such a physiological time delay 
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is not taken into account in the generalized transfer function used in the SphygmoCore 
device (Pauca et al. 2001). It means that the estimation of the CBP waveform from the 
RPP signal is not a function of time. Since the SphygmoCor device was used in this 
study for obtaining the CBP waveform, time delays between CBP and RPPG waveforms 
were observed (Figure 3.22 (top)). Such time is definitely not same among all 
participants meaning that it is an exclusive value for each subject due to different 
physiological and metabolic conditions. Therefore, it is not possible to propose a 
generalized transfer function. Same issue was reported in similar works -including the 
SphygmoCor- and synchronization is suggested as the solution (Ding et al. 2011; 
Guelen et al. 2008).  Accordingly, CBP and RPPG segments are aligned with respect to 
time. Figure 3.20 shows a typical CBP-RPPG segment before and after synchronization.  
 
 
Figure 3.20 A typical pair of CBP-RPPG before (top) and after (down) 
synchronization 
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3.6 SYSTEM IDENTIFICATION 
As quoted earlier, the main objective of this research is to assess endothelial 
functionality using a forward model between CBP and RPPG waveforms. In fact, such 
model is estimated using baseline data and then used as a robust model while endothelial 
cells are stimulated. Variation(s) of the model is then considered as the endothelial 
response. To this end, a CBP→RPPG model should be estimated for each subject. In 
this research, the Matlab system identification toolbox was used to identify a linear 
parametric model between CBP and RPPG. The analytical steps and interpretation of 
model behavior before and after doing the FMD test are explained in following parts. 
3.6.1 Creation of Time-series Data 
Referring to Figure 2.8, each model should have at least one input and one output. In 
fact, the model is the mathematical expression of relation between system input and 
output. According, CBP and RPPG are defined as model input and output respectively. 
As explained earlier, each set of data is fragmented into several segments with the same 
length of 3 sec. Segments were then used to create the so-called time-series data. To 
this end, each CBP segment is considered as model input while its corresponding RPPG 
segment is considered as model output. Figure 3.21 illustrates the protocol which is 
used to create the time-series data. 
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Figure 3.21 Creation of time-series data using RPPG segment (y1, output) and its 
corresponding CBP segment (u1, input) 
 
A typical time-series data and its constructive segments is also shown in Figure 3.22. 
 
Figure 3.22 Representation of a typical time-series: RPPG as model output (y1) and 
its corresponding CBP as model input (u1) 
3.6.2 Model Determination 
One of the key parameters in system modeling is the type of a model which is used to 
describe relations between model input and output (Ljung 1999). In this regard, a 
primary analysis may help to identify the best suited model structure concerning data, 
model and effective factors on model output. In this research, several model structures 
were investigated over data obtained from the pilot study. In addition, model structures 
in similar studies were studied. Auto-regressive with exogenous (ARX) model was 
previously used -in a similar study by our team- and showed a convinced stability and 
accuracy (Shariati & Zahedi 2005). Therefore, it is used to estimate a forward model 
between the CBP and the RPPG waveforms in this study. In general, the mathematical 
relation between model input CBP(t) and output RPPG(t) in ARX model is defined by 
the following equation: 
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where, the na is the order of denominator (number of poles), the nb is the order of 
numerator (number of zeros), the nk is the time delay between model input and output, 
the a(k) and b(k) are coefficients of numerator and denominator respectively and ε(t) is 
the residual noise (Ljung 1999) By convention and following the theory of system 
identification, the ARX model is shown as ARX [na nb nk] in this study (Ljung 1999).  
3.6.3 Model Order 
After determination of model structure, the order of a polynomial equation should be 
specified. As mentioned earlier, constructive data were synchronized to each other so 
that the physiological lag time between CBP and RPPG was removed (i.e. nk=0). In 
order to determine the number of poles and zeros (na and nb), different model orders 
from ARX [1 1 0] to ARX [5 5 0] were investigated. Referring to section 2.7.2, results 
were then compared to each other based on fitness and the FPE. As can be seen in Figure 
3.23, models with na and nb below 3 were found unstable because of low fitness value 
and high FPEs. The ARX [4 4 0] model had highest fitness value while having the 
lowest FPE value. It was also observed that there is no significant improvement 
concerning model quality for higher model orders (i.e. ARX [5 5 0]) Therefore, the 
model ARX [4 4 0] was selected this study.  
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Figure 3.23 Goodness of models in terms of fitness (left) and FPE (right) 
 However, it should be noted that, different model orders may work better for 
some specific segments. In other words, the ARX [4 4 0] generally works well for all 
data (segments) whereas different models may predict system output more precisely. 
This issue is shown in Figure 3.24. As can be seen, goodness of different model orders 
against a specific segment has been investigated. Compare to ARX [4 4 0] model, the 
ARX [5 5 0] has a better performance although the ARX [4 4 0] has a convinced 
performance too (Figure 3.26 (up)). In contrast, the ARX [5 5 0] model does not work 
well for another segment whereas the ARX [4 4 0] does (Figure 3.26 (bottom)). 
 
 
Figure 3.24 Goodness of different model orders against two typical segments 
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3.6.4 Interpretation of Pole-Zero 
The pole-zero analysis is normally done in system modeling to ensure the stability of a 
proposed model. In this regard, pole(s) and zero(s) are drawn in the unit circle to find 
out how far they are from the circle. A proposed model can be considered as a stable 
model if its poles and zeros are located inside the unit circle. Figure 3.25 illustrates the 
pole-zero diagram of the ARX [4 4 0] model. As can be seen in this figure, all poles and 
zeros are located inside the unit circle confirming the stability of a proposed model.  
 
Figure 3.25 Pole-zero diagram of a typical ARX [4 4 0] model 
3.6.5 Model and Segments in Baseline Mode 
As quoted earlier, data was continuously recorded along three different modes; baseline, 
blockage and cuff release. CBP-RPPG models were initially estimated over baseline 
data to ensure that the model is estimated under normal condition (i.e. without stimulus). 
An estimated model was then used -as a criterion- to represent the endothelial 
performance after conducting the FMD stimulus. The whole steps of system modeling 
were done by system identification toolbox of the Matlab as can be seen in Appendix 
D. The used steps are explained in the following parts. 
a) Self-Model 
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Referring to section 3.5.4, same numbers of CBP and RPPG segments were obtained 
for each particular subject. Accordingly, individual models were estimated by 
considering CBP segment as model input and its corresponding RPPG segment as 
model output. In fact, self-models refer to a model between each CBP segment and its 
corresponding RPPG segment. This was done by "iddata" command in Matlab as can 
be seen in Appendix D. The same model structure and order was used for sets of data 
(i.e. all subjects and in all days). The focus of models was set to be stability. 
 The goodness of an estimated model was then evaluated via the parameter of 
fitness which was obtained by applying an estimated model to its constructive data 
(estimated RPPG versus measured RPPG). Afterwards, model-derived and measured 
RPPG waveforms were compared to each other using the "compare" command in the 
Matlab as can be seen in Figure 3.26. Fitness value and coefficients of all estimated 
models were then saved into the excel file. As quoted earlier, the process of exporting 
data from Matlab to the excel file was automatically done by "xlswrite" command in 
the Matlab. Data of each particular subject were saved into subject's sheet. At the end 
of this step, several forward CBPRPPG models were obtained for each subject. 
 
Figure 3.26 Representation of self-modeling 
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b) Computation of Average model 
Outcome of the last section was obtaining several self-models for each set of data. 
Fitness values of such models were mostly found high. However, a few of self-models 
in each data set were found unstable mainly due to the effect of motion artifacts (e.g. 
moving or shaking during data collection). In this regard, the threshold value of 70% 
was considered in order to identify unstable models (Ljung 2010). Accordingly, those 
unstable models were discarded and only stable self-models with fitness value of higher 
than 70% were considered for further analysis.  
 However, it was not possible to trace the endothelial functionality via several 
self-models. Hence, an average model was considered to be used as a single model for 
assessing the endothelial performance. It was done by getting average among 
coefficients of stable self-models explained above (i.e. fitness ≥ 70%). An averaged 
model was exclusively computed for each particular subject. It was then applied to 
whole segments in baseline and results (fitness values) were saved into the excel file. 
As a summary, a single CBPRPPG model was computed for each subject in order 
to assess the endothelial activity. Figure 3.27 illustrates the algorithmic chart of such 
processing. Figure 3.28 shows graphical view of the modeling. 
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Figure 3.27 Algorithm of computational steps 
  
Figure 3.28 Graphical representation of modeling  
 Referring to research hypothesis, this model is supposed to have a stable 
behavior during the baseline where there is no stimulation. Goodness of a typical 
average model during the baseline is shown in Figure 3.29. 
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Figure 3.29 Goodness of a typical average model at the beginning (top), middle 
(middle) and end (button) of the baseline 
3.6.6 Average Model in Release Mode 
The main objective of this study is to assess the endothelial dysfunction based on the 
CBP-RPPG model. The procedure of preparing baseline data and obtaining an average 
model were explained above. In the following sections, steps of preparing release data 
and procedure of assessing the endothelial reaction via average models are explained. 
 As a first step, the last five minutes of each signal were separated and considered 
as release data. It was then fragmented into several segments with the same length of 
three seconds. Each segment was then normalized and synchronized (exactly like the 
processing procedure in section 3). Afterwards, a time series data were created by 
addressing the CBP segment as model input and its corresponding RPPG segment as 
model output.  
 Average models -which are obtained in baseline- were then used to assess the 
endothelial performance after releasing the pressure cuff. In this regard, average model 
was applied over release data (i.e. release segments) and fitness values were saved and 
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considered as endothelial response. These data were then plotted in order to capture the 
Endothelial-related changes across the brachial artery. Figure 3.30 illustrates the 
goodness of a typical model -of a healthy subject- before and after releasing the pressure 
cuff. As can be seen, for a healthy subject, fitness values are significantly dropped. In 
contrast, for an unhealthy subject, fitness values are not considerably changed, as can 
be seen in Figure 3.31. 
 
Figure 3.30 Goodness of a typical average model of a healthy subject at the 
beginning (top), middle (middle) and end (bottom) of baseline (left) 
and release (right) data 
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Figure 3.31 Goodness of a typical average model of an unhealthy subject at the 
beginning (top), middle (middle) and end (bottom) of baseline (left) 
and release (right) data 
a) Golay Filter 
Graphical representation of fitness values -obtained in release mode- showed several 
uneven small lines while illustrating a meaningful trend in overall view. It was observed 
among all fitness curves. In general, two types of changes were observed among all 
curves in release mode; small changes (uneven small lines) and an overall trend. 
According to the theory of the FMD-US test, such small changes in vessel diameter are 
not considered in calculation of vessel dilatation (final FMD percentage) (Corretti et al. 
2002). In other words, FMD value is obtained by comparing values of vessel diameter 
in baseline and release conditions. Hence, the overall trend of fitness curve was 
considered as an indicator of the endothelial performance. In order to capture the overall 
trend of fitness curves, all fitness values were smoothed by the Golay filter (Schafer 
2011). Using this filter, the mentioned small uneven lines were ignored while an overall 
trend was better appeared (Luo, Ying, He, et al. 2005). The Golay filter was applied to 
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whole data (baseline and release) by the "sgolayfilt" command in Matlab. The details 
of using this code can be seen in appendix D. Figure 3.32 shows a typical fitness curve 
before and after applying the Golay filter.  
 
Figure 3.32 A typical fitness curve before (top panel) and after (down panel) 
smoothing by the Golay filter 
3.6.7 Data Analysis after Cuff Release 
Initial analysis showed that fitness curves are quite stable in baseline whereas there is a 
peak-alike trend in release data. This matter can be seen in Figure 3.33. In fact, when 
the pressure cuff is released, fitness values were remarkably dropped and then slowly 
become better (higher). Hence, release data were separated into five windows with the 
same length of one minute. Such strategy provided a practical way for processing data 
step by step in order to capture the endothelial-related vasodilatation in the brachial 
vessel. Figure below illustrates those windows. 
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Figure 3.33 A typical fitness curve with analytical windows 
3.6.8 Endothelial Dysfunction Assessment 
As mentioned above, the main objective of separating fitness curves into several 
windows was to implement different analytical strategies to detect changes in each 
window individually. Initial investigation -among fitness curves of healthy subjects-
showed that fitness values drops immediately after releasing the pressure cuff and then 
gradually tends to mean fitness value of the baseline. However, such an ascending trend 
was not observed among non-healthy subjects. Hence, rise time, slope, mean fitness 
value and height of peak were considered to be analyzed in the first window. However, 
only stability and mean fitness value were considered among window 2 to window 5 
because a peak-alike trends was observed only in the first window. Details of computing 
these parameters are explained below. 
 Rise Time: This parameter can be considered as one of the most important 
features in signal processing. In fact, it indicates how fast a peak can take place. In the 
first window, rise time was calculated by subtracting time values of maximum and 
minimum points of a peak. Figure 3.34 illustrates the rise time (red line) in window 1. 
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Figure 3.34 A typical fitness curve with considered parameters in window 1 
 Slope: The slope of a peak was calculated by dividing the subtraction of critical 
points ( y ) over subtraction of their corresponding time values ( x ) as can be seen in 
the Figure above (blue color). The inverse tangent of obtained value was then computed 
to represent the slope in degrees scale. This approach can be mathematically expressed 
via the following equation: 
Slope degree = )(tan
minmax
minmax1
tt
FitnessFitness


 (3.6) 
where Fitnessmax shows a highest (maximum) fitness value of a peak, Fitnessmin  shows 
a lowest (minimum) fitness value of a peak and tmax and tmin show time values 
corresponding to maximum and minimum values of a peak respectively (blue line in 
Figure 3.31). Such a calculation was done using "atand" command in Matlab as can be 
seen in Appendix D. In this research, values of slop were computed across all fitness 
values (i.e. every two points) in the first minutes. These values were then averaged and 
a single value was used as the slope of curve in the first window. 
 Mean fitness value: Mean fitness value was used as a potential parameter to 
detect changes in window 1. It was simply computed by averaging among fitness values 
of window 1. The "mean" command in Matlab was used for this step of analysis among 
all windows.   
93 
 
 Height of peak: In addition to the parameters explained above, height of peaks 
was also taken into account as a potential indicator of the endothelial reaction. In fact, 
this parameter was considered because it was found dissimilar among healthy subjects. 
The height of peak was calculated by subtracting maximum fitness value from 
minimum fitness value as can be seen in Figure 3.35.  
 
Figure 3.35 Representation of different values of height of peak 
 Stability: Irrespective of the first window (ascending trend), the stability was 
found a potential parameter to ensure the goodness of fitness curve in other windows. 
According to the hypothesis of this research explained in chapter II, vessel diameter 
should be increased after releasing the pressure cuff -endothelial reaction- and then 
slowly backed to its normal condition (vessel size in baseline). In this regard, it is very 
important to follow the trend of fitness curve to ensure it tends to mean fitness value. 
However, such trend was not linear -particularly after window 3- meaning that it varies 
toward a mean fitness value. In order to find a valid range of such variation, degree of 
variation in baseline was considered. It relies on a fact that in baseline, no stimulus is 
applied and thus fitness values have a convinced stability despite having high values of 
fitness. For each particular subject, range of variation in own baseline was computed by 
subtracting highest fitness value from lowest fitness value. Result was considered as a 
criterion of stability among windows 2 to 5. A typical range of stability in baseline is 
graphically shown in Figure 3.36. 
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Figure 3.36 Variations of a typical fitness curve in baseline  
3.7 STATISTICAL ANALYSIS 
Nowadays, statistics is widely used in different parts of science including clinical 
researches. In fact, statistical analysis provides a mathematical interpretation in which 
research outcome can be better presented. Statistical analysis can be considered as an 
inseparable part of clinical researches. However, this field is considerably progressed 
to that extent that the biostatistics itself is now established as a special category of the 
statistics. It contains many definitions, parameters, phrases and formulas. Obviously, 
only some of them are used in clinical researches based on research objectives. In this 
research, the sensitivity, specificity and receiver operating characteristics (ROC) are 
used to interpret results of the proposed approach in conjunction with results of the 
FMD-US technique (as a gold standard). Definition of basic statistical parameters can 
be seen in Appendix F. Other phrases are described here. 
 Standard deviation (SD): Standard deviation can be considered as a 
complementary parameter of the variance to show how spread out data is. It is the square 
root of the variance which is computed by the following equation:  
2
1
)(
1
xx
n
SD i
n
i
 
  
(3.7) 
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where n is a number of data, xi is a set of data and 

x is the mean.  
 Coefficient of variation (CV): The coefficient of variation is a statistical 
parameter used for indicating dispersion of a distribution. This parameter is obtained by 
the following equation:   
x
SD
CV 
 
(3.8) 
where SD and 

x representing the standard deviation and variance respectively. 
 Null hypothesis (H0): Null hypothesis refers to a hypothesis claiming if a 
proposed technique is applied among different groups, same outcome is achieved. 
Although probability of happening such hypothesis is not high in clinical researches but 
it should be either disapproved or nullified by evidence obtained during a research. 
Rejection of H0 shows that the null hypothesis is not plausible so that research 
hypotheses can be accepted. In contrast, if evidence(s) is failed to reject the H0 then it 
can be concluded that the null hypothesis is plausible and thus research hypotheses 
should be rejected. The null hypothesis is this research is that there is no significant 
difference between endothelial reaction of healthy and unhealthy subjects based on the 
proposed PPG technique.  
 Statistical Error: Statistical error is used to show a difference between retained 
and true values. The statistical error is usually expressed in terms of type including type 
I error and type II error. In general, type I error -which is also known as alpha ( )- 
refers to a wrong rejection of a true null hypothesis (false positive). Besides, type II 
error -which is also known as beta (  )- indicates the failure to reject a false null 
hypothesis (false negative). Table 3.1 shows the relationship between truth/falseness of 
the null hypothesis. 
Table 3.1 Statistical errors 
 H0 true  H0 false 
Accept H0 Correct! Type II error 
Reject H0 Type I error Correct! 
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3.7.1 Statistical Tests 
In clinical researches, it is always important to find out the level of significance between 
two (or even more) sets of data. The analysis of variance (ANOVA) can be mentioned 
as one of the most popular statistical approaches to conduct such analysis. The 
parameter of p-value is used in this analysis to represent the statistical significance 
between two sets of data. Using the ANOVA test, a p-value is compared with a given 
type I error (α). In this regard, if a p-value obtained less than a type I error, then it can 
be concluded that there is a significant difference between two sets of data. However, 
an obtained p-value of greater than type I error can confirm insignificant difference 
between data.   
 In this study, the ANOVA test is used to analysis the effect of proposed 
technique among healthy and non-healthy groups. In fact, it provides a practical way 
for ensuring the performance of the PPG technique -to assess the endothelial 
dysfunction- over different subjects so that the suitability of the proposed technique 
among healthy and non-healthy groups can be analyzed. To this end, the level of 
confidence was set to 95% for confirming the quality of a proposed technique. Thus, a 
value of 0.05 was considered as a threshold value of testing the means between healthy 
and non-healthy groups. Therefore, a value of difference of less than 0.05 (p< 0.05) was 
considered as a significant difference.  
 Sensitivity (Sn): One of the key factors in clinical research is the ability of a 
proposed method to detect abnormality which is already identified and confirmed by an 
alternative method (i.e. Gold standard). Such analysis is expressed via the parameter of 
sensitivity referring to the proportion of positives that are correctly detected by a gold 
standard technique (Indrayan 2012). In other words, the sensitivity of a test refers to the 
proportion of people who are considered as patient by an established method. This is 
called positive detection in biostatistics. Conversely, the percentage of incorrect 
detection by a proposed technique -compare to gold standard- is known as false positive 
detection (e.g. healthy people who are identified as a patient incorrectly). The sensitivity 
is obtained via the following equation: 
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Sensitivity (%) = 100
True Positives
(True Positives) + (False Negatives)
 (3.9) 
For example, if method B is considered as a proposal technique to detect a specific 
disease while method A is known as an establish method for identifying that disease, 
then the percentage of true positive detections -which correctly identify those people 
with that disease- is known as sensitivity.  
 Specificity (Sp): In contrast to the sensitivity, specificity focuses on true 
negative detections. In other words, the specificity relates to the percentage of healthy 
people who are confirmed to have no disease (instead of capturing those with disease). 
Such detection is known as the true negative while incorrect detection is considered as 
false negative. In the above example, the percentage of correct detections to identify 
healthy people -rather than patients- is considered as the specificity. The specificity is 
obtained via the following equation: 
Specificity (%) = 100
True Negatives
(True Negatives) + (False Positives)
 (3.10) 
 Accuracy: Accuracy can be known as one of the most popular parameters in 
biostatistics for indicating the degree of conformity between an established approach 
and a proposed technique. It can be obtained via the following equation:  
Accuracy (%) = 100
TN + TP
(Total sample population )
 (3.11) 
where TN and TP show true negative and rue positive respectively. 
 Contingency Table: This table is widely used in clinical research to give an 
overall view about accuracy of a proposed technique. It is consisted of totally four cells 
as shown in Figure 3.37. 
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Figure 3.37 The contingency table 
3.7.2 Receiver operating characteristic (ROC) 
The receiver operating characteristics (ROC) is a graphical curve -known as the ROC 
curve- which is used to evaluate the accuracy of a diagnostic test (Indrayan 2012). The 
ROC curve is plotted in terms of the true positive (sensitivity) against the false positive 
(specificity). Thus, each point on the ROC curve shows a pair of sensitivity-specificity 
corresponding to a particular value of threshold. Although the range of both sensitivity 
and specificity are normally considered between 0 to 100 but in the ROC curve, such 
range is mostly considered between zeros to one. In this case, the horizontal axis is 
marked by the "1-specificity" as can be seen in Figure 3.38. The ROC curve is normally 
explained in term of the area under the curve (AUC). In fact, the AUC is a measure of 
how well a method can distinguish healthy and non-healthy subjects. The highest value 
of the AUC is "1" which is usually expressed as a percentage (0-100%). Ideally, the 
convexity of the ROC curve should tend to the value one. In other words, proximity to 
value 1 represents the degree of the accuracy of a used method.    
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Figure 3.38 Representation of three hypothetical ROC curves showing the 
diagnostic accuracy of the gold standard (lines A; AUC=1), a typical 
ROC curve (curve B; AUC=0.85) and a diagonal line corresponding to 
random chance (line C; AUC=0.5). 
Source: Zou et al. 2007 
 In this study, the FMD-US technique was used -as an established technique- to 
assess the endothelial performance. Hence, results of the proposed PPG technique were 
compared with values of FMD obtained from the FMD-US technique. The ROC curve 
was used to show such comparison. To this end, heights of peaks were calculated -as 
explained above- and put into a matrix. In addition, values of FMDs were similarly put 
in the second column of that matrix. In order to be able to use the binary classifier 
system (ROC), the value of 10% was used as the threshold value (Corretti et al. 2002). 
It means all FMD values which are greater than the threshold are considered as one 
whereas those values which are less than the threshold value are considered as zero. 
Then, both FMD and peak values were graphically classified via the ROC curve. It was 
done by the "perfcurve" command in Matlab as can be seen in Appendix D. Result of 
the classification was then plotted like the ROC curve in Figure 4.25. 
3.8 CHAPTER SUMMARY 
This chapter has begun by giving an overall view about whole study. In this regard, the 
role of pilot study and its effect on improving main research were explained. Details of 
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research proposal were then reviewed. The FMD-US technique was mentioned as an 
established approach to assess the endothelial performance non-invasively. The 
procedure of data collection -from protocol to system setup and configuration- was then 
explained. Besides, procedure of taking blood -for blood test- to access individual's 
clinical parameters at the time of data collection was discussed. Afterwards, whole 
analytical steps were explained in details. After preparing signals via standard signal 
processing techniques, the parametric model ARX [4 4 0] was used as a potential model 
structure for estimating a forward model between CBP and RPPG waveforms. It was 
then mentioned that this model was exclusively estimated for each particular subject in 
order to be used as a criterion to assess the endothelial performance. It was then 
explained that goodness of a CBPRPPG model before (baseline) and after releasing 
the pressure cuff (cuff release) was followed via the fitness parameter. It was mentioned 
that fitness curve has a stable behavior during the baseline time whereas there is a peak-
alike curve right after releasing the pressure cuff. The peak was then considered as a 
potential mark of the endothelial reaction. Thus, it was deeply analyzed. Afterwards, 
the role of statistics in clinical research was reviewed. The ROC curve was then 
explained as an established tool for indicating the suitability in diagnostic techniques 
(binary classification).  
  
 
CHAPTER IV 
RESULTS AND DISCUSSION  
4.1 ULTRASOUND MEASUREMENTS 
As mentioned earlier, the FMD-US technique was used in this research -as an 
established technique- to assess the endothelial performance non-invasively. Using this 
technique, the endothelia-related vasodilatation can be observed during the FMD test. 
At present, borders of brachial artery (vessel walls) can be viewed via ultrasound 
imaging. Irrespective of its associated costs and operator dependency, this technique is 
the most attended technique to assess the ED non-invasively. However, the issue of 
measuring vessel diameter is different from obtaining vessel borders. In other words, 
an additional program is needed for measuring the distance between two sides of the 
brachial vessel. Indeed, such measurement plays an important role on accuracy of the 
FMD-US technique (Bots et al. 2005; Peretz et al. 2007; Thijssen et al. 2011). As quoted 
in the last chapter, the cardiovascular suite program was used for measuring the brachial 
diameter during in this research. The measurement was done off-line with exactly the 
same procedure among all subjects. Results of such measurement are discussed in the 
following sections. 
4.1.1 Arterial Diameter in Baseline 
The procedure of measuring vessel diameter was explained in details in section 3.6. 
Following the time chart of data collection (Figure 3.2) ultrasound images were 
continuously obtained for three minutes during the baseline. Using the cardiovascular 
suite program, brachial diameters were measured pixel by pixel. However, an averaged 
diameter was finally reported by the program as a brachial diameter in baseline. These 
values were obtained and imported in the excel file. Figure 4.1 shows values of brachial 
diameter in the baseline.    
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Figure 4.1 Brachial diameters in baseline 
 Obviously, diameter of brachial artery is not same among different subjects even 
in a specific group. As can be seen in the figure above values of brachial diameter are 
mostly between 2-4 mm. Interestingly, this range is in a good match with brachial 
diameters -of adult subjects- obtained in other studies (Atkinson & Batterham 2013; 
Thijssen et al. 2008).The mean value of brachial diameters in this research is about 3.2 
mm as illustrated in the figure above (the green dotted line). 
4.1.2 Arterial Diameter after Cuff Release 
The same procedure and calibrating factor was used for measuring the brachial diameter 
during reactive hyperemia (after cuff release). A normal endothelium is supposed to 
react to the FMD stimulus by releasing the NO which leads to increasing the vessel 
diameter. This phenomenon is gradually took place until reaching to a maximal 
diameter (peak point). Afterwards, the vessel diameter is slowly decreased until back to 
the normal situation (baseline). Such trend can be viewed in the cardiovascular suite via 
a graph as shown in Figure 4.2. As can be seen in this figure, there are two horizontal 
lines in each graph. The lower line shows the mean value of brachial diameter in 
baseline and the higher line shows the mean value of brachial diameter after releasing 
the pressure cuff. The top picture shows a normal endothelial reaction (significant 
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changes in diameter) whereas the button picture shows insignificant changes in the 
brachial artery (an impaired endothelium).  
 
 
Figure 4.2 Variations of brachial diameter in healthy (top) and non-healthy (down) 
subject 
 However, there is no option to export constructive values of curves. In this 
regard, assessment to a specific point -in the curve- is only possible by putting a mouse 
over that point while the shift key is pressed. Using this program, final degree of vessel 
dilatation (FMD%) is automatically computed by dividing maximum value of vessel 
diameter over the minimum value in the baseline. All peak values were manually 
obtained and exported to the excel file. Figure 4.3 shows peak values of brachial 
diameter during the state of reactive hyperemia (after cuff release). 
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Figure 4.3 Representation of vessel diameter in brachial artery after cuff release 
4.1.3 Computation of the FMD Index 
Finding the variation rate in brachial diameter -during the FMD test- can be truly 
considered as the most important part of the FMD-US technique. This rate is expressed 
as the FMD% which is obtained via the following equation (Corretti et al. 2002): 
𝐹𝑀𝐷% =
Dpeak − DBaseline
DBaseline
 (4.1) 
where Dpeak and DBaseline indicate mean value of diameter in release and baseline modes 
respectively. The same equation is used in the cardiovascular suite program so that a 
value of FMD% is automatically computed after conducting the measurement.  
 Since this research is about endothelial assessment, the functionality of the 
endothelial layer is considered for classifying subjects into healthy and non-healthy 
groups. In this regard, the FMD-US technique was used to assess the endothelial 
performance. Referring to the FMD-US technique, FMD values of equal or greater than 
10% (FMD≥10%) are considered as normal (healthy endothelium) whereas values of 
less than such threshold (FMD<10%) are considered as abnormal (impaired 
endothelium) (Corretti et al. 2002). Thus, those with FMDs less than 10% were 
considered as non-healthy subjects whereas others (FMD≥10%) were considered as 
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healthy subjects. Figure 4.4 shows values of FMD% among all subjects. As can be seen, 
the green dotted line illustrates the threshold value of the FMD (FMD=10%) so that 
upper points indicate healthy subjects whereas lower points show non-healthy subjects. 
Thus, sixty three subjects were classified into healthy group whereas another thirty were 
put into non-healthy group. 
 
Figure 4.4 Categorization of subjects based on FMD values 
4.2  DATA ANALYSIS IN BASELINE VIA CBPRPPG MODEL  
In this study, CBPRPPG model is used as a criterion to represent the endothelial 
activity before (baseline) and after releasing the pressure cuff (cuff release). According 
to the research hypothesis, the goodness of such a model is supposed to be affected by 
the FMD stimulus. In this regard, the endothelial performance was evaluated during the 
baseline and after releasing the pressure cuff in order to trace the endothelial-related 
changes in brachial artery. Steps of model estimation were explained in details in the 
last chapter. Results are discussed in the following parts.  
4.2.1 Fitness of Self-Model 
As mentioned in section 3.5.5, several CBPRPPG models were obtained in the 
baseline. Models were then applied to its constructive data to ensure the suitability of 
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that model. Fitness values were then obtained and averaged resulting in a single fitness 
value in baseline for each subject. Figure 4.5 shows such values.  
 
Figure 4.5 Mean fitness values of self-models in Baseline with mean of 86% 
(green dotted line) 
 Referring to the Figure above, highest and lowest fitness values were obtained 
95% and 72% respectively. According to the theory of system identification, a fitness 
value of less than 70% shows an unsuitable model (Ljung 1999). Hence, the lowest 
fitness value of 72% -in this research- confirms the goodness of the ARX [4 4 0] model 
structure for this analysis. Mean fitness value of self-models in baseline was obtained 
around 86 as illustrated in the figure above. Moreover, no meaningful relationship was 
observed among fitness values. It means, the proposed method has the same effect on 
all subjects regardless of age, gender, nationality and etc.  
4.2.2 Fitness of Average Model 
An average model was computed by getting average among coefficients of all self-
models as explained in section 3.5.5. Thus, a single average model was obtained for 
each particular subject. This model was then applied to all segments in Baseline. Figure 
4.6 shows mean fitness values of all average models.  
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Figure 4.6 Mean fitness values of Average models in Baseline 
 As can be seen in the Figure above, most of mean fitness values were found 
greater than 70% with highest and lowest fitness values of 87% and 21% respectively. 
However, totally nineteen points (fitness values) were observed less than 70% including 
seventeen points between 60%-70% and only two points less than 60%. The effect of 
motion artifact can be mentioned as the main cause of obtaining such low values of 
fitness. Despite this, it should be noted that a single model structure (ARX [4 4 0]) was 
used among all data. It means that if the order of a model was exclusively estimated for 
each participant then a higher fitness values could be obtained. The idea of using 
different model order for each set of data (exclusive model estimation) is obviously not 
practical because the main objective of this method is to assess the endothelial 
performance rather than get high fitness values. Besides, a single criterion must be used 
among all subjects to examine the endothelial reaction. Therefore, the ARX [4 4 0] 
model structure was used and data which produced low fitness values were reconsidered 
in terms of the stability (Ljung 1999). Figure 4.7 shows three fitness curves with good 
(a), medium (b) and poor (c) fitness values as discussed above. Results confirmed that 
data with mean fitness value of 59% (Subject 14) can be still used as it has a good 
stability (Figure 4.7.b). In contrast, data which produced the lowest fitness value of 21% 
(subject 58) was found unstable and thus excluded from any further analysis (Figure 
4.7.c).  
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Figure 4.7 Three typical fitness curves with high (top), medium (middle) and poor 
(down) fitness values 
4.3  DATA ANALYSIS AFTER CUFF RELEASE VIA CBPPPG MODEL 
The main objective of this research is to assess the endothelial performance via PPG 
model. To this end, an average model of a subject was exclusively used to reflect the 
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endothelial activity of that particular subject after conducting the FMD stimulus (cuff 
release). It provides a practical way to evaluate the endothelial performance based on 
its normal activity during the normal condition (baseline). Hence, the trend of fitness 
curves (fitness values) after releasing the pressure cuff was considered -as the criterion- 
to assess the endothelial activity. Figure 4.8 illustrates variations of fitness values in 
baseline and after releasing the pressure cuff. As can be seen in this Figure, average 
model has a stable behavior in the baseline (figure top left, fitness=89%). However, 
fitness values are considerably dropped after releasing the pressure cuff. Accordingly, 
fitness value drops to value 43% and gradually increase to value 82% which is very near 
to the fitness value which is obtained in baseline. According to the importance of such 
trend, fitness curves were smoothed in order to provide a better way for tracing the 
endothelial reaction (as explained in section 3.5.6). Results are discussed in the 
following parts. 
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Figure 4.8 Representation of fitness changes of a typical healthy (top) and non-
healthy (down) subject during the FMD stimulus 
4.3.1 Results of Smoothing Fitness Curves 
All fitness curves were smoothed via the Savitzky–Golay filter. Although primary 
(visual) comparison -between raw and filtered fitness curves- showed insignificant 
changes but it was investigated among all data via numerical analysis. In this regard, a 
filtered fitness curve was subtracted from its primary curve so that several values were 
obtained. By obtaining the mean value, a distance between each single value and the 
mean value was measured (variance). All variance values were then averaged to 
represent a single value for each set of data. In this regard, a high value of variance 
shows that there is a significant change between primary and filtered curves. In contrast, 
a low value of variance confirms an insignificant change in a curve before and after 
smoothing. Results are shown in Figure 4.9.  
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Figure 4.9 Comparison between primary and filtered curves via variance 
 As can be seen in Figure above, the maximum and minimum values of (mean) 
variance were obtained 12.5 and 1 respectively. Such range shows a confident degree 
of change caused by smoothing (Luo, Ying & Bai 2005). Figure 4.10 shows a typical 
fitness curve before and after applying the Golay filter. As can be seen in this figure, it 
is difficult to trace the trend of fitness curve after releasing the pressure cuff in the 
primary diagram (top). It also makes the analysis complex because a complicated 
algorithm may be needed for processing fitness curves. In fact, the Golay filter provides 
a better situation for capturing the endothelial-related changes (i.e. peak) as shown in 
the figure below (down). 
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Figure 4.10 A typical fitness curve before (top) and after (down) applying the Golay 
filter 
4.3.2 Analysis in Windows 
In order to trace the endothelial activity after releasing the pressure cuff (the FMD 
stimulus), fitness curves -in release part- were fragmented into five windows as 
discussed in last chapter. Referring to the FMD-ultrasound technique, the first minute 
after releasing the pressure cuff can be considered as a "gold" time to capture the peak 
of Endothelial reaction (Corretti et al. 2002). After this time, vessel diameter is 
gradually backed to the normal situation (width) so that the endothelial reaction is 
accordingly reduced. As discussed in the last chapter, three parameters were considered 
in the first window: rise-time, slope and height of peak. Results are discussed in the 
following part.  
 Window 1: The first window was analyzed with the main aim of finding some 
reliable parameter to in order to distinguish healthy subjects from patients. Therefore it 
is very necessary to analyze data specifically over healthy and non-healthy groups. As 
mentioned earlier, subjects were classified into healthy and non-healthy group based on 
the FMD-US examination. Thus, data analysis was individually done over each group.  
 Rise Time: This parameter was used to analyze the ascending time in window 
1. In fact, rise time represents the spending time between minimum and maximum 
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fitness values which are corresponding to the release and peak time respectively. In 
other words, the rise time indicates how fast the vessel diameter can reach to its 
maximum (widest) diameter. This test was separately done over healthy and non-
healthy groups. Figure 4.11 shows rise-time values in first windows among healthy 
(blue) and non-healthy (red) groups. 
 
Figure 4.11 Rise time values among healthy (blue) and non-healthy (red) subjects 
 As can be seen in the figure above, rise time values are mostly less than 4sec 
among both healthy (blue) and non-healthy (red) subjects. In other words, there is 
meaningful relationship between values obtained among healthy and non-healthy 
groups. In fact, there is no exclusive range of rise time among healthy (or non-healthy) 
subjects. Therefore, the parameter of rise time cannot be used as a reliable parameter to 
identify those with ED.  
 Slope: Primary analysis showed that, the parameter of slope is varied from one 
subject to another. Thus, this parameter was investigated to find out whether it can be 
used -as a criterion- to detect patients or not. Slopes of fitness curves in the first window 
are shown in the Figure 4.12. As can be seen in this figure, these values are quite 
scattering compare to the rise time chart. Besides, there are no meaningful relationship 
between slope values obtained from healthy (blue) and non-healthy (red) groups. In 
other words, the endothelial activity cannot be evaluated via the parameter of slope. 
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Figure 4.12 Slope Values among healthy (blue) and non-healthy (red) subject 
 Height of peak: This parameter refers to the difference of maximum and 
minimum values of fitness which are corresponding to the peak and starting times 
respectively. It has been widely used for analyzing the endothelial response in the FMD-
US technique (Pyke & Tschakovsky 2007; Stoner & Sabatier 2012; Thijssen et al. 
2009). In fact, the height of peak can be considered as a reliable indicator of vascular 
changes caused by the FMD stimulus. The association between height of peak -in FMD 
ultrasound technique- and ED is already established. Hence, a healthy endothelium 
represents a high peak whereas an impaired endothelium reflects a very short peak 
(Pyke & Tschakovsky 2007). Such difference is not only used to assess the ED but also 
used to indicate the degree of the endothelial performance.  
 In this study, a fitness curve was considered to assess the endothelial activity. 
As mentioned above, this curve has a peak-alike trend similar to the peak of reactive 
hyperemia in the FMD-US technique. Thus, the parameter of height of peak was 
considered. To this end, a difference between maximum and minimum values of fitness 
-in the first window- was considered as the height of peak. Figure 4.13 show heights of 
peaks among both healthy (blue) and non-healthy (red) subjects. As can be seen, heights 
of peaks of non-healthy subjects are mostly less than twenty whereas it is greater than 
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twenty among healthy subjects. Such a meaningful relationship was used as a reliable 
criterion to identify the endothelial dysfunction in this research (PPG-based technique). 
As a conclusion, the value of twenty was considered as the threshold in this work so 
that the endothelial performance can be evaluated via this approach. Using this 
classification, height of peak of less than twenty represents an impaired endothelium 
(Endothelial dysfunction) whereas higher values show a normal endothelium.  
 
Figure 4.13 Height of peaks among healthy (blue) and non-healthy (red) subjects 
 In a separate analysis, the height of peak was obtained by subtracting a first 
value of fitness -after releasing the pressure cuff- from a mean value of fitness in 
baseline. However, results confirmed that there is no significant change between this 
approach and the one mentioned above. Figure 4.14 show differences (subtraction) 
between peak values obtained by the mentioned approaches. As can be seen in the chart 
below, results of subtraction are mostly around zero confirming that peak values can be 
faithfully obtained by subtracting the maximum from minimum fitness values in the 
first window. 
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Figure 4.14 Differences (subtraction) between values of peaks obtained by different 
methods 
 Window 2-5: As mentioned in chapter III, the peak time occurred right after 
releasing the pressure cuff. Thus, fitness curve tends to its mean fitness value in the 
baseline. Such trend shows that the endothelial-related changes in the brachial vessel is 
declining and going to back to the normal (baseline) situation. Therefore, the test of 
stability was done over windows 2 to 5 to ensure that vessel diameter is decreased until 
reaching to the normal diameter. Procedure of conducting the analysis of stability was 
explained in section 3.5.7. As mentioned, outcome of this part was a single value -for 
each subject- showing the mean value of variation between each window and mean 
fitness value in the baseline. Results are shown in Figure 4.15. 
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Figure 4.15 Representation of stability in last four minutes of fitness curves 
4.4 Results in Conjunction with Ultrasound Images 
This section contains results of comparison between FMD-US technique and the 
proposed PPG technique concerning the ED assessment. In fact, final outcome of both 
techniques is the binary classification of subjects based on endothelial activity. 
Accordingly, healthy refers to normal endothelial reaction whereas non-healthy refers 
to impaired endothelial reaction.  
4.4.1 Healthy Group 
As quoted earlier, results of the FMD-US technique showed normal endothelial reaction 
among sixty two subjects. Thus, these subjects were categorized into the healthy group 
including both male and female genders. Such a classification relies on the fact that the 
FMD-US test is not a gender-related practice. In other words, this approach is globally 
accepted as a practical way to assess the endothelial performance regardless of subject's 
gender, age, nationality, etc (Herrington et al. 2001). Results of the FMD-US technique 
were discussed above (section 4.1). Results of the proposed technique are discussed 
below in conjunction of the FMD-US technique.  
 
 
a) Results of the PPG 
In the proposed technique, the parameter of height of peak was considered to reflect the 
endothelial reaction as mentioned earlier. Interestingly, the PPG model showed a good 
capability for identifying those with normal endothelium (and ED). Figure 4.16 show 
values of heights of peaks among the healthy group. As can be seen, values of peak are 
mostly greater than the threshold value of twenty which is illustrated by the green 
dotted-line in this figure. Thus, sixty one subjects were re-recognized as healthy by the 
proposed technique whereas only two subjects were wrongly identified with having 
normal endothelium. Such comparison confirms the suitability of the proposed 
118 
 
technique to recognize those people with normal endothelium (healthy). In this regard, 
the correlation between the PPG technique and the FMD-US (as a reference) is 
approximately 96% in healthy group.  
 
Figure 4.16 Assessment of the endothelial layer via the PPG model with threshold 
value of twenty (green dotted line) 
Although the endothelial activity can be evaluated via the PPG model, values of peaks 
are varied as can be seen in the figure above. Such dispersion can be also observed 
among values of FMD as shown in Figure 4.17.  
 
Figure 4.17 Values of FMD among healthy group with threshold value of ten as 
illustrated by the green dotted line 
0
20
40
60
80
100
120
0 20 40 60 80 100 120
S
ca
li
n
g
 A
x
is
Healthy subjects
Height of Peak
0
5
10
15
20
25
0 20 40 60 80 100 120
V
al
u
es
 o
f 
F
M
D
 (
%
)
Healthy Subjects
FMD (%)
119 
 
As can be seen in the figure above, all FMD values are greater than ten percent 
(threshold value) which confirm the normal activity of the endothelium in this group. 
The minimum and maximum values of FMD among this group were obtained 10% and 
21% respectively. Thus, the range of FMD values can be considered between 10-20 
percent. Similarly, values of peak -obtained from the proposed technique (figure 4.14)- 
are also varied from values 21 to 95. However, values of peak are mostly between 20 
and 75 as can be seen in figure 4.15. In other words, there are only two values which 
are too high (greater than 75). Although the degree of dispersion is different between 
these two techniques, the issue of dispersion can be considered as a common issue in 
both techniques. This issue can be justified by explaining the relationship between 
physiological conditions of the brachial artery during the FMD test with focus on vessel 
diameter.  
 As quoted earlier, the brachial vessel is fully blocked via a pressure cuff in the 
FMD test. As the pressure cuff is released, a density of blood is suddenly rushed into 
the brachial artery. This time can be considered as a peak time in which the brachial 
vessel increases to its widest condition (maximum vessel diameter). Such dilatation is 
mainly caused by the NO which is secreted from the endothelial cells. However, a 
volume of the released NO (bioavailability of NO) is not the same among all people  
(Tousoulis et al. 2012). Moreover, the effectiveness of the NO may be different from 
one person to another as it is a function of current metabolic and physiological 
conditions (Green et al. 2014). Therefore, a degree of vasodilatation could be dissimilar 
among different groups. In other words, there is no certain value (or range) for the FMD 
to assess the endothelial performance (Peretz et al. 2007).  
 Results of the PPG model showed a meaningful relationship between 
endothelial-related changes in vessel diameter and fitness values. In this regard, lowest 
fitness value is obtained just a few seconds after releasing the pressure cuff (peak time). 
Fitness values are then become higher while the brachial diameter is recovering to its 
normal condition (diameter). In other words, there is an inverse relationship between 
brachial diameter and fitness values meaning that low fitness values represent 
vasodilatation while high fitness values indicate no changes in vessel diameter. 
Although, similar trend in fitness curves was observed among healthy group but a 
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difference between maximum and minimum values of fitness (height of peak) is not 
same among different subjects in this group. This phenomenon confirms that the 
proposed technique can reflect the endothelial performance similar to the FMD-US 
technique (Pyke & Tschakovsky 2007).  
 Figure 4.18 shows two fitness curves which produce maximum and minimum 
vales of peak. As can be seen, the trend of increasing fitness values -after releasing the 
pressure cuff- is similar. However, values of peak are significantly different from each 
other. 
 
 
 
 
Figure 4.18 Two fitness curves with minimum (top) and maximum (down) 
peak values 
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4.4.2 Non-Healthy Group 
The procedure of classifying subjects into healthy (non-healthy) group was explained 
above. Following this procedure, a FMD value of less than ten percent (FMD<10) was 
considered as an indicator of impaired endothelium. Thus, thirty subjects were 
identified with ED. These subjects were categorized under the non-healthy group. 
Values of FMD of non-healthy subjects are shown in Figure 4.19. 
 
Figure 4.19 FMD values of non-healthy subjects 
Likewise last session, the proposed PPG technique was used among non-healthy group 
to find out how well the PPG technique can recognize patients (those with confirmed 
ED).  
a) Results of the PPG 
To this end, the parameter of (height of) peak was calculated among non-healthy 
subjects with the same procedure as healthy group. So that, those with a peak value of 
less than twenty (the threshold value in the PPG technique) were identified as patient. 
Values of height of peak among non-healthy subjects -obtained in the PPG approach- 
are shown in Figure 4.20. 
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Figure 4.20 Values of height of peak among non-healthy subjects with threshold 
value of twenty (green dotted line) 
 Considering the total number of thirty subjects in the non-healthy group, the 
proposed PPG technique confirmed the ED of twenty six subjects in this group. In other 
words, only four subjects were wrongly detected as a healthy subject with normal 
endothelial reaction. As can be seen in the figure above, minimum and maximum values 
of height of peak are 6 and 29 respectively. The variation of peak values among the 
non-healthy group is considerably low compare to the healthy group. Reason can be 
explained by considering the endothelial reaction (fitness curves) in healthy and non-
healthy groups. As can be seen in Figure 4.21, two types of fitness curve were observed 
among non-healthy subjects: curves with inadequate (poor) peaks and curves with even 
no peak.  
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Figure 4.21 Two types of endothelial reaction among non-healthy group: poor 
reaction (top) and no reaction (down) 
 As explained earlier, a healthy endothelium is supposed to show a peak-alike 
response after releasing the pressure cuff. However, analysis among fitness curves of 
non-healthy subjects showed that the peak is either low or not even exists. In fact, a low 
peak curve (response) indicates an inadequate endothelial performance whereas curves 
with no peak show a certain ED meaning that the diameter of the brachial vessel is not 
changed before (baseline) and after (release) applying the FMD stimulus. This 
phenomenon can be also considered as a poor endothelial reaction versus insignificant 
endothelial reaction. 
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4.5 STATISTICAL ANALYSIS 
4.5.1 Distribution of Data 
As mentioned before, data of this research were collected at department of cardiology, 
hospital university Kebangsaan Malaysia (PPUKM) among two ethnic groups: 
Malaysians and Iranians. According to the main objective of this research (ED 
assessment) data were collected among those with and without CV abnormalities. To 
provide healthy groups, subjects were mostly invited from outside the hospital on 
voluntary basis as mentioned in chapter III. Although this group was supposed to be 
free of any CV abnormality, essential tests (i.e. clinical test) were done to confirm that 
they are free from any risk factor at the time of data collection. Besides, inpatients of 
the PPUKM hospital were considered as potential non-healthy subjects. Some of them 
were then selected -by our medical partner- based on research criteria. They were then 
asked to participate in this research voluntarily. Figure 4.22 shows data distribution in 
terms of ethnicity. In addition, data distribution in terms of gender can be seen in Figure 
4.23. 
   
a) All subjects b) Healthy subjects c) Non-healthy subjects 
Figure 4.22 Data distribution in terms of ethnicity in total (a), healthy (b) and non-
healthy (c) views 
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Figure 4.23 Data distribution in terms of gender 
4.5.2 Statistical Analysis among Different Groups 
a) Gender 
In clinical researches, the parameter of gender should be taken into account in order to 
interpret results. In other words, the suitability of a proposed technique among both 
male and female subjects should be evaluated. In general, performance of the CV 
system is not same among male and female subjects. For instance, it is already 
demonstrated that the recovery time after conducting an endovascular repair is 
considerably longer in women rather than men (Grootenboer et al. 2013). However, 
there is no significant difference among male and female subjects in terms of FMD 
values (Hu et al. 2008; Sader & Celermajer 2002). In other words, the endothelial 
performance can be fairly evaluated via the FMD-US technique among both male and 
female subjects.  
 The goodness of the PPG technique to detect the ED among males and females 
was also investigated in this research. Results of this study showed that there is an 
insignificant difference between peak values among male and female subjects. Using 
the ANOVA test, the p-values are obtained 0.79 and 0.20 in healthy and non-healthy 
groups respectively. Since both of these values are greater than type I error ( 05.0 ), 
it can be concluded that the proposed PPG technique can be used to assess the 
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endothelial performance regardless of the issue of gender. Results of the ANOVA test 
are shown in Table 4.1.  
Table 4.1 Gender-based ANOVA analysis in PPG technique 
α = 0.05 
Parameters Count Sum Average Variance F P-value F crit  
Healthy subjects         
Males 34 1507 44 243 
0.06 0.79 3.99 
 
Females 29 1318 45 350     
Non-healthy subjects         
Males 18 256 14 36 
1.64 0.20 4.19 
 
Females  12 203 16 25     
 
b) Aging  
Aging can be truly considered as a critical parameter in CV performance (Dahlöf 2010). 
Thus, the effect of age was studied in this research to ensure the suitability of the PPG 
technique over different age groups. To this end, subjects were classified into tens 
groups. Such classification is shown in Figure 4.24. 
  
Figure 4.24 Data distribution among healthy (left) and non-healthy (right) groups 
in terms of age  
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 The ANOVA test was done to ensure whether the PPG technique can be used 
over different age-groups or not. In this regard, an appropriate range of age should be 
considered for the classification. In general, the elderly age starts at 65 years old 
(Organization 2010). However, the association between the endothelial dysfunction and 
age was considered -in this research- in order to find an appropriate age for 
classification. Although there is no certain age for the ED, the range of 45-50 years old 
is mostly addressed in prior works as a potential age of starting the ED (Seals et al. 
2011). Therefore, the age of 50 was considered as a potential age of starting the ED. 
Thus, subjects were classified into two groups of age: below 50 and above 50. Peak 
values were then considered in the analysis. 
 The ANOVA analysis showed an insignificant change in peak values among 
young and elderly subjects. Details of this analysis are shown in Table 4.2. in which 
values of statistical parameters (sum, average and variance) are rounded up for a better 
representation. The last three columns of this table contain source of variations (F, P-
value and F crit) between so-called young and elderly groups. As can be seen in this 
table, both P-values are greater that type I error (α = 0.05) confirming insignificant 
changes of peak values among healthy and non-healthy groups. 
Table 4.2 Age-based ANOVA Analysis for the PPG Technique 
α = 0.05 
Parameters Count Sum Average Variance F 
P-
value 
F 
crit  
Healthy subjects         
Group < 50 47 2194 46 307 
2.20 0.14 3.99 
 
Group > 50 16 631 39 206     
         
Non-healthy subjects         
Group < 50 23 374 16 34 
3.04 0.09 4.19 
 
Group > 50 7 84 12 15     
 
c) Healthy and Non-Healthy:  
As mentioned in chapter III, the parameter of height of peak was considered to assess 
the ED in this research. In this regard, the value of twenty was determined as the 
threshold value. Statistical analysis (ANOVA test) showed that there is a significant 
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difference between peak values of healthy and non-healthy subjects. Result of this 
analysis is shown in Table 4.3. As can be seen in this table, the obtained p-value is less 
than type I error (α=0.05) showing a significant difference between peak values in 
healthy and non-healthy groups. It confirms that the parameter of (height of) peak can 
be effectively employed to identify those with ED. Accordingly, the first hypothesis -
in section 1.5- becomes true.  
TABLE 4.3      Difference of peak values among healthy and non-healthy 
groups in the PPG technique 
SUMMARY      
Groups Count Sum Average Variance   
Non-healthy 30 459,828 15,327601 32,954   
Healthy 63 2826,24 44,860998 288,191   
       
ANOVA       
Source of Variation SS df MS F P-value F crit 
Between Groups 17725,8 2 17725,792 85,6932 9,1E-15 3,94569 
Within Groups 18823,5 91 206,85178    
       
Total 36549,3 93        
 
4.5.3 Clinical Parameters 
As mentioned in chapter III, blood was taken from all participants in order to assess 
clinical parameters at the time of data collection. Table 4.4 shows an overall view of 
clinical variables in this study. Considering the value of 0.05 for type I error (α=0.05), 
there is no significant difference between clinical parameters among healthy and non-
healthy groups. It shows that clinical parameters (per se) cannot be used to assess the 
ED.  
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TABLE 4.4 Descriptive variables of the study  
  Healthy   Non-Healthy   
           ANOVA 
Clinical Variables  unit Min 
Ma
x 
Mea
n 
S
D 
 
Min 
Ma
x 
Mea
n 
S
D p-value 
Age years 30 71 42 12  30 70 36 12 0.05< 
Systolic BP mmHg 105 134 114 11  105 190 125 18 0.05< 
Diastolic BP mmHg 60 105 75 9  55 113 75 11 0.05< 
Pulse rate BPM 40 110 70 12  48 110 63 12 0.05< 
*Fasting blood 
glucose 
mmol/
L 3.8 8.4 4.65 
1  
4 9.7 5.8 
1 0.05< 
**Total cholesterol 
mmol/
L 
2.5
3 5.16 3.78 
1  3.2
9 7.96 5 
1 0.05< 
*Normal range of Fasting blood glucose: [5.6 - 6.9] mmol/L 
**Normal range of total cholesterol: < 3.37mmol/L 
4.5.4 Sensitivity and Specificity 
As mentioned earlier, the main aim of conducting statistical analysis is to evaluate the 
suitability of the proposed technique among different people (Glantz 2005). In other 
words, it is very important to know whether a method is only restricted to a specific 
group or can be widely used over different people with dissimilar characteristics (e.g. 
gender, age, ethnicity, etc.). The basic parameters of statistics are explained in details 
in section 3.6. In the following parts, results of the statistical analysis are discussed. As 
mentioned above, the final outcome of the proposed technique is a binary detection of 
ED. In other words, final result would be either healthy (normal) or non-healthy 
(impaired) endothelium so that the proposed technique can be considered as a binary 
assessment of the endothelial layer. As shown in Table 4.5 (contingency table) totally 
six cases were detected wrongly by the PPG technique in this research.  
TABLE 4.5 Statistical errors 
 True  False 
Positive 26 2 
Negative 61 4 
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According to the table above, results of the binary detection can be summarized as 
below: 
 True Positive: Totally 26 subjects were identically detected as non-healthy (those 
with ED) via both FMD-US and the PPG approaches. 
 True Negative: Similarly, 61 subjects were identically identified as healthy (those 
with normal endothelium) via both techniques. 
 False Positive: However, 2 subjects were detected as non-healthy via the PPG 
technique whereas results of FMD analysis confirmed that they are healthy.  
 False Negative: In addition, there are 4 subjects who are identified as healthy via the 
PPG technique whereas results of the FMD analysis showed they are non-healthy.  
 Following equations 3.7 and 3.8, the sensitivity and specificity of the proposed 
technique are obtained 86% and 96% respectively. Using equation 3.9, accuracy is 
obtained for 63%. 
 As quoted earlier, the ROC curve is an established method for representing the 
suitability of a proposed method in terms of sensitivity and specificity. Referring to 
section 3.6, the area under curve (AUC) is known as the most important parameter in 
the ROC diagram. In fact, the AUC shows how well a method can perform as a binary 
classifier to detect abnormalities. Therefore, it can show the actuality of the proposed 
technique for detecting the ED among both healthy and non-healthy groups. Figure 4.25 
illustrates the ROC diagram of the proposed technique. As can be seen, a value of AUC 
is mentioned in the middle of ROC diagram. Considering the maximum value of 100 
for the AUC, an obtained value of 96% confirms that the proposed technique can be 
faithfully used -as a binary classification- to detect the ED among all people.  
131 
 
 
Figure 4.25 The ROC curve of this study 
4.6 CHAPTER SUMMARY 
Results of the ultrasound imaging and PPG technique have been elaborated in this 
chapter. It is begun with the results of the ultrasound imaging providing a precise 
assessment to the endothelial performance. Results were then discussed. Finally, 
subjects were classified into healthy and non-healthy groups based on the current 
activity of the endothelium obtained by the FMD-US. 
 Results of the PPG technique are then expressed in details. It is discussed 
separately over baseline and release data. At first, the goodness of the auto-regressive 
with exogenous model structure (ARX) for estimating a forward CBPRPPG model 
is discussed. Results show that this model has a reliable performance for representing 
the endothelial reaction during the FMD test. Using this model, a peak-like trend is 
captured among fitness curves as a result of stimulating the brachial artery through the 
FMD test. Results of analysis the peak is then showed and discussed endorsing the 
suitability of using the "height of peak" for assessing the endothelial performance in the 
PPG technique.  
 Statistical analysis shows that values of peak are significantly different among 
healthy and non-healthy groups. It confirms that the -parameter of- height of peak can 
be effectively used to identify the ED. Results of the proposed technique are then 
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compared with results of the US imaging reflecting convinced values of sensitivity, 
specificity and accuracy of 86%, 96% and 93% respectively. The AUC is also obtained 
around 96%. Thus, endothelial stimulation (FMD test) is performed on a large artery 
(brachial) while endothelial reaction is assessed also from brachial artery (i.e. excluding 
from effects of the autoregulation). Therefore, it can be concluded that proposed 
technique is able to assess the so-called pure endothelial functionality without capturing 
non-endothelial factors.   
  
 
CHAPTER VI 
CONCLUSION AND FUTURE WORK  
5.1 CONCLUSION 
Endothelial dysfunction has been known as an early marker of atherosclerosis and 
further CV diseases. In fact, it has been demonstrated that early assessment of ED may 
lead to early detection of CV abnormalities and thus, control related diseases by 
adequate and on-time treatments. As explained, endothelial assessment can be done 
mainly via invasive and non-invasive approaches. The main limitation of invasive 
approach is that, it is limited to coronary patients due to invasive nature of such 
technique. In contrast, FMD-US has been introduced as an established and most 
attended technique to assess the endothelial performance non-invasively. However, this 
technique requires special system setup as well as an experienced sonographer. It is then 
mentioned that proposing a cost-effective and operator independent technique -to assess 
the endothelial performance- has been particularly attended over last decade. In this 
regard, previous researchers proposed the PPG technique to assess the endothelial 
functionality. For instance, in the latest work by Rosmina Jaafar, a PPG-based technique 
has been introduced to identify ED among both healthy and risk groups (Jaafar 2009). 
In this technique, endothelial layer is stimulated across subject's peripheral artery while 
endothelial reaction is assessed from subject's index PPG signal. This study has truly 
shown the possibility of detecting the ED via PPG. Results of this study have also shown 
good agreement with results of the FMD-US technique (i.e. reference technique). 
Accordingly, specificity and sensitivity of this technique were obtained 59% and 63% 
respectively. However, using this technique, both endothelial and non-endothelial 
factors can be captured. As discussed, it is mainly due to the issue of autoregulation in 
small arteries. In other words, in this technique, endothelial stimulation was truly done 
across subject's peripheral artery but endothelial reaction was captured from smaller 
artery in which the autoregulation moderates vascular tuning in addition to endothelial 
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mechanism. Therefore, non-endothelial factors (i.e. effects of autoregulation) were also 
captured from subject's index finger.  
5.2 Research Finding and Research Hypothesis 
 In the current study, a new technique is investigated to assess the endothelial 
performance via PPG. Using the proposed technique, the endothelial performance can 
be evaluated by a forward model between the CBP and radial PPG [CBPRPPG]. 
Goodness of such model before (baseline) and after releasing the pressure cuff is 
considered as a criterion to reflect the endothelial performance (i.e. fitness curves).  
 Refereeing to research hypothesis (chapter I), goodness of such model is 
supposed to vary among healthy subjects whereas it is supposed to fix (i.e. insignificant 
change) among unhealthy subjects. According to results (chapter IV), this matter has 
been approved. It was observed that, in healthy group, values of peak after releasing the 
pressure cuff (i.e. height of peaks) are significantly varied compared to baseline. In 
contrast, there is no significant variation after releasing the pressure cuff among 
unhealthy subjects. Such comparison was done via threshold value of twenty (height of 
peak) obtained in conjunction with FMD-US test. This issue was also examined via the 
statistical analysis. It has shown that there is a significant difference between peak 
values in healthy and non-healthy groups. This result confirms the suitability of the 
proposed technique to identify the ED. 
 Moreover, the proposed PPG technique is supposed to have similar results as 
FMD-US technique (research hypothesis, chapter I). Results also confirmed that there 
is a high agreement between these two techniques concerning ED assessment. As 
explained in chapter IV, in total, only six cases were wrongly detected using the 
proposed technique compared to the FMD-US technique. Therefore, it can be concluded 
that the proposed technique can identify ED as good as the FMD-US technique.  
 Furthermore, it was stated in research hypothesis (chapter I) that there is no 
difference among male and female subjects concerning height of the peak. This issue 
has been also proofed in chapter IV. It was shown that there is no significant variation 
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concerning peak values among male and female subjects. This matter was also 
examined via the statistical test.   
 Using the PPG technique, ultrasound device is not needed for capturing the 
endothelial activity so that the role of operator (sonographer) can be considerably 
reduced. In addition, associated costs (e.g. ultrasound machine, high frequency 
transducer, etc.) can be moderated. Furthermore, the PPG technique may provide a 
reliable way for the self-assessment of the endothelial performance by a user friendly 
device. However, the PPG sensor is remarkably sensitive to even small movements. 
Moreover, the issue of contact pressure between the PPG sensor and subject's skin 
should be highly taken into account before start recording data. These items can be 
addressed as critical limitations of the proposed technique. In this research, the PPG 
sensor was wrapped around the target site (brachial artery) and the quality of signals 
were visually checked -by operator in site- before start data collection. Besides, all 
participants were asked to avoid any movement during data collection. This helped to 
record optimal signals. 
 Another limitation of using the PPG sensor is the issue of temperature in a data 
collection room. PPG signals obtained from an uncontrolled room may not be reliable 
due to inadequate blood perfusion in target vessel. Therefore, temperature of a data 
collection room should be maintained between 28-32ºC to avoid any temperature-
caused disturbance on subject's blood circulation. In this study, room temperature was 
kept in this range during all data collection sessions. It was done using an adjustable 
temperature control key in the data collection room. 
 Number of participants can be considered as a common limitation of clinical 
researches. While high number of participants can improve the quality of work, the 
sample size should be estimated realistically based on research objectives and 
limitations (Hulley et al. 2013). Another difficulty is the issue of variety in sample 
population. Usually, it is very difficult to find healthy subjects among elderly people. 
On the other side, young individuals are normally in a good health condition without 
any risk factor. This issue may lead to misbalancing on variety of data. Nevertheless, it 
is unavoidable particularly in FMD-based researches (Peretz et al. 2007). 
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5.3 Contribution 
The main contribution of this work is to exclude effect(s) of autoregulation from the 
endothelial response in order to capture the pure endothelial reaction. In this regard, 
endothelial stimulation was done across subject's peripheral artery while endothelial 
response was assessed from subject's brachial artery. It was explained that the 
phenomenon of autoregulation is just in small arteries (e.g. finger, tow, auricle, etc.) 
and not the brachial segment. 
 Moreover, vessel diameters were automatically and continuously measured 
using the Cardiovascular Suit Program. Accordingly, variations of brachial changes 
were also obtained by comparing mean diameter of vessel diameter before and after 
releasing the pressure cuff. The experiment was also done via upgraded system setup 
including a high frequency transducer and rapid cuff inflator. 
 Furthermore, endothelial assessment was done via a forward model between 
CBP and RPPG rather than analyzing AC components of PPG signal. This approach 
provides a reliable way to trace the endothelial response from releasing the pressure 
cuff until end of experiment. In addition, it enhances the quality of analysis as even 
small changes can be identified. Accordingly, specificity and sensitivity of the proposed 
technique are obtained 96% and 86% respectively. Compare to the latest work (Rosmina 
Jaafar), such high values could be considered as higher reliability of the proposed 
technique.  
 
5.4 SUGGESTIONS FOR FUTURE WORKS 
The following issues were observed during data collection and data analysis which 
might be considered to improve the quality of final outcome in future works. 
5.4.1. System Setup 
Software of the SphygmoCor device needs the whole screen of a computer to be run 
and display the central and radial blood pressure waveforms in real-time. In addition, 
another computer is needed for displaying the radial PPG signal as well as storing data. 
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Therefore, two computers were essentially needed (used) in this research. Irrespective 
of its cost, using two computers require more system setup -which is time consuming- 
and operator's consideration during whole data collection time. This problem can be 
managed by customizing the software of the SphygmoCor so that its window can be 
minimized allowing PPG signals to be displayed in the same computer. However, such 
customization must be done by the manufacturer because the software cannot be 
adjusted by user. This matter was understood at the middle of data collection. Thus, it 
was not possible to transfer the SphygmoCor device to the manufacturer (in Australia) 
for solving this problem as it was an essential part of data collection. 
 Right placement of the PPG sensor over subject's skin was found very tough and 
time consuming. Solving this problem requires an automated system not only to place 
the PPG sensor right over the radial artery but also to apply an adequate pressure in 
order to obtain an optimal PPG signal. To the best of our knowledge, such system was 
not commercially available at the time of data collection and thus it can be even 
considered as a worth pursuing project for further PPG-based investigations. If this 
system cannot be used (find) in future works, getting help from assistant may mange 
the problem in a better way.   
5.4.2 Sample Population 
This research investigates the possibility of assessing the endothelial performance via 
the PPG approach. Results show that the proposed technique can be reliably employed 
-as a binary classifier- to detect the endothelial dysfunction. However, providing a 
reliable way to obtain the degree of endothelial dysfunction can be considered in future 
works. To this end, the sample size should be increased. In fact, more number of 
subjects can guarantee the reliability of a proposed technique. Besides, the sample 
population should be expanded to different nationalities including different ranges of 
age. In addition, it is good to balance the quantity of healthy and non-healthy subjects 
particularly from the age viewpoint. In this regard, the main issue would be providing 
healthy subjects among elderly people and non-healthy subjects among young people.  
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5.4.3 Procedure of Data Acquisition 
As mentioned earlier, the flow mediated dilatation (FMD) test was used in this study 
for stimulating the endothelial layer (cells). Using this test, the brachial blood 
circulation is blocked for five minutes and then suddenly unblocked leading to the state 
of reactive hyperemia (vascular dilatation). However, it was observed that most of 
subjects were feeling discomfort during such long time blood occlusion over the 
brachial artery. Alternatively, the endothelial layer can be stimulated by injecting some 
pharmacological substances such as Nitroglycerin. However, the injection requires 
subject's agreement and an authorized person (e.g. medical doctor, nurse) as well as 
ethical agreement from a medical Centre.  
 In this research, the ultrasound imaging was used during data collection in order 
to capture the Endothelial activity before (baseline) and after applying the FMD 
stimulus (after cuff release). Ultrasound images were then analyzed offline using an 
automatic edge-detection software. However, there is a possibility of measuring the 
brachial diameter during the FMD test in case of using a modern ultrasound system 
accompanied by an edge detection software. In this regard, an ultrasound device should 
be connected to a computer in which the software is installed in. Such configuration and 
system setup should be done by an experienced FMD operator (sonographer). A 
synchronous measurement of the brachial diameter can guarantee a right assessment to 
the endothelial activity as well as reducing analysis time. 
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APPENDIX B 
CONCENT FORM 
1) English Version 
I ______________________________________________ (patients’ name), bearing a 
postal address at _____________________________________________________ 
have agreed to take part in the study: 
“Noninvasive technique for Endothelial dysfunction assessment using a radial 
PPG-CAP modeling in healthy and non-healthy subjects” 
The nature and purpose of the study has been explained to me in detail by 
Dr./Mr./Ms._______________ who is carrying out the study. I was able to ask him/her 
questions regarding all aspects of the study. In addition, he/she had given me a copy of 
the participant information leaflet. 
My identity will not be disclosed and I can withdraw from the study at any time, and it 
will not affect my treatment. 
 
Signature of patient: 
I/C No: 
Date: 
 
 
Signature of doctor: Name: 
Date: I/CNo: 
 
  
Signature of witness: Name: 
Date: I/CNo: 
2) Malay Version 
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1) Malay Version 
Saya, ____________________________________________ (namapesakit), yang 
beralamatdi ________________________________________________________ 
telahbersetujuuntukmengambilbahagiandalampenyelidikan yang bertajuk: 
“Tekniksecaratidakinvasifuntukpenilaiandisfungsiendotelialdenganmenggunaka
npemodelan PPG-CAP radial bagisubjekdalamkeadaan yang sihatdantidaksihat” 
Sayatelahdiberipenjelasansepenuhnyaolen Dr._________________________ 
mengenaikeadaandantujuannya. 
Sayadibenarkanuntukbertanyabeliaumengenaisemuaaspekpenyelidikanitu. Beliau juga 
telahmemberisayasatusalinankertasmaklumatuntukpesakit. 
Identitisayaakandirahsiakandansayaberhakmenarikdiripadabila-bila masa, 
danianyatidakakanmempengaruhirawatansaya. 
 
Tandatanganpeserta: 
No.K.P: 
Tarikh: 
 
Tandatanganpegawaiperubatan: Nama penuh: 
Tarikh: No.K.P.: 
 
Tandatangansaksi: Nama penuh: 
Tarikh: No.K.P.: 
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APPENDIX C 
DATA COLLECTION FORM 
 
                                Subject 
Number 
                                Sampling 
Date/Time   
 
                                                                                   Session Number 
 
 
 
 
PERSONAL PROFILE 
 
Full Name 
 
 
 
 
Date of Birth 
 
 
Gender 
 
Nationality/Ethnicity  
 
Pre-pilot (FKAB)- FMD excluded 
 
 
 
Pilot 
 
 
Principal sampling (PPUKM) 
 
 
 
 
 
 
 
 
  
Age: 
 
Male 
 
 
Female 
 
  
 
Land line 
 
 
Cell Phone 
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Contact 
Number 
 
 
 
Weight (kg)  
  
Height (cm)  
  
Waist Diameter (cm)  
  
Body Temperature                                 ºC  
 
Occupation 
 
 
Kindly answer the following questions: 
 
1. Have you felt any pain across your chest? If so, when? How long it does normally 
takes? 
 
 
2. Do you attend the physical activities frequently? How often? 
 
 
3. Are you smoker? If so, for how long? 
 
4. Have you had any heart failure, cardiovascular abnormalities or diabetic in your 
first order   
family? (Father, Mother or Siblings) 
 
 
5. How long normally you sleep during a day?  
 
 
In order to get a reliable result, you must follow the protocol strictly which 
described to you earlier. Kindly tick the headline of the protocol (below) if 
you follow it otherwise please declares the violation. 
 
Email 
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        Fasted over night (at least 12h) 
 Avoid any physical exercise over last three days 
 Stop medications since three days ago 
 Do not be in menstruation cycle 
 Do not drink any beverage over night 
 
 
MEDICAL PROFILE 
 
Blood Pressure 
 
 
 
 
 
 
PATIENTS BASELINE DEMOGRAPHY & RISK FACTORS 
 
 
 Hypertension 
 Diabetic Mellitus 
 Dyslipidemia (LDL > 3.4    TC > 5.6) 
 Active Smoker (up to 1 month) 
 Positive family heredity for permanent heart disease   
 
 
NOTES TO OPERATOR 
 
Terms and conditions of sampling 
1. Vitamin supplementation and antioxidants are not allowed since three days before 
sampling 
Left Arm 
 
Systolic 
(mmHg) 
 
 
Diastolic 
(mmHg) 
 
 
Pulse 
(BPM) 
 
Right Arm 
 
Systolic 
(mmHg) 
 
 
Diastolic 
(mmHg) 
 
 
Pulse 
(BPM) 
 
Averaged 
 
Systolic (mmHg) 
 
 
Diastolic (mmHg) 
 
 
Pulse (BPM) 
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2. Medication is not allowed since three days before sampling 
3. Smoking (even smoke exposure) is not allowed since one day before sampling  
4. Not food and drink is allowed since 12 hours before sampling 
5. Female shouldn’t be in menstrual cycle 
6. No physical exercise is allowed since 12 hours before sampling 
 
  
TO OPERATOR … 
 
1. Have you strictly followed the protocol of sampling and FMD test? 
  
 
2. Have you seen any abnormality during the sampling? If so, please explain in details. 
 
 
 
Name                                                                                   Date & time 
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APPENDIX D 
MATLAB CODE 
 
% Reading Data 
 
clear all; clc 
Subject="Subject ID"; 
WD=cd; 
 
if Subject<10 
Data_Folder=['F:\vahid\PhD\Raw Data FMD-US at HUKM 2014\Renamed Data for 
Matlab Analysis\S00' int2str(Subject) '\Session 1'] 
Filename=['S00' int2str(Subject) ' Session1.txt'] 
 
elseif Subject<100 
Data_Folder=['F:\vahid\PhD\Raw Data FMD-US at HUKM 2014\Renamed Data for 
Matlab Analysis\S0' int2str(Subject) '\Session 1'] 
Filename=['S0' int2str(Subject) ' Session1.txt'] 
 
elseif Subject>=100 
Data_Folder=['F:\vahid\PhD\Raw Data FMD-US at HUKM 2014\Renamed Data for 
Matlab Analysis\S' int2str(Subject) '\Session 1'] 
Filename=['S' int2str(Subject) ' Session1.txt'] 
end 
 
cd(Data_Folder) 
signal=load(Filename);  
cd(WD) 
RawCBP=detrend(signal(:,1)); % Derived CBP 
RawRPressure=detrend(signal(:,2)); % Radial Pressure 
RawRPPG=detrend(signal(:,3)); % Radial PPG 
RawFPPG=detrend(signal(:,4)); % Finger PPG 
 
 
SF=(max(RawRPressure)-min(RawRPressure))/(max(RawRPPG)-min(RawRPPG));    
RawRPPG=RawRPPG*SF;  
N=length(RawRPPG);  
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CBP_BL=detrend(RawCBP(1:t_BL*Fs)); 
RPressure_BL=detrend(RawRPressure(1:t_BL*Fs)); 
RPPG_BL=detrend(RawRPPG(1:t_BL*Fs)); 
FPPG_BL=detrend(RawFPPG(1:t_BL*Fs));  
 
% Find&Cancel delay 
 
S1=RPPG_BL;S2=CBP_BL; 
C=xcorr(S1,S2); 
[Value Idx] =max(C); 
Delay_Signals_Baseline=length(S1)-Idx; 
 
if Delay_Signals_Baseline> 0 
S2=S2(1+Delay_Signals_Baseline:end); 
S1=S1(1:end-Delay_Signals_Baseline); 
 
else 
S1=S1(1-Delay_Signals_Baseline:end); 
S2=S2(1:end+Delay_Signals_Baseline); 
end 
 
CBP_BL=S2; 
RPPG_BL=S1; 
 
LPF=VS_2_LPF1;B=LPF.Numerator; 
 
CBP_BL=filter(B,1,CBP_BL); % Filtered CBP 
RPressure_BL=filter(B,1,RPressure_BL); % Filtered Radial pressure 
RPPG_BL=filter(B,1,RPPG_BL); % Filtered radial PPG 
FPPG_BL=filter(B,1,FPPG_BL); % Filtered finger PPG 
 
 
CBP_BL=detrend(resample(CBP_BL,100,Fs)); 
RPressure_BL=detrend(resample(RPressure_BL,100,Fs)); 
RPPG_BL=detrend(resample(RPPG_BL,100,Fs)); 
FPPG_BL=detrend(resample(FPPG_BL,100,Fs)); 
 
% Definition of Input/Output and Segmentation 
 
IN=CBP_BL;OUT=RPPG_BL; 
 
disp('Calculating Baseline Fitness Values...') 
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seg=3; fs=100; 
num_seg=floor(length(CBP_BL)/(seg*fs)); 
segments_IN=zeros(2*fs,num_seg); 
segments_OUT=zeros(2*fs,num_seg); 
 
SEGMENTS_IN_BL=cell(num_seg,1); 
SEGMENTS_OUT_BL=cell(num_seg,1); 
 
Fitness_idv=[];Fitness_avr=[];index=[];SF2=[];SF3=[]; 
fit=[];Coeff_A_BL=[];Coeff_B_BL=[];Just_Fitness=[]; 
 
for i=1:num_seg; 
start=(i-1)*fs+1; 
stop=start+(seg*fs)-1; 
segments_IN(:,i)=detrend(IN(start:stop)); 
segments_OUT(:,i)=detrend(OUT(start:stop)); 
SF2=[SF2 ; max(segments_IN(:,i))]; 
SF3=[SF3 ; max(segments_OUT(:,i))]; 
 
segments_IN(:,i)=(segments_IN(:,i))/max(segments_IN(:,i)); 
segments_OUT(:,i)=(segments_OUT(:,i))/max(segments_OUT(:,i)); 
 
S1=segments_IN(:,i);S2=segments_OUT(:,i); 
 
Find_Delay;Cancel_Delay; 
 
SEGMENTS_IN_BL{i,1}=S1; 
SEGMENTS_OUT_BL{i,1}=S2;  
 
% Creation of time-series data in Baseline 
 
DATA=iddata(SEGMENTS_OUT_BL{i,1},SEGMENTS_IN_BL{i,1},1/fs); 
opt=arxOptions('focus','stability'); 
Model_each_Seg=arx(DATA,[4 4 0],opt); 
[y_idv, fit_idv, x0_idv] = compare(DATA,Model_each_Seg); 
Fitness_idv(i,1)=[fit_idv]; 
 
% Obtain model coefficients 
 
[Coeff_A_BL(i,:),Coeff_B_BL(i,:)] = polydata(Model_each_Seg); 
Fitness_idv(i,2)=Coeff_A_BL(i,1); 
Fitness_idv(i,3)=Coeff_A_BL(i,2); 
Fitness_idv(i,4)=Coeff_A_BL(i,3); 
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Fitness_idv(i,5)=Coeff_A_BL(i,4); 
Fitness_idv(i,6)=Coeff_A_BL(i,5); 
 
Fitness_idv(i,7)=Coeff_B_BL(i,1); 
Fitness_idv(i,8)=Coeff_B_BL(i,2); 
Fitness_idv(i,9)=Coeff_B_BL(i,3); 
Fitness_idv(i,10)=Coeff_B_BL(i,4); 
Just_Fitness(i,1)=Fitness_idv(i,1); 
 
Reference=70; 
index=find(Just_Fitness<Reference); 
end 
 
Fitness_idv(index,:)=[]; 
[row,column]=size(Fitness_idv); 
for i=1:row; 
Avr_A0=1; 
Avr_A1=sum(Fitness_idv(:,3))/row; 
Avr_A2=sum(Fitness_idv(:,4))/row; 
Avr_A3=sum(Fitness_idv(:,5))/row; 
Avr_A4=sum(Fitness_idv(:,6))/row; 
 
Avr_B1=sum(Fitness_idv(:,7))/row; 
Avr_B2=sum(Fitness_idv(:,8))/row; 
Avr_B3=sum(Fitness_idv(:,9))/row; 
Avr_B4=sum(Fitness_idv(:,10))/row; 
 
% Definition of an Averaged model in BaseLine(BL) 
 
A=[Avr_A0 Avr_A1 Avr_A2 Avr_A3 Avr_A4]; 
B=[Avr_B1 Avr_B2 Avr_B3 Avr_B4]; 
Model_Avr_BL=idpoly(A,B,[],[],[],0,1/fs); 
end 
 
% Apply the Averaged model to all segments 
 
for i=1:num_seg;  
%DATA=iddata(segments_OUT(:,i),segments_IN(:,i),1/fs); 
DATA=iddata(SEGMENTS_OUT_BL{i,1},SEGMENTS_IN_BL{i,1},1/fs); 
[y_avr, fit_avr(i,:), x0_avr] = compare(DATA,Model_Avr_BL); 
Fitness_avr_BL=[fit_avr]; 
end 
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%Data Analysis in Release: 
 
Number_Total_Segments_BL=num_seg; 
Reference; 
Number_Fitness_Below_Reference=length(index); 
Number_segments_above_Reference=(num_seg)-(length(index)); 
 
CBP_RLS=detrend(RawCBP((t_RLS*Fs):end)); 
RPressure_RLS=detrend(RawRPressure((t_RLS*Fs):end)); 
RPPG_RLS=detrend(RawRPPG((t_RLS*Fs):end)); 
FPPG_RLS=detrend(RawFPPG((t_RLS*Fs):end)); 
 
S1=RPPG_RLS;S2=CBP_RLS; 
C=xcorr(S1,S2); 
[Value Idx] =max(C); 
Delay_Signals_Release=length(S1)-Idx; 
 
if Delay_Signals_Release> 0 
S2=S2(1+Delay_Signals_Release:end); 
S1=S1(1:end-Delay_Signals_Release); 
 
else 
S1=S1(1-Delay_Signals_Release:end); 
S2=S2(1:end+Delay_Signals_Release); 
end 
 
RPPG_RLS=S1; CBP_RLS=S2;  
 
LPF=VS_2_LPF1;B=LPF.Numerator; 
 
CBP_RLS=filter(B,1,CBP_RLS); % Filtered CBP 
RPressure_RLS=filter(B,1,RPressure_RLS); % Filtered Radial pressure 
RPPG_RLS=filter(B,1,RPPG_RLS); % Filtered radial PPG 
FPPG_RLS=filter(B,1,FPPG_RLS); % Filtered finger PPG 
 
CBP_RLS=detrend(resample(CBP_RLS,100,Fs)); 
RPressure_RLS=detrend(resample(RPressure_RLS,100,Fs)); 
RPPG_RLS=detrend(resample(RPPG_RLS,100,Fs)); 
FPPG_RLS=detrend(resample(FPPG_RLS,100,Fs)); 
 
% Creation of time-series data in Release 
 
IN=CBP_RLS;OUT=RPPG_RLS; 
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disp('Calculating Release Phase Fitness Values...') 
Fitness=[]; 
Nb_Seg_IN=floor(length(IN)/(length_seg*fs)); 
IN_seg=zeros(2*fs,Nb_Seg_IN); 
OUT_seg=zeros(2*fs,Nb_Seg_IN); 
 
SEGMENTS_IN_RLS=cell(Nb_Seg_IN,1); 
SEGMENTS_OUT_RLS=cell(Nb_Seg_IN,1); 
 
Fitness_idv_RLS=[];Coeff_A_RLS=[];Coeff_B_RLS=[]; 
stop=0;  
 
for i=1:Nb_Seg_IN; 
start=stop+1;     
stop=start+(length_seg*fs)-1; 
IN_seg(:,i)=detrend(IN(start:stop)); 
OUT_seg(:,i)=detrend(OUT(start:stop)); 
 
IN_seg(:,i)=(IN_seg(:,i))/max(IN_seg(:,i)); 
OUT_seg(:,i)=(OUT_seg(:,i))/max(OUT_seg(:,i)); 
 
S1=IN_seg(:,i);S2=OUT_seg(:,i);  
Find_Delay;Cancel_Delay; 
SEGMENTS_IN_RLS{i,1}=S1; 
SEGMENTS_OUT_RLS{i,1}=S2;    
 
% Creation of time-series data in Release 
    
DATA_RLS=iddata(SEGMENTS_OUT_RLS{i,1},SEGMENTS_IN_RLS{i,1},1/fs); 
% Apply the averaged model (in BL) to all segments in RLS 
[y_RLS, fit_RLS(i,:), x0_RLS] = compare(DATA_RLS,Model_Avr_BL); 
Fitness_avr_RLS=[fit_RLS]; 
end 
 
% Computation of Mean Values 
 
[row1,column1]=size(Just_Fitness); 
Mean_Self_Fitness_BL=sum(Just_Fitness(:,1))/row1; 
 
[row2,column2]=size(Fitness_avr_BL); 
Mean_Fitness_avr_BL=sum(Fitness_avr_BL(:,1))/row2; 
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[row3,column3]=size(Fitness_avr_RLS); 
Mean_Fitness_avr_RLS=sum(Fitness_avr_RLS(:,1))/row3; 
 
frame=round((Nb_Seg_IN)/2); 
remainder = rem( frame,2); 
 
if  remainder==0; 
frame=(frame)+1; 
end 
 
frame=(frame)-10; 
Filtered_Fitness_avr_RLS = sgolayfilt(Fitness_avr_RLS,4,frame); 
frame_BL=round((num_seg)/2); 
remainder = rem( frame_BL,2); 
 
if  remainder==0; 
frame_BL=(frame_BL)+1; 
end 
 
frame_BL=(frame_BL)-10; 
Filtered_Fitness_avr_BL = sgolayfilt(Fitness_avr_BL,4,frame_BL); 
 
% window1; t=0:1min 
 
for i=1:30; 
window1(i,1)=Filtered_Fitness_avr_RLS(i,1); 
end 
 
[row4,column4]=size(window1); 
Mean_Fitness_avr_RLS_window1=sum(window1(:,1))/row4; 
 
y2_1=max(window1); 
y1_1=min(window1); 
x2_1 = find(window1 == y2_1); 
x1_1 = find(window1 == y1_1); 
slop1=((y2_1)-(y1_1))/((x2_1)-(x1_1)); 
Degree_slop1=atand(slop1); 
height1=(y2_1)-(y1_1); 
length1=(x2_1)-(x1_1); 
 
% window2; t=1:2min 
 
for i=30:60; 
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window2(i,1)=Filtered_Fitness_avr_RLS(i,1); 
end 
 
[row5,column5]=size(window2); 
Mean_Fitness_avr_RLS_window2=sum(window2(:,1))/row5; 
 
if (max(Mean_Fitness_avr_RLS_window2)-
min(Mean_Fitness_avr_RLS_window2))<10 
EP2_stability=1; 
else EP2_stability=0; 
end 
y2_2=max(window2); 
y1_2=min(window2); 
x2_2 = find(window2 == y2_2); 
x1_2 = find(window2 == y1_2); 
slop2=((y2_2)-(y1_2))/((x2_2)-(x1_2)); 
Degree_slop2=atand(slop2); 
height2=(y2_2)-(y1_2); 
length2=(x2_2)-(x1_2); 
 
% window3; t=2:3min 
 
for i=60:90; 
window3(i,1)=Filtered_Fitness_avr_RLS(i,1); 
end 
[row6,column6]=size(window3); 
Mean_Fitness_avr_RLS_window3=sum(window3(:,1))/row6; 
 
if  Mean_Fitness_avr_RLS_window2<Mean_Fitness_avr_RLS_window3   
EP3_mean=1; 
else EP3_mean=0; 
end 
 
if (max(Mean_Fitness_avr_RLS_window3)-
min(Mean_Fitness_avr_RLS_window3))<10 
EP3_stability=1; 
else EP3_stability=0; 
end 
 
% window4; t=3:4min 
 
for i=90:120; 
window4(i,1)=Filtered_Fitness_avr_RLS(i,1); 
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end 
 
[row7,column7]=size(window4); 
Mean_Fitness_avr_RLS_window4=sum(window4(:,1))/row7; 
 
if  Mean_Fitness_avr_RLS_window3<Mean_Fitness_avr_RLS_window4  
EP4_mean=1; 
else EP4_mean=0; 
end 
 
if (max(Mean_Fitness_avr_RLS_window4)-
min(Mean_Fitness_avr_RLS_window4))<10 
EP4_stability=1; 
else EP4_stability=0; 
end 
 
 
% window5; t=4:5min 
 
for i=120:Nb_Seg_IN; 
window5(i,1)=Filtered_Fitness_avr_RLS(i,1); 
end 
[row8,column8]=size(window5); 
Mean_Fitness_avr_RLS_window5=sum(window5(:,1))/row8; 
 
if  Mean_Fitness_avr_RLS_window4<Mean_Fitness_avr_RLS_window5  
EP5_mean=1; 
else EP5_mean=0; 
end 
 
if (max(Mean_Fitness_avr_RLS_window5)-
min(Mean_Fitness_avr_RLS_window5))<10 
EP5_stability=1; 
else EP5_stability=0; 
end 
 
% Plot results from Main program 
 
t1=[1:1:length(Fitness_avr_BL)]*length_seg; 
t2=[length(Fitness_avr_BL):length(Fitness_avr_BL)+length(Fitness_avr_RLS)-
1]*length_seg; 
t3=[1:1:length(Fitness_idv_RLS)]*length_seg; 
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figure, subplot(2,1,1);plot(t1-(t_BL),Fitness_avr_BL,'*-',t2-
(t_BL)+length_seg,Fitness_avr_RLS,'*-');grid on; 
title('Original Fitness Values (no filtered)','FontSize',12); 
subplot(2,1,2);plot(t1-(t_BL),Filtered_Fitness_avr_BL,'*-',t2-
(t_BL)+length_seg,Filtered_Fitness_avr_RLS,'*-');grid on; 
axis([-180 300 0 140]); 
line([-180 300],[100 100],'Color','black','LineWidth',1.5); 
title(['Subject = ', num2str(Subject), '          Model ARX [4 4 0];          Before & After 
Release (Filtered using sgolayfilt)'],'FontSize',12); 
legend('Averaged model (Baseline)','Averaged model (Release)',4); 
xlabel('Time (sec). Time = 0 corresponds to cuff release');ylabel('Fitness %') 
text(-180, 135,['Gender : ',num2str(Gender)],'FontSize',12); 
text(-140, 135,['Age : ',num2str(Age)],'FontSize',12); 
text(-110, 135,['Nationality : ',num2str(Nationality)],'FontSize',12); 
text(-40, 135,['Invited From : ',num2str(Invited_From)],'FontSize',12); 
text(58, 135,['Smoking : ',num2str(Smoking)],'FontSize',12); 
text(39, 106,['Family History : ',num2str(Family_History)],'FontSize',12); 
text(-180, 106,['HSCRP : ',num2str(HSCRP)],'FontSize',12); 
text(-140, 106,['Primary Diagnosis : ',num2str(Primary_Diagnosis)],'FontSize',12); 
text(-40, 106,['SBP/DBP/HR : ',num2str(SDHR)],'FontSize',12); 
text(110, 135,['Mean Fitness Averaged Model in BL = 
',num2str(round(Mean_Fitness_avr_BL)), ' %'],'FontSize',12); 
text(110, 120,['Mean Fitness Averaged Model in RLS = 
',num2str(round(Mean_Fitness_avr_RLS)), ' %'],'FontSize',12); 
text(110, 106,['Mean Fitness Averaged Model in window = 
',num2str(round(Mean_Fitness_avr_RLS_window1)), ' %'],'FontSize',12); 
text(230, 135,['Endothelial Reaction = ',num2str(EP)],'FontSize',12); 
 
% Export Data into the Excel File 
 
xlswrite('Endothelial Performance by Code.xls', EP1_mean, 1, ['A' 
num2str(Subject)]); 
xlswrite('Endothelial Performance by Code.xls', EP1_slope,1, ['B' num2str(Subject)]); 
xlswrite('Endothelial Performance by Code.xls', EP2_mean,1, ['C' num2str(Subject)]); 
xlswrite('Endothelial Performance by Code.xls', EP2_slope,1, ['D' num2str(Subject)]); 
xlswrite('Endothelial Performance by Code.xls', EP2_stability,1, ['E' 
num2str(Subject)]); 
xlswrite('Endothelial Performance by Code.xls', EP3_mean,1, ['F' num2str(Subject)]); 
xlswrite('Endothelial Performance by Code.xls', EP3_slope,1, ['G' num2str(Subject)]); 
xlswrite('Endothelial Performance by Code.xls', EP3_stability,1, ['H' 
num2str(Subject)]); 
xlswrite('Endothelial Performance by Code.xls', EP4_mean,1, ['I' num2str(Subject)]); 
xlswrite('Endothelial Performance by Code.xls', EP4_slope,1, ['J' num2str(Subject)]); 
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xlswrite('Endothelial Performance by Code.xls', EP4_stability,1, ['K' 
num2str(Subject)]); 
xlswrite('Endothelial Performance by Code.xls', EP5_mean,1, ['L' num2str(Subject)]); 
xlswrite('Endothelial Performance by Code.xls', EP5_slope,1, ['M' num2str(Subject)]); 
xlswrite('Endothelial Performance by Code.xls', EP5_stability,1, ['N' 
num2str(Subject)]); 
xlswrite('Endothelial Performance by Code.xls', EP,1, ['P' num2str(Subject)]);
172 
 
APPENDIX E 
LIST OF PUBLICATIONS 
 
International Conferences 
1. Vahid Sohani, Edmond Zahedi, KalaivaniChellappan and MohdAlauddinMohd 
Ali. “A Review of Commercially Available Non-Invasive Vascular Screening 
Technologies for Clinical Applications”, IEEE conference, 2012, Langkawi, 
Malaysia. 
 
2. Vahid Sohani, Edmond Zahedi, M. A. Mohd. Ali, GanKokBeng, 
KalaivaniChellappan, "A Dynamic Model between Central Aortic Pressure and 
Radial Photoplethysmogram: Experimental Proof of Concept", IEEE 
conference, 2014, KLCC, Malaysia. 
Journals 
3. Edmond Zahedi, Vahid Sohani, M. A. Mohd. Ali, KalaivaniChellappan, 
GanKokBeng: “Experimental Feasibility Study of Estimation of the Normalized 
Central Blood Pressure Waveform from Radial Photoplethysmogram”, Journal 
of Healthcare Engineering, Vol. 6, No. 1, 2015, Pages 121-144. 
 
4. Shahab Rooznow, Vahid Sohani, "Integrate Band-pass Filter Design for 
13.56MHz RFID Reader", Journal of Applied Sciences Research,Vol. 8(2), 
2012, Pages. 1018-1025. 
 
Symposium 
5. Vahid Sohani, Edmond Zahedi, M. A. Mohd. Ali, Axel Hunger, GanKokBeng, 
KalaivaniChellappan: "Estimation of the central blood pressure waveform from 
the radial photoplethysmogram", 1st YRA MedTech Symposium, April 2015, 
Duisburg, Germany. 
 
 
 
 
 
173 
 
 
APPENDIX F 
DEFINITION of BASIC STATISTICAL PARAMETERS 
a) Objective of Statistics 
The main objective of doing statistical analysis in clinical research is to investigate the 
suitability of a proposed technique to be clinically used. To this end, a proposed 
technique should be evaluated by enlarging the sample size while including different 
groups of subjects (e.g. male and females, old and young, etc.). Therefore, outcome of 
the statistical analysis should provide some information about suitability of a proposed 
approach among specific groups. 
b) Basic Statistical Parameters 
Population (N): Population refers to all (available) subjects in a clinical research. In 
other words, population equals to total number of participants including male, female, 
healthy, non-healthy, young, old and etc. 
 Sample (n): A sample can be considered as a subset of population which 
contains specific subjects of whole population. Criteria of such selection depend on 
research objectives. For instance, if a clinical research aims to find out the possibility 
of a technique among non-healthy people then male patients may consider as a specific 
group of study. 
 Median: Median is a statistical parameter used for indicating lower and higher 
half of a data. The median is normally obtained by sorting all observations (values of 
data) from smallest to largest and then selecting a middle value. So that the so-called 
low half of data can be distinguished from high half of data. 
 Mean ( x ): In statistics, mean is used for representing the central tendency of a 
set of data. Using the following equation, a mean can be obtained by averaging among 
all values: 
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(3.4) 
where n is a number of data and  xi is a set of data. 
 Variance: Variance can be considered as a statistical index to show how close 
(far) a set of numbers are from each other. In fact, it is a measure of the spread of the 
values in a distribution. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX G 
DETAILS OF THE CARDIOVASCULAR SUITE PROGRAM 
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Window 1: This window shows the brachial artery and its surrounding tissue. The red 
color shows the artery at the time of systole in which blood is rushed in to the brachial 
artery. In addition, the ECG signal can be seen at the bottom of this window (the green 
signal). Some basic information about subject (e.g. name, ID) and place of data 
collection can be also found at the top of this window.  
 Window 2: This window can be known as a control panel. In fact, the basic 
parameters of measurement (e.g. calibration, region of interest) should be initially 
determined here. Figure 3.15 shows this window.  
 
Figure 3.15 The control panel of the cardiovascular suite program 
 The "CALIB" refers to the calibration. In fact, it provides the program some 
basic information about the size of the image obtained by ultrasound system. This 
parameter should be determined before starting a new examination. In order to setup 
Window 1 Window 2 
Window 3 
Window 4 
Window 5 
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the calibration, the CALIB button should be pressed and then, a known distance be 
determined across the ultrasound image (i.e. in front of the scaling part of the ultrasound 
image (left side of the window 1)). It can be done by clicking on one end and drag the 
mouse to the other extreme. The scaling can be saved by selecting the appropriate value 
from the drop-down menu which is in front of the CALIB button. 
 The "ROI" is the abbreviation of "region of interest" which indicates that part of 
the brachial artery that needs to be measured by the program. Such a measurement is 
done pixel by pixel. In order to run this application, the button of ROI should be 
activated so that the region of interest can be determined by dragging the mouse across 
the brachial artery. This region plays an important role on accuracy of the measurement. 
Hence, special attention should be paid to determine this region. There is a numerical 
range in front of the ROI button which indicates the size (width and height) of the ROI 
in millimeter. Such a range is measured as 8.695 - 5.072 in Figure 3.15.  Figure 3.16 
shows a close view of the ROI box across the brachial artery. As can be seen, the length 
of window is well located alongside the brachial artery.  
 
Figure 3.16 Graphical determination of ROI across the brachial artery  
 The "ELAB" refers to the word enable. The measurement can be done once this 
button is pressed. There are two parameters in front of this button; SRTAP and SRTAN 
which are related to the Doppler analysis. Since this analysis was not used in this 
research, these parameters are considered zero.   
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 In order to be able to record the measurement and its parameters, the button of 
REC must be pressed. The "REC" refers to the record which activates the process of 
recording. There is a value in front of this button which represents the current diameter 
of the brachial artery. As can be seen in Figure 4.20 this value is 3.023. 
 The last button in control panel is the "RESET" which is an action for deleting 
the values of brachial diameter which is already measured. This option is used in case 
of wrong determination of region of interest. A number in front of this option indicates 
the time (e.g. 00:27 in Figure 4.20). 
 Window 3: This window plots values of brachial diameter over the time. In other 
words, this curve is a graphical representation of diameter changes from the beginning 
till present. The dimension of the brachial diameter and time are millimeter and second 
respectively. The curve in window 3 of the Figure 4.20 shows vascular dilatation caused 
by the FMD stimulus.   
 Window 4: The cardiovascular suite program has an option to trace (measure) 
the brachial diameter while data is obtaining from an ultrasound machine. In other 
words, it provides a way of a real-time measurement during the test. Window 4 shows 
the instantaneous diameter chart. This chart can feedback sonographer to ensure that the 
setup (e.g. subject's arm, ultrasound probe, etc.) remains fix during data collection.  
 Window 5: This window shows a curve which is used for the Doppler analysis. 
In this research, the Doppler analysis was not used so that this window is deactivated. 
Once the measurement is done, result box is appeared. 
